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ABSTRACT

The incorporation of nonviral vectors into biomaterial matrices has been
employed to improve localization at the implant site and to protect from loss by clearance
or extracellular barriers. However, several limitations such as detrimental crosslinking
mechanisms, uncontrolled burst release require improved design of matrix-based gene
delivery systems that provides sustained and controlled vector release as well as
overcomes extracellular barriers to gene transfer in proximity to target cells. The longterm objective of this dissertation project is to provide the basis for the eventual creation
of tissue engineering scaffolds that combine structural and biological activity through the
creation of composite materials consisting of polymeric fibers with hydrogel coatings
encapsulating nonviral vectors for localized gene delivery. The primary focus of this
dissertation was to develop hydrogels with suitable physical/chemical properties for the
localized, sustained gene delivery application; including variable degradation rate for
controlled release, mild crosslinking conditions compatible with vector encapsulation,
and minimal swelling after crosslinking to maintain stability as a fiber coating. The
hypothesis was that vector release from hydrogel coatings in intimate proximity with
adherent cells will overcome extracellular barriers to gene transfer and increase
transfection efficiency relative to conventional bolus delivery methods.
In order to concentrate nonviral vectors for efficient hydrogel loading, several
approaches to vector lyophilization were investigated. The inclusion of 10% sucrose as a
cryoprotectant was shown to preserve DNA structural integrity and biological activity. In
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addition, incubation of nonviral vectors with sodium tripolyphosphate was shown to
effectively release DNA from nonviral gene complexes, which provides a basis for
accurate measurement of vector/DNA release. To develop polymer-based gene
encapsulation system for gene delivery, hydrolytically degradable hydrogels with various
degradation-kinetics were developed and characterized. First, linear poly(ethylene
glycol)(PEG) polymers were modified with ester bonds of varying susceptibility to
hydrolytic degradation and crosslinkable acrylate groups. Hydrogels were prepared by
photopolymerization and shown to variable degradation rates and controlled release of a
model macromolecule. Secondly, hydrogels crosslinked by Michael-type addition from
various acrylate-terminated four-armed amphiphilic poloxamine (Tetronic®) were
evaluated. It was shown that the physical properties of these gels are attributable to both
temperature-dependent noncovalent interactions and covalent crosslinking. Hydrogels
prepared from Tetronic T904 did not experience significant swelling after crosslinking
and were shown to form stable coatings on polymer fibers. Finally, lyophilized nonviralgene complexes were incorporated within T904-based hydrogels. DNA integrity and
sustained release was observed although the kinetics was not considered optimal due to
delayed release. Preliminary transfection experiments using an in vitro model with
serum-containing medium demonstrated that released vectors could transfect surrounding
cells, although the efficiency of transfection was limited and further improvements to the
gene delivery system are required.

iii

DEDICATION

To my mom, Kyong Ae Kim with love and in great respect

iv

ACKNOWLEDGMENTS

It has been a joyful journey in Clemson. Since I joined Dr. Webb’s lab, I have
shared the sweet and bittersweet times with my dear lab mates, Rebecca Cribb, Kedar
Datar, Jay Kutty, and Sagar Joshi. I was warmly welcomed by them and made to feel at
home in a new, strange environment. It is a pleasure to thank them, as they helped me in
the pursuit of my dissertation research and to ultimately finish my studies.
My graduate studies would not have been the same without priceless friendships.
I am particularly thankful to my friends Cheryl Gomillion, Aditee Kurane, Chartrisa
Simpson (LaShan) and Mary Tedder (Betsy). We not only studied, relaxed and shared the
good and bad times all together, but they were also willing to help me at anytime when I
had a hard time. I cannot express my gratitude enough, for a long-standing four-year
friendship, to my dear friends Sharmi Martin and Adrian Bersabe. Their friendship and
hospitality have supported and entertained me over the many years of our friendship.
They have consistently helped me maintain balance between my work and personal life. I
must acknowledge as well, the many friends, colleagues, students and professors, who
assisted, advised, and supported my research and writing efforts over the years. Carla
Cioffi, Cassie Gregory, Gyo-Young Park, Azi Samadi, Rodolfo Valdes, Roeun Eang,
Estefania Alvarez, Sandra Deitch (Sandy), Adam Kirn, Rohan Kumar, Gary Thompson,
Victor Maximov, Brittany McGowan, Cheryl Parzel, … I was lucky to have them and
will remember them forever. I am grateful to the many people who shared their memories
and experiences.

v

It would have been so difficult to finish the Bioengineering Ph.D. program
without my best friend, Yong-Ung Lee. Since we advanced our friendship for more than
10 years, he has always stood on my side, listening to of all my complaints and stressful
situations. I am very happy with the fact that he finally found the right woman to marry.
I would like to express the deepest appreciation to my committee members, Karen
Burg, Andrew Metters and Naren Vyavahare, who have generously given their time and
expertise to better my work. I thank them for their contribution and their good-natured
support.
My great thanks and appreciation are extended to Jeoung Soo Lee for serving as a
mentor throughout the time it took me to complete this research. I need to emphasize that
I have learned such great, advanced research knowledge from her. Being trained by her
was one of the most important and formative experiences in my life.
Finally, this dissertation would not have been possible without the thoughtful
advice and the expert guidance of my esteemed advisor, Dr. Ken Webb. He always
inspired me to greater efforts, to pursue new ideas and creativeness, as well as
encouraged me to overcome the frustrations of this time. I have learned enormous things
to become a better scientist from him during my Ph.D. studies. Of course, my gratitude
can hardly repay his help, not only with multiple revisions of this dissertation, but also
with many rational suggestions to improve my sentences and clarify my arguments.
I will remember all of the people here in Clemson and miss them so much.

vi

TABLE OF CONTENTS

Page
TITLE PAGE .................................................................................................................... i
ABSTRACT..................................................................................................................... ii
DEDICATION ................................................................................................................ iv
ACKNOWLEDGMENTS ............................................................................................... v
LIST OF TABLES ......................................................................................................... xii
LIST OF FIGURES ......................................................................................................xiii
CHAPTER
I.

INTRODUCTION ......................................................................................... 1

II.

GENE THERAPY: APPROACHES AND CHALLENGES ........................ 8
2.1. Introduction ....................................................................................... 8
2.1.1. General concept of gene therapy/delivery ..................................... 8
2.1.2. Vector-assisted delivery systems ................................................... 9
2.1.2.1. Viral vectors ................................................................................ 9
2.1.2.2. Nonviral vectors ........................................................................ 12
2.1.3. Barriers to gene delivery .............................................................. 16
2.1.3.1. Barriers to viral gene delivery................................................... 19
2.1.3.2. Barriers to nonviral gene delivery............................................. 19
2.1.4. Systemic gene delivery ................................................................ 21
2.1.5. Local gene delivery ...................................................................... 23
2.1.5.1. Ex vivo gene therapy ................................................................. 23
2.1.5.2. In vivo gene therapy .................................................................. 23
2.1.6. Current problems of nonviral-mediated local gene delivery ....... 24
2.1.6.1. Cellular responses ..................................................................... 24
2.1.6.2. Environmental interactions ....................................................... 25
2.2. Conclusions ..................................................................................... 26

III.

BIOMATERIAL MATRICES FOR LOCALIZED GENE DELIVERY .... 28
3.1. Introduction ..................................................................................... 28
3.1.1. Vector encapsulation systems ...................................................... 29

vii

Table of Contents (Continued)
Page
3.1.1.1. Natural polymer hydrogels ....................................................... 30
3.1.1.2. Synthetic polymer hydrogels .................................................... 35
3.1.1.3. Scaffolds ................................................................................... 39
3.1.2. Substrate-mediate delivery........................................................... 41
3.2. Conclusions ..................................................................................... 44
IV.

METHODS FOR GENE COMPLEX STABILIZATION DURING
LYOPHILIZATION AND pDNA QUANTITATION.......................... 49
Abstract .................................................................................................. 49
4.1. Introduction ..................................................................................... 50
4.2. Materials and Methods .................................................................... 53
4.2.1. Materials ...................................................................................... 53
4.2.2. Transformation of plasmid into chemically competent E. coli and
DNA purification ................................................................................... 54
4.2.3. Optimization of conventional transfection................................... 55
4.2.4. Effect of various cryoprotectants on the in vitro transfection
efficiency................................................................................................ 56
4.2.5. Gel retardation assay .................................................................... 57
4.2.6. Decomplexation of gene complex ............................................... 57
4.2.7. PicoGreen quantification of DNA ............................................... 58
4.2.8. Reverse transfection in the presence of serum ............................. 58
4.2.9. Statistical analysis ........................................................................ 59
4.3. Results ............................................................................................. 59
4.3.1. Optimization of transfection condition ........................................ 59
4.3.2. Decomplexation of gene complex ............................................... 64
4.3.3. Reverse transfection ..................................................................... 68
4.4. Discussions ..................................................................................... 70
4.5. Conclusions ..................................................................................... 74

V.

A NOVEL SYNTHETIC ROUTE FOR THE PREPARATION OF
HYDROLYTICALLY DEGRADABLE SYNTHETIC
HYDROGELS ....................................................................................... 75
Abstract .................................................................................................. 75
5.1. Introduction ..................................................................................... 76
5.2. Materials and Methods .................................................................... 78
5.2.1. Materials ...................................................................................... 78
5.2.2. Synthesis of photopolymerizable, degradable, and crosslinkable
PEG macromers ..................................................................................... 80

viii

Table of Contents (Continued)
Page
5.2.2.1. Preparation of PEG-bis-(chloroacetate),
PEG-bis-(2-chloropropanoate), and PEG-bis-(4-chlorobutyrate) .......... 81
5.2.2.2. Preparation of PEG-bis-(acryloyloxy acetate)[PEG-bis- AA],
PEG-bis-(acryloyloxy propanoate) [PEG-bis-AP], and PEG-bis(acryloyloxy butyrate)[PEG-bis-AB]..................................................... 82
5.2.3. Hydrogel preparation ................................................................... 82
5.2.4. Degree of gelation and swelling behavior ................................... 83
5.2.5. Hydrogel degradation................................................................... 83
5.2.6. Cytocompatibility ........................................................................ 84
5.2.7. Controlled release of IgG ............................................................. 84
5.2.8. Hydrogel coating .......................................................................... 85
5.2.9. Plasma surface modification ........................................................ 85
5.2.10. Statistical analysis ...................................................................... 86
5.3. Results ............................................................................................. 86
5.3.1. Synthesis of degradable, crosslinkable PEG-based macromers .. 86
5.3.1.1. Preparation of PEG-bis-(chloroacetate), PEG-bis-(2chloropropanoate), and PEG-bis-(4-chlorobutyrate) ............................. 86
5.3.1.2. Preparation of PEG-bis-(acryloyloxy acetate)[PEG-bis- AA],
PEG-bis-(acryloyloxy propanoate) [PEG-bis-AP], and PEG-bis(acryloyloxy butyrate)[PEG-bis-AB]..................................................... 89
5.3.2. Gel content and swelling behavior ............................................... 91
5.3.3. Hydrogel degradation................................................................... 92
5.3.3.1. Influence of macromer concentration on degradation .............. 93
5.3.3.2. Influence of macromer chemical composition on degradation . 93
5.3.4. Cytocompatibility ........................................................................ 94
5.3.5. Controlled release of IgG ............................................................. 95
5.3.6. Stability of hydrogel coating on the CCP fiber............................ 96
5.4. Discussions ..................................................................................... 97
5.5. Conclusions ................................................................................... 102
VI.

PHYSICAL AND CHEMICAL PROPERTIES OF TETRONIC®-BASED
HYDROGELS ..................................................................................... 104
Abstract ................................................................................................ 104
6.1. Introduction ................................................................................... 105
6.2. Materials and Methods .................................................................. 108
6.2.1. Materials .................................................................................... 109
6.2.2. Acrylation of Tetronic® ............................................................ 109
6.2.2.1. Preparation of acrylated T1107 (Acryl-T1107) ...................... 109
6.2.2.2. Preparation of acrylated T904 (Acryl-T904) .......................... 110

ix

Table of Contents (Continued)
Page
6.2.3. Gelation analysis ........................................................................ 111
6.2.3.1. Reverse thermal gelation......................................................... 112
6.2.3.2. Covalent crosslinking.............................................................. 112
6.2.4. Degree of gelation and swelling behavior ................................. 113
6.2.5. Hydrogel degradation................................................................. 114
6.2.6. Cytotoxicity................................................................................ 114
6.2.7. Hydrogel coating ........................................................................ 115
6.2.8. Plasma surface modification ...................................................... 116
6.2.9. Characterization of hydrogel coating ......................................... 116
6.2.9.1. Quantification of hydrogel coating ......................................... 116
6.2.9.2. Visualization of hydrogel stability on the CCP fibers ............ 117
6.2.10. Statistical analysis .................................................................... 117
6.3. Results ........................................................................................... 118
6.3.1. Tetronic® acrylation .................................................................. 118
6.3.2. Reverse thermal gelation............................................................ 119
6.3.3. Chemical gelation via Michael-type addition ............................ 122
6.3.4. Degree of gelation and swelling behavior ................................. 122
6.3.5. Hydrogel degradation................................................................. 125
6.3.6. Cytotoxicity................................................................................ 127
6.3.7. Hydrogel coating characterization ............................................. 129
6.4. Discussions ................................................................................... 133
6.5. Conclusions ................................................................................... 139
VII.

PRELIMINARY STUDIES ON GENE DELIVERY FROM TETRONIC®BASED HYDROGELS ....................................................................... 141
Abstract ................................................................................................ 141
7.1. Introduction ................................................................................... 143
7.2. Materials and Methods .................................................................. 144
7.2.1. Gene complex incorporation with hydrogels ............................. 144
7.2.2. The effect of hydrogel degradation products on PicoGreen
assay ..................................................................................................... 145
7.2.3. Interaction of hydrogel degradation product with released
DNA ..................................................................................................... 146
7.2.4. Determination of plasmid DNA incorporation efficiency ......... 146
7.2.5. In vitro release of plasmid DNA ................................................ 147
7.2.6. Modification of hydrogels with adhesive ligands ...................... 147
7.2.7. Cell transfection through hydrogel compositions ...................... 148
7.2.8. Statistical analysis ...................................................................... 149
7.3. Results ........................................................................................... 149

x

Table of Contents (Continued)
Page
7.3.1. The effect of hydrogel components on the DNA stability ......... 149
7.3.2. The effect of the hydrogel degradation products on PicoGreen
assay ..................................................................................................... 152
7.3.3. Interaction of hydrogel degradation product with released
DNA ..................................................................................................... 154
7.3.4. Plasmid DNA incorporation efficiency ..................................... 154
7.3.5. In vitro release of plasmid DNA ................................................ 156
7.3.6. Modification of hydrogels with adhesive ligands ...................... 158
7.3.7. Cell transfection through hydrogel compositions ...................... 159
7.4. Discussions ................................................................................... 163
7.5. Conclusions ................................................................................... 169
VIII.

CONCLUSIONS AND RECOMMENDATIONS .................................... 171
8.1. Conclusions ................................................................................... 171
8.2. Recommendations ......................................................................... 175

APPENDICES ............................................................................................................. 180
A:
B:
C:
D:
E:

N/P ratio calculation .................................................................................. 181
Calculation of depth and width of the CCP fiber....................................... 183
Mechanical properties of photocrosslinked, linear PEG-based hydrogels 184
Mechanical properties of Tetronic®-based hydrogels ............................... 186
Reversible swelling behavior of Tetronic®-based hydrogels .................... 191

REFERENCES ............................................................................................................ 193

xi

LIST OF TABLES

Table

Page

3.1

Collagen GAMs applications ....................................................................... 32

4.1

Glass transition and crystal melt temperatures for DMRIE-C-DNA complexes
lyophilized with various additives ............................................................... 53

5.1

Gel content and equilibrium water content .................................................. 92

6.1

Structural properties and CMC at pH7.4 and 25°C ................................... 108

6.2

Tetronic® 1107 CMC values at four different pHs and 23°C±0.5°C........ 108

6.3

The formula for preparing Tetronic®-based hydrogel crosslinked via Michaeltype addition............................................................................................... 113

6.4

Rheological properties of various acrylated Tetronic®-based hydrogels .. 121

6.5

Gel content of various acrylated Tetronic®-based hydrogels ................... 122

6.6

Width of the groove in the dry state........................................................... 130

6.7

Depth of the groove in the dry state ........................................................... 130

6.8

Structural properties of different Tetronic® derivatives ........................... 135

C-1

Tensile properties of hydrogels polymerized from solutions containing
varying concentrations of PEG-bis-AA macromers .................................. 184

C-2

Tensile properties of 10% w/v PEG-bis-acrylate hydrogels with varying
chemical composition ................................................................................ 184

xii

LIST OF FIGURES

Figure

Page

1.1

Hypothesis; nonviral gene transfer from degradable hydrogel coating with
various degradation rate on CCP fiber and transfection of targeting cells in the
direct contact with the topographical support of hydrogel and CCP fiber .... 4

1.2

Diagram of research outline in the dissertation ............................................. 5

2.1

Schematic generalized representation of delivery of a DNA-based therapeutic
using a viral or nonviral DNA delivery vector: (1) complexation and/or
entrapment of DNA-based therapeutic with DNA delivery vector; (2)
interaction of DNA-based therapeutic-vector complex with cell membrane; (3)
cellular internalization via receptor- or non-receptor-mediated endocytotic
pathways; (4) endosomal breakdown; (5) cytoplasmic release of DNA-based
therapeutic-vector complex or DNA-based therapeutic alone (Cytoplasm is the
site of action for antisense oligonucleotides, aptamer, ribozymes, DNAzymes,
and cytoplasmic plasmid DNA expression systems); (6) dissociation of DNAbased therapeutic from vector; (7) nuclear translocation of viral vectors or
DNA-based therapeutics. (Nucleus is the site of action for transgenes in
plasmids for gene therapy, siRNA generating plasmids, and antigene
oligonucleotides.) ......................................................................................... 18

3.1

Photograph of agarose gel electrophoresis showing conformations of plasmid
DNA released from dimethacrylated poly(lactic acid)-b-poly(ethylene glycol)b-poly(lactic acid) (PEG-PLA-DM) with 8.5 LA/PLA block hydrogels in the
absence of protective additives. First lane is non-encapsulated DNA in a
solution of degraded polymer, second lane is the released, encapsulated DNA
................................................................................................................ 36

3.2

Representative release profiles for cumulative release of DNA complexes
from HA-PEG gels. Release studies performed in the presence of PBS (a) or
150U/ml HAase (b). The percentages of PEG and HA in the hydrogel are;
PEG6:HA1(■), and PEG8:HA1(▲) for mechanically stable gels and
PEG2:HA1 (□), PEG4:HA2(○), and PEG4:HA4 (∆) for fully degradable gels
................................................................................................................ 38

xiii

List of Figures (Continued)
Figure

Page

3.3

In vitro DNA release kinetics and agarose gel electrophoresis. (A) Cumulative
DNA release from scaffolds loaded with 200, 400, or 800µg of plasmid (n=4
per dose) (B) Image of an agarose gel containing DNA released from a
scaffold at different times. Lane 1: molecular weight marker, Lane 2:
unincorporated plasmid, Lane 3-7: DNA released at days 1, 3, 7, 14 and 21,
respectively .................................................................................................. 41

3.4

Schematically generalized representation of biomaterial matrices for localized
gene delivery of a DNA-based therapeutic using a nonviral DNA delivery
vector: (a) Vector encapsulation systems and (b) Substrate-mediated delivery
...........................................................................................................46-47

4.1

Comparison of transfection efficiency of PEI-pGFP complexes at various N/P
ratios; freshly prepared complex (= FC), lyophilized complex with 5% w/v
glucose (= LC, 5% glucose), lyophilized complex with 10% w/v sucrose (=
LC, 10% sucrose), p<0.05, letters represent the significant difference between
groups ........................................................................................................... 60

4.2

Transfection efficiency of XG-based complexes with various preparation
conditions; freshly prepared XG-pGFP complex (= FC XG), lyophilized XGpGFP complex with 3.5mg glucose (= LC XG, 3.5mg glucose), LC XG with
5% w/v glucose (10mg) (= LC XG, 5% glucose), LC XG with 7mg sucrose (=
LC XG, 7mg sucrose), and LC XG with 10% w/v sucrose (20mg) (= LC XG,
10% sucrose) ................................................................................................ 61

4.3

Relative transfection efficiency of lyophilized complexes over freshly
prepared complexes, p<0.05, * represents significant difference in comparison
with freshly prepared complex..................................................................... 62

4.4

Transfection of NIH 3T3 fibroblasts after administration of freshly prepared
(a, b) PEI-pGFP complex and (c, d) XG-pGFP complex, and lyophilized (e, f)
PEI –pGFP complex and (g, h) XG-pGFP complex with 10% w/v sucrose;
Green fluorescent images of pGFP transfected fibroblasts on the left and blue
fluorescent images of DAPI nucleic acid stained fibroblasts on the right .......
...........................................................................................................63-64

xiv

List of Figures (Continued)
Figure

Page

4.5

The percent amount of DNA measured over the naked DNA at pH7.4 as
control after the various decomplexation treatment, 30 min incubation for
decomplexation, p<0.05, * and # represent significant difference of each
complex between pH12 TE treatment and 120mg/ml STP treatment, and
significant difference between complexes treated with 120mg/ml STP,
respectively .................................................................................................. 65

4.6

Images of an agarose gel electrophoresis to show stability of plasmid DNA
before and after decomplexation with (1) pH12 TE treatment for 30minincubation and (2) 120mg/ml STP treatment for 4 hour-incubation;
Decomplexation of (a) PEI-pGFP complexes and (b) XG-pGFP complexes,
Lane 1: 1kb DNA ladder .............................................................................. 66

4.7

The efficiency of various decomplexation methods for XG-mediated
complexes, 30 min incubation for decomplexation, p<0.05, letters represent
the significant difference between treatments.............................................. 67

4.8

The effect of incubation time on decomplexation of XG-mediated complex
with 120mg/ml STP, p<0.05, * and # represent significant difference relative
to 0.5 hr incubation FC XG and LC XG, respectively................................. 68

4.9

NIH 3T3 fibroblasts transfected by PEI complex (a) in the conventional
delivery method and (b) in the reverse transfection method in the presence of
10% bovine growth serum, cells were cultured on the substrate without
fibronectin .................................................................................................... 69

4.10

Comparison of the transfection efficiency between conventional bolus method
and reverse transfection method, performed in the presence of 10% BGS,
p<0.05, * represents significant difference in comparison with conventional
bolus transfection with fibronectin (FN) coating on the Petri dish surface .....
................................................................................................................ 70

5.1

Cross-section of a single PLLA capillary channel polymer (CCP) fiber..... 80

5.2

Synthetic route for preparation of degradable, crosslinkable PEG-bis-acrylate
macromers .................................................................................................... 80

5.3

Structure and 1H-NMR spectrum of (a) PEG-bis-(chloroacetate), (b) PEG-bis(2-chloropropanoate) and (c) PEG-bis-(4-chlorobutyrate) .....................87-88

xv

List of Figures (Continued)
Figure

Page

5.4

Structure and 1H-NMR spectrum of (a) PEG-bis-(acryloyloxy acetate), (b)
PEG-bis-(acryloyloxy propanoate) and PEG-bis-(acryloyloxy butyrate) .......
...........................................................................................................90-91

5.5

Degradation mechanism of PEG-bis acrylates and expected products ........ 92

5.6

Mass loss of hydrogels polymerized from solutions containing different
concentrations of PEG-bis-AA macromers; 10% w/v (▲), 20% w/v (■), and
40% w/v (♦) ................................................................................................. 93

5.7

Mass loss of different PEG-bis-acrylate hydrogels at 10% w/v; PEG-bis-AA
(▲), PEG-bis-AP (□), and PEG-bis-AB (○)................................................ 94

5.8

Viability and morphology of human dermal fibroblasts encapsulated within
PEG-bis-AA hydrogels after 1 day (a) and 7 days (b) in culture and cultured
on the hydrogel surface for 1 day (c) and 5 days (d) (Scale bars = 100µm)....
................................................................................................................ 95

5.9

Release of human IgG from 40% w/v hydrogels crosslinked from macromers
of varying chemical composition; PEG-bis-AA (▲), PEG-bis-AP (□), and
PEG-bis-AB (○) ........................................................................................... 96

5.10

Hydrogel delamination from the capillary channel polymer (CCP) fiber; 20%
w/v PEG-bis-AA was coated and images were taken (a) before and (b, c) after
hydrogel swelling in water ........................................................................... 97

6.1

Synthetic route for preparation of acrylated Tetronic® macromers .......... 106

6.2

Phase diagram of aqueous solutions of Tetronic® 908 ............................. 107

6.3

Tetronic® structure (T1107: n=60, m=19; T904: n=15, m=17) and
representative 1H-NMR spectrum of Acryl-T1107.................................... 119

6.4

The effect of temperature on the viscosity of Tetronic® solutions containing
different composition of T1107 and T904 at 30% w/v; 100/0 (×), 75/25 (●),
50/50 (■), and 0/100 (▲). (b) A figure is shown the result of viscosity only at
4°C ............................................................................................................. 120

6.5

Viscosity of the Tetronic® solution containing different composition of
T1107 and T904 (30% w/v) at 0.1s-1 shear rate ......................................... 121

xvi

List of Figures (Continued)
Figure

Page

6.6

Volumetric swelling ratio of various Tetronic®-based hydrogels immediately
following polymerization (initial) and at equilibrium, p<0.05, * represents the
significant difference between initial and equilibrium, letters represent
significant difference between groups ....................................................... 124

6.7

The effect of temperature on the volumetric swelling ratio of various
Tetronic®-based hydrogels, p<0.05, * represents significant difference
between two temperatures, letters represent the significant difference between
groups ......................................................................................................... 124

6.8

Degradation (a) and swelling behavior (b) of various Tetronic®-based
hydrogels; 100/0 (×), 75/25 (●), 50/50 (■), and 0/100 (▲) ....................... 126

6.9

In vitro cytotoxicity determined by live/dead assay; (a) 1 day NIH 3T3
fibroblasts culture and (b) 4 days culture around Tetronic®-based hydrogels
(Scale bars = 50µm) ................................................................................... 128

6.10

Phase contrast (left column) and fluorescent (right column) images of
hydrogel coatings on the capillary channel polymer (CCP) fiber; (a, b) images
of only fiber without hydrogel coating (c, d) hydrogel-coated fiber before
immersion in 37°C water, (e, f) hydrogel-coated fiber immediately after
immersion in 37°C water (Scale bars = 100µm) ....................................... 132

6.11

Degradation mechanism of acrylated Tetronic®-based hydrogel and expected
products ...................................................................................................... 138

7.1

The effect of Michael-type addition polymerization on the stability of gene
complexes and released DNA following hydrogel preparation by Method I (a)
or Method II (b). (a) Lane 1: 1kb DNA ladder, Lane 2: naked pGFP, Lane 3:
naked pGFP + DTT solution, Lane 4: LC PEI + DTT solution without
decomplexation, Lane 5: after crosslinking, decomplexation with 120mg/ml
STP. (b) Lane 1: 1kb DNA ladder, Lane 2: naked pGFP, Lane 3: naked pGFP
+ Acryl-T904 solution, Lane 6: LC PEI without decomplexation, Lane 7: LC
PEI + Acryl-T904 solution without decomplexation, Lane 8: after
crosslinking, decomplexation with 120mg/ml STP ................................... 151

xvii

List of Figures (Continued)
Figure

Page

7.2

Electrophoretic behavior of T904; (a) Agarose gels containing EtBr; Lane 1:
naked pGFP+Acryl-T904, Lane 2: naked pGFP+unmodified T904, Lane 3:
LC PEI+Acryl-T904, Lane 4: LC PEI+unmodified T904, (b) Agarose gels
prepared without EtBr; Lane 5 and 7: Acryl-T904 with EtBr, Lane 6 and 8:
unmodified T904 without EtBr; For lane 5 and 6, 20µl of 30% w/v either
Acryl-T904 or unmodified T904 solution was added. The image of lane 7 and
8 is a visible light photograph of lane 5 and 6 ........................................... 152

7.3.

The effect of concentration of the hydrogel degradation products on DNA
detection by PicoGreen assay; (a) Decomplexation by use of pH12 TE and (b)
120mg/ml STP treatment for decomplexation, p<0.05, * and # represent
significant difference in comparison with 0% w/v degradation product and 1%
w/v degradation product, respectively ....................................................... 153

7.4

Interaction of unmodified T904 macromers (100µl, 30% w/v in 50mM PBS)
with DNA, p<0.05, letters and * represent significant difference between
groups and in comparison with pH7.4 PBS group, respectively ............... 154

7.5

Initial DNA amount loaded within T904 based hydrogel; p<0.05, letters
represents significant difference between groups, Method I: DNA or LC PEI
was resuspended in DTT solution, Method II: DNA or LC PEI was
resuspended in Acryl-T904 solution .......................................................... 156

7.6

In vitro release of DNA from LC PEI-T904 hydrogels; DNA decomplexation
(a) by pH12 TE treatment and (b) by 120mg/ml STP treatment, Method I: LC
PEI was resuspended in DTT solution, Method II: LC PEI was resuspended in
Acryl-T904 solution ................................................................................... 157

7.7

NIH 3T3 proliferation on the LC PEI-T904 hydrogels with various cell
adhesive molecules; 4 days in culture on (a, b) fibronectin-modified hydrogels
and (c, d) acrylated peptide-modified hydrogels, figures on the left are
hydrogel prepared by Method I and figures on the right are hydrogel prepared
by Method II (Scale bars = 100µm) ........................................................... 159

xviii

List of Figures (Continued)
Figure

Page

7.8

Transfection of NIH 3T3 fibroblasts at 48 hour post-transfection in the
presence of 10% BGS and esterase (15units/ml) via gene complex released
from T904-based hydrogel prepared by Method I; (a) 1day and (b) 3days
hydrogel degradation. Gene complex with increased volume was used. Phase
contrast and fluorescent images on the left column and only fluorescent
images on the right column. Asterisk and arrows indicate a hydrogel and
transfected cells, respectively. (4x magnification, Scale bars = 100µm) ........
.............................................................................................................. 161

7.9

Transfection of NIH 3T3 fibroblasts at 48 hour post-transfection in the
presence of 10% BGS and esterase (15units/ml) via gene complex released
from T904-based hydrogel prepared by Method II; (a) 1day and (b) 3days
hydrogel degradation. Gene complex with increased volume was used. Phase
contrast and fluorescent images on the left column and only fluorescent
images on the right column. Asterisk and arrows indicate a hydrogel and
transfected cells, respectively. (4x magnification, Scale bars = 100µm) ........
.............................................................................................................. 162

A-1

Adenine-nucleotide; one base of DNA ...................................................... 180

B-1

Calculation of depth and width of one groove at the capillary channel polymer
(CCP) fiber ................................................................................................. 182

D-1

Tensile properties of various Tetronic®-based hydrogels, p<0.05, * represents
significant difference between two temperatures, letters represent the
significant difference between groups ....................................................... 188

D-2

Bonding strength of various Tetronic®-based hydrogels, p<0.05, * represents
significant difference between groups ....................................................... 189

E-1

The reversible swelling behavior of various Tetronic®-based hydrogels; 100/0
(×), 75/25 (●), 50/50 (■), and 0/100 (▲). The change in temperature ranged
from 4°C to 37°C ....................................................................................... 191

xix

CHAPTER ONE
INTRODUCTION

The concept of gene delivery was introduced as an alternative to protein delivery
or cell transplantation to overcome short half-life, low bioavailability, systemic toxicity,
high cost of manufacturing, etc. [1-3] Systemic gene delivery or simple injection of
naked plasmid DNA (pDNA) has been a common application in the pharmaceutical area.
However, the transfection efficiency of naked pDNA is relatively low and effective only
at the injection site. In addition, even low-level gene expression is often sufficient to
stimulate the immune system. [4] To improve the efficiency and stability of gene
delivery, both viral and nonviral vectors were developed for gene transfer. To date, viral
vectors have achieved much greater transfection efficiency. However, viruses can only
accommodate transgene inserts of limited size and may be immunogenic and mutagenic.
[5-7]. As an alternate method, nonviral vectors for gene delivery have been widely
investigated. [8-12] One major concern of using nonviral vectors is their toxicity after
systemic application and inability to achieve levels of transfection efficiency and duration
of gene expression comparable to viral systems. [13-17] Successful results in tissue
regeneration were limited to very few tissues such as bone and even though there have
been a few reports of gene therapy for complex tissue regeneration, most of promising
studies were based on viral vectors. [18-20] One major limitation of systemic
administration of nonviral gene delivery technology is the external barrier of efficient
vector transport and concentration at the cell surface as well as the internal barriers of
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endosomal escape and transgene delivery to the nucleus. The incorporation of nonviral
vectors

into

biomaterial

matrices

protect

vectors

from

extracellular

degradation/clearance, increase their local concentration at the target site, and achieve
localized expression of therapeutic genes. [21, 22]
Biodegradable and biocompatible polymeric materials have been widely studied
in tissue engineering as matrices to provide space for induced tissue development and
delivery of cells and/or biologically active molecules to specific sites. The incorporation
of pDNA into biomaterial matrices and subsequent transfection of endogenous or
transplanted cells offers an attractive approach to localized, sustained delivery of
therapeutic proteins such as growth factors because the major limitation of protein
therapy was the difficulty in maintaining concentrations over sufficient time period to the
desired therapeutic response. [23, 24] Matrix-based gene transfer can provide retention of
pDNA which allows sustained expression of therapeutic protein within the target tissue.
In addition, this local delivery system can overcome low levels of transfection following
systemic plasmid injections as well as prompt degradation of naked DNA in the
circulation.
Matrix-based approaches to gene delivery have been categorized into two
mechanisms: polymeric encapsulation and substrate-mediated delivery. [25] In
encapsulation systems, vectors are generally homogeneously incorporated throughout the
3D structure of the matrix during fabrication. [19] Vector release is controlled by
diffusion, hydrolytic/proteolytic degradation, or a combination of both mechanisms
depending on the physical and chemical properties of the vector. In the substrate-
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mediated approach, vectors are immobilized to the surface of the matrix after fabrication.
[17, 26] Both approaches have shown improved transfection efficiency, transgene
expression, and therapeutic efficacy relative to bolus administration by simple injection
without a supporting matrix.
The long-term objective of this research project is to create complex scaffolds that
provide structural support for cells as well as therapeutic protein expression via gene
delivery through the creation of composite materials consisting of capillary channel
polymer (CCP) fibers with hydrogel coatings encapsulating nonviral vectors for localized
gene delivery. Mass transport of vectors to target cells and the potential for degradation
during this process is one of the key barriers to successful gene transfer. Although this
has been overcome by increasing vector concentrations, this approach commonly results
in increased cytotoxicity and off-target effects. The approach in this dissertation is based
on the long-term hypothesis that vector release from hydrogel coatings in intimate
proximity with adherent cells will overcome mass transport limitations and increase the
probability of cell-DNA contact leading to increased transfection efficiency and sustained
ectopic gene expression using relatively low vector concentrations. (Figure 1.1) Although
CCP fibers with 8 micrometer scale surface grooves running parallel to the fiber axis
have previously been shown to promote alignment of a variety of cell types by
topographic guidance, the fabrication of PLLA-based fibers requires melt extrusion at
elevated temperatures incompatible with the incorporation of biological molecules.
Therefore, the main goal of this project is the development of materials suitable for the
formation of thin hydrogel coatings that can be stably formed within the fiber grooves
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and provide controlled degradation kinetics suitable for the delivery of nonviral vectors.
In addition, while nonviral vectors have been incorporated into several types of
structurally organized scaffolds, their distribution within the scaffold is typically
homogeneous. [19, 25] Ultimately, the functional regeneration of complex tissues is
likely to require the delivery of multiple bioactive molecules with variable temporal and
spatial patterns. A unique, long-term capability of this approach is that, relative to other
biomaterial fabrication technologies, individual fibers with distinct coating formulations
can be easily integrated into a single heterogeneous scaffold using a variety of existing
textile technologies, similar to the weaving of a multi-colored fabric. Through variation
of the physicochemical properties of various hydrogel coatings, it will be possible to
simultaneously deliver a variety of bioactive molecules including pharmaceuticals,
neurotrophins, recombinant DNA, and therapeutic small RNAs from a single device with
variable and independent control of dose and kinetics.

Figure 1.1. Hypothesis; nonviral gene transfer from degradable hydrogel coating
with various degradation rate on CCP fiber will provide transfection of targeting
cells in the direct contact with the topographical support of hydrogel and CCP fiber
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This dissertation mainly consists of three objectives as shown in Figure 1.2. The
first objective was to develop effective methods for preparing lyophilized gene
complexes without a change in DNA integrity and transfection efficiency. The second
objective was to develop hydrolytically degradable synthetic hydrogels, followed by the
characterization of their properties including degradation kinetics and geometrical
stability as hydrogel coating. Finally, the transfection efficacy of the selected hydrogel
system encapsulating optimized gene complex in the presence of serum was investigated
in the final research objective.

Figure 1.2. Diagram of research outline in the dissertation

The objectives of each chapter in this dissertation are summarized as follows:
Chapter 2 reviews the concepts and fundamentals of gene delivery including
strengths and weaknesses of various vector systems. Through this extensive review of
gene delivery systems, this chapter identifies key issues for successful gene transfer that
are necessary for the development of an ideal gene delivery system.
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Chapter 3 reviews biomaterial matrix-based approaches to gene delivery. Two
widely studied approaches, polymeric encapsulation and substrate-mediated delivery are
described.
Chapter 4 investigates two major requirements for the development of matrixbased gene delivery. First, the feasibility of lyophilization is discussed for the
stabilization of nonviral-mediated gene delivery with various cryoprotectants. Second,
various decomplexation methods are compared to measure plasmid DNA amount after
condensation with nonviral vectors. In addition, a preliminary reverse gene transfer
approach is performed to predict the transfection efficacy of hydrogel-encapsulated
nonviral vectors in the presence of serum as a pilot study.
Chapter 5 describes the development of novel, degradable, and photocrosslinkable
PEG-based hydrogels (adapted from Cho and others [27]). Synthesized using chemical
intermediaries that form ester linkages with variable alkyl chain length, these macromers
are shown to form hydrogels with variable degradation kinetics and consistent physical
properties. The resulting data demonstrates the suitability of these materials for controlled
release of bioactive molecules. At the end of Chapter 5, the inability of these materials to
form coatings on CCP firms is demonstrated and discussed.
Chapter 6 characterizes Tetronic® based hydrogels that are composed of
amphiphilic block copolymers. The current study evaluates various compositions of
Tetronic® 1107 and 904 and shows that their physical properties are derived from both
covalent and noncovalent crosslinking mechanisms. A formulation is identified that does
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not undergo additional swelling at physiological temperature after crosslinking and this is
shown to be capable of forming stable coatings on CCP fibers.
Chapter 7 evaluates Tetronic® based hydrogels as a vector encapsulation gene
delivery system. The incorporation efficiency, stability, and release kinetics of nonviral
vector after Michael-type addition is investigated. Finally, the potential of this optimized
hydrogel gene delivery system is addressed through cell transfection on the degradable,
thin hydrogel.
Chapter 8 outlines the major conclusions and recommendations for future studies
on the use of hydrogel compositions for nonviral gene delivery addressed in this study.
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CHAPTER TWO
GENE THERAPY: APPROACHES AND CHALLENGES

2.1.

Introduction
Gene therapy has recently been defined as “a method to provide a patient’s

somatic cells with the genetic information required for producing specific therapeutic
proteins to correct or modulate disease”. [3] Two primary applications of gene therapy
are i) correction of genetically-based disease and ii) transient overexpression of a protein
capable of initiating or altering a biological process such as angiogenesis or tissue
regeneration. [2, 3, 5] Although some successful reports have suggested the use of naked
DNA, long-term expression with efficient gene delivery has not been accomplished yet.
[20] To improve the efficiency and stability of gene delivery, both viral and nonviral
vectors have been developed for gene transfer. The objective of this chapter is to review
the concepts and fundamentals of gene delivery including strengths and weaknesses of
various vector systems.
2.1.1. General concept of gene therapy/delivery
Gene therapy starts with the introduction of an appropriate vector either directly
into the body (in situ delivery) or cultured cells prepared for transplantation (ex vivo
delivery).

In

situ

delivery

may

be

achieved

by

systemic

(intravascular

injection/inhalation) or local routes (direct injection into the target tissue or implantation
of a vector-loaded scaffold). Once the therapeutic transgene is introduced to its target, it
needs to be transcribed and the resulting mRNA needs to be translated into the
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therapeutic protein. Most transgene products are soluble, secreted proteins that bind to
receptors on appropriate target cells to induce a biological effect, resulting in a
therapeutic outcome. [3] In the case of systemic delivery, however, there are two primary
problems. One is the lack of specificity, and another is systemic toxicity caused by viral
vectors and/or the transgene. [4, 28] Systemic delivery to the nervous system is further
limited by the poor penetration of vectors through the blood-brain or blood-spinal cord
barriers. At present, to overcome these problems, two approaches to localized gene
delivery have been investigated, ex vivo and in vivo. For ex vivo approach, cells are
transfected in vitro before their transplantation to the target tissue. In the in vivo case,
host cells are genetically modified via in situ vector delivery either by simple injection or
implantation of gene-carrying materials.
2.1.2. Vector-assisted delivery systems
Delivery systems or vectors play a critical role in providing the ideal properties in
the DNA delivery. Their properties should include high transfection efficiency, cell
specificity, low immunogenicity or toxicity, stability with transgene formulation and
biodegradability. [29] Currently available DNA vectors can be classified into viral and
nonviral vectors.
2.1.2.1. Viral vectors [30]
Retrovirus
Retroviruses are a family of viruses that store their genetic material in the form of
RNA. When a retrovirus infects a host cell, its RNA produces a DNA copy via reverse
transcription carried out by reverse transcriptase carried in the virus. This DNA copy is
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integrated into the genome of the host cell with an integrase enzyme carried in the virus.
The virus then replicates as part of the cell’s DNA. Retrovirus has been shown to achieve
1-30% transduction efficiency. While integration into the host genome can provide longterm gene expression, one problem is that the viral DNA is randomly inserted at an
arbitrary position, possibly leading to mutagenesis if a gene essential to cell cycle
regulation is disrupted. Another problem is that most retroviruses generally infect only
dividing cells. The cloning capacity of retroviral vectors inserting size is 9-12kb.
Lentivirus
One genus of retroviruses is lentiviruses. The lentiviral vectors typically used are
derived from human immunodeficiency virus (HIV-1). This virus can be used to
transduce both dividing and non-dividing cells such as neurons, distinguishing them from
general retroviruses. Lentiviral vectors also insert transgenes into the host genome via the
reverse transcriptase/integrase mechanism. The cloning capacity of lentirival vectors
cloning capacity is 9-13.5kb. [31] Lentiviral vectors exhibited more suitable to deliver
D15A transgene, a neutrotrophin with BDNF and NT-3 activities, than adenoviral and
retroviral vectors in vitro and in vivo. [32] Due to their ability to transfect non-dividing
and provide stable, long-term gene expression, lentiviruses have been preferred vectors
for neural applications.
Adenovirus
Adenoviruses store their genetic material in the form of double-stranded DNA
and can accommodate transgenes of 4-5kb. When these viruses infect a host cell, the viral
transgene is not incorporated into the genome of the host cell. The viral DNA is left free
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in the nucleus of the host cell and is transcribed just like other genes. However, viral
genes are not replicated when the cell undergoes cell division so the viral DNA cannot be
transmitted to daughter cells. Therefore, adenovirus-mediated gene expression is
transient. Adenovirus has several advantages including high transduction efficiency,
capability for infection of many cell types, and the ability to transfect non-dividing cells.
However, adenovirus still carries the common problems induced by general viral vectors
(the severe immune response including both the innate and adaptive immunity). [33]
Adeno-associated virus (AAV)
Adeno-associated viruses (AAVs) are small viruses with a genome of single
stranded DNA and a cloning capacity of 5 kb. These viruses can incorporate genetic
material into the host genome and infect both dividing and non-dividing cells. As with
lentiviruses, the ability to transfect postmitotic cells such as neurons has promoted the use
of AAV in neural applications. AAV has generally been found to be less pathogenic and
immunogenic relative to adenoviruses.
Herpes simplex virus (HSV)
Herpes simplex virus (HSV), especially HSV type 1 (HSV-1), has been
investigated as a vector for gene transfer to the nervous system. These viruses carry a
linear double stranded DNA molecule of 152kb. 40-50 kb of foreign DNA can be
accommodated within the virus. [34] These viruses infect a wide range of cell types.
They have relatively prolonged expression compared to other viruses. However, due to
complications of herpes infection such as encephalitis, it is difficult to develop as vectors
for gene therapy.
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2.1.2.2. Nonviral vectors
Naked DNA
Plasmid DNA (pDNA) is a circular form of double-stranded DNA carried by
many bacteria that contains its own replication origin and typically an antibioticresistance gene that allows for selective growth of bacterial carrying a plasmid of interest.
Plasmids are typically several thousand kb and can be readily modified to include
mammalian promoters and genes, usually in the form of open reading frames without
introns

created

by

reverse

transcription

of

mRNA.

[35]

Direct

pDNA

injection/microinjection is the simplest of nonviral methods. This strategy is independent
of the length and sequence of the DNA. Naked pDNA has been administered
intramuscularly and expressed for up to 19 months. [36] However, since pDNA is a large
and negatively charged molecule, it is difficult for it to interact with the negatively
charged cell membrane and consequently internalize into cells for gene transfection.
Consequently, extremely high doses are commonly required and generally very low
transfection efficiencies have been observed in comparison to other methods. [37]
Liposomes/cationic lipids
Lipids with cationic head groups can bind and condense pDNA. Their
hydrophobic lipid tail groups help in forming liposomes and can interact with cell
membranes. As stated above, lipoplex achieve relatively low transfection efficiency
compared to viral vectors. Because liposomes are taken up by cells by means of
endocytosis, fuse with endosomes and inefficiently release DNA from endosomes unless
an endosomolytic agent is added to the formulation, limited amounts of DNA are able to
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reach the nucleus. [38, 39] To improve lipoplex transfection efficiency, current
approaches have focused on the conjugation of pH-sensitive and membrane-active
peptides, which destabilize the endosomal membrane and increase the release of pDNA
into the cytoplasm prior to endosomal degradation. [40-42]
Poly(L-lysine) (PLL)
The positively charged primary ε-amines of PLL condense pDNA and form
donuts/toroids of 25-50nm in diameter or short stem/rod structures of 40-80nm long in
water. To form stable complexes with DNA, MW of PLL is required higher than 3000 in
order to have sufficient number of primary amines in the PLL backbone. [2] One of the
drawbacks of PLL-DNA complexes is aggregation and precipitation of complexes at high
salt concentration or in physiological saline at all charge ratios of complexes. [43]
Although PLL was an early material investigated for nonviral gene delivery, its current
use is limited by several factors. In general, PLL-DNA complexes cause a relatively high
level of cytotoxicity, which results in 40-60% cell viability after in vitro transfection.
Relative to PEI (discussed below), PLL also exhibits relatively low transfection
efficiency. This has been attributed to i) strong DNA binding to form interpolyelectrolyte complexes, hindering its release in the cytoplasm/nucleus, and ii) the
higher pKa of its amines relative to PEI, hindering its ability to act as a proton sponge.
[44] To increase the solubility of PLL-DNA complexes in aqueous media, PLL has been
modified with hydrophilic dextran by a reductive amination reaction between ε-amino
groups of PLL and the reductive ends of dextran, but dextran chains don’t considerably
hinder the electrostatic interaction between DNA and PLL. [45] PLL-DNA complexes
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with covalently linked PEG exhibited 30-fold higher transfection efficiency than PLLDNA complex in order to decrease both cytotoxicity and salt-induced aggregation. [46]
The circulation of PLL-DNA complex depends on the molecular weight of PLL. Most of
20kDa PLL-DNA complexes were localized in the liver (80%), kidney (0.8-1.9%), lung
(1-2%) and aggregated in the blood through interaction with negatively charged serum
protein in the blood. When using longer PLL chains such as 211kDa, PLL-DNA
complexes had long blood circulation time and were localized in the liver (47%) and not
aggregated. The merit of using PLL is that a targeting moiety can be easily coupled to
PLL by chemical conjugation for targeted delivery.
Polyethylenimine (PEI)
There are two types of PEI, branched and linear form. Linear PEIs are already
commercialized as transfection reagents such as ExGen 500. Branched PEIs are
theoretically composed of 25% primary, 50% secondary, 25% tertiary amines. But, the
branching degree of commercially available PEI actually shows 1:1:1 ratio. Primarily the
PEIs larger than 10kDa have been used successfully in transfection studies. However,
higher MW PEI (> ~48kDa) reduced transfection efficiency in vivo (the results are
somewhat contradictory in vitro) and showed cytotoxicity. [47, 48] Among the various
PEI forms studied, liner PEI (L-PEI) of 22kDa and branched PEI (B-PEI) of 25kDa are
the most effective transfection vectors used in vitro and in vivo. PEI-DNA complexes
exhibit a narrow particle size distribution, which presumably allows high cellular uptake
of the plasmids leading to high transfection efficiency. PEIs have their own method of
endosome disruption via the proton-sponge effect. Linear PEIs consist of almost entirely
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secondary amines while branched forms are theoretically 75% secondary and tertiary
amines. The overall protonation level is about 10-20% at pH7 and increases up to 40% at
pH5. [49] Based on these properties, the amines present in the PEI become protonated in
the low pH endosomes, which not only protects DNA from degradation, but also
increases water uptake into the endosome and leads to endosomal rupture and release of
DNA into the cytoplasm. [50] This proton sponge hypothesis has been supported by
several studies, showing a decrease in acidification as well as an increase in chloride
concentration and the relative volume in PEI-containing endosomes (140% increase).
[51] Additionally, quarternization of amine groups present in PEIs decreased transfection
efficiency by about 20-fold because of the removal of protonable amine groups. [52]
Although the high cation density of PEI contributes to highly condensed PEI-DNA
complexes and relatively good transfection efficiency in some cases, the excessive
amount of free amine groups in PEI polymers causes significant cytotoxicity and is
highly dependent on MW of PEI. [48, 53] Furthermore, it is known that less than 30kDa
of hydrophilic polymers can be eliminated by the kidney. Unless their size is less than
30kDa or they are enzymatically degraded, high MW PEI is not recommended as
delivery vectors. Even though low MW PEI was used, the ratio of nitrogen in PEI to
phosphate group in DNA (N/P ratio), salt concentration and presence of serum in the
environment strongly influenced aggregation of complexes. [54, 55] For example, an
increase of salt concentration (e.g. NaCl > 50mM) promoted aggregation of PEI-DNA
complexes. [56, 57] Although N/P ratio that increases particle size is still controversial, it
affected a change in particle size. [54, 58] PEGylation via the primary amino groups in
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PEI enhanced the water solubility and reduced the surface charge of complexes by PEG
shielding effect and subsequently decreased polyplex self-aggregation and promoted
polyplex stability in the presence of serum proteins. [38] Low MW PEI was covalently
linked with degradable bonds, which increased the overall polymer hydrophilicity and
MW without toxicity. [59] This degradable site can promote the clearance of the polymer
after DNA release.
Dendrimers/polyamidoamine (PAMAM)
Dendritic PAMAM provides a low MW structure and a high density of positive
surface charge. [60] The surface charge and diameter of any starburst polyamidoamine
(PAMAM) dendrimer can be easily controlled by the number of synthetic steps taken to
produce it. For example, five steps of polymerization generate 5th-generation dendrimer.
Dendrimers condense plasmids via electrostatic interactions of their terminal primary
amines with the pDNA phosphate groups. The particle size, surface charge and gene
transfer efficiency of complexes are influenced by the dendrimer concentration in the
complexes.
2.1.3. Barriers to gene delivery [37]
Figure 2.1 is a schematic representation of the delivery, uptake and intracellular
fate of gene delivery systems. The first inherent factors to efficient gene delivery can be
the inefficient cellular uptake of naked DNA or gene complex. A combination of several
factors such as charge, size, and poor stability in the extracellular environment is
considered as a potent barrier to cellular uptake. [29, 35, 61] For example, the negatively
charged DNA causes inadequate cellular association due to its electrostatic repulsion.
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High MW DNA is often too big to internalize via endocytosis. Without any protection by
vector, plasmids undergo a rapid degradation caused by nucleases following
administration both intravenously and intramuscularly. Nucleases recognize the
phosphodiester linkage in the DNA backbone, resulting in hydrolytic degradation.
Upon endocytic internalization, delivered genes are trapped within endosomal
vesicles, where DNA molecules are inactivated and eventually degraded due to acid
hydrolysis activated by lysosomal enzymes at pH 5-6. Failure of DNA escape from these
structures has been demonstrated as one of the major barriers to efficient gene delivery. If
DNA safely escapes from the endosome, it enters the cytosol and should traverse the
cytosol to enter the nucleus. However, large DNA molecules (>2000 base pairs in length)
experiences a substantial diffusion barrier according to its low diffusion coefficient in the
cytosol (<1% of the diffusion coefficient in water). [62] Although DNA can reach the
nuclear membrane, transport of plasmid by nuclear pores is limited due to the size of
nuclear pores. Nuclear pores change their size from <9nm in diameter to <26nm
depending on their closed and open states, respectively. [61] For example, if DNA is of
size in 1000bp (660kDa), its size is approximately 3400 Å (=340nm; bp = base pair(s)
one bp corresponds to circa 3.4 Å of length along the strand), which is considerably
larger than nuclear pore size. [63] Finally, when delivered DNA overcomes all of these
barriers, DNA is accessible to the transcriptional machinery and can produce the desired
therapeutic protein. Although these various barriers to gene delivery contribute to
inefficient gene delivery, it is not obvious that all the delivery systems are incapable of
efficiently delivering genes to various tissues.
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Figure 2.1. Schematic generalized representation of delivery of a DNA-based
therapeutic using a viral or nonviral DNA delivery vector: (1) complexation and/or
entrapment of DNA-based therapeutic with DNA delivery vector; (2) interaction of
DNA-based therapeutic-vector complex with cell membrane; (3) cellular
internalization via receptor- or non-receptor-mediated endocytotic pathways; (4)
endosomal breakdown; (5) cytoplasmic release of DNA-based therapeutic-vector
complex or DNA-based therapeutic alone (Cytoplasm is the site of action for
antisense oligonucleotides, aptamer, ribozymes, DNAzymes, and cytoplasmic
plasmid DNA expression systems); (6) dissociation of DNA-based therapeutic from
vector; (7) nuclear translocation of viral vectors or DNA-based therapeutics.
(Nucleus is the site of action for transgenes in plasmids for gene therapy, siRNA
generating plasmids, and antigene oligonucleotides.) [29]
[Reprinted from The AAPS Journal 7 (2005) E61-E77, Siddhesh D. Patil, David G.
Rhodes, and Diane J. Burgess, DNA-based therapeutics and DNA delivery systems:
A comprehensive review, Copyright (2005) with permission from The American
Association of Pharmaceutical Scientists]
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2.1.3.1.Barriers to viral gene delivery
Application of viral vectors uses the natural ability of viruses to infect host cells.
In brief, viruses bind to cell surface receptors on the cell membrane and internalize either
by endocytosis or by fusion with the plasma membrane. The viral DNA then escapes due
to conformational changes or the disruption in viral coat proteins and traverses the
cytoplasm to reach the nucleus by use of the cytoskeletal network, finally enters nucleus
in size of 2.5-250kb DNA through nuclear pore complexes or during the breakdown of
the nuclear membrane during mitosis. Viral vectors may be the most efficient vectors.
70% of clinical trials utilized viral vectors including retrovirus, adenovirus, adenoassociated virus, herpes simplex virus, etc. Unfortunately, viral vectors may provoke
mutagenesis and carcinogenesis. [5] In addition, administration of a viral vector induces
an immune response. In 2000, Marshall reported severe problems using viruses indicated
by the sudden death of an 18-year-old patient. [6, 7] In the case of using viral vectors,
especially adenoviral vectors, the severe innate or/and adaptive immune responses
induced a significant problem including the patient’s death. [13, 33] Moreover, the
immune response may eliminate both the vector and the transfected cells and reduce the
gene transfer efficacy as well as the duration of transgenic protein expression. The
intensity of the immune response depends on several variables such as the type of virus,
dose, the administration route, the nature of transgene, etc. [33, 64] Additional
disadvantages include limited DNA carrying capacity or limitation in the size of the
transgene to be delivered, and lack of target specificity.
2.1.3.2. Barriers to nonviral gene delivery
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Considering these safety issues and disadvantages, nonviral vectors based on
plasmid DNA (pDNA) offer an attractive alternative due to their relatively lower
immunogenicity. While naked DNA is used in some applications, more commonly it is
condensed by the formation of polyelectrolyte complexes with cationic lipids (lipoplex)
or polymers (polyplex). In contrast to naked DNA that is repelled from the cell
membrane due to its negative charge, lipoplex and polyplex formulations achieve a
neutral or slightly positive charge that increase binding to the cell membrane. One
advantage of nonviral vectors is greater control of their molecular composition for
simplified manufacturing and analysis than viral vectors. The various size of the
transgene can be delivered as well. However, nonviral methods showed low levels of
transfection

and

gene

expression,

potentially

caused

by

toxicity

and

aggregation/instability of vectors. High molecular weight (MW) polycations delivered to
cultured cells and in animals are significantly more toxic than low MW polycations. [47,
53] In addition, highly charged particles rapidly aggregated in high ionic strength
solutions due to the decrease in the protective electrostatic layer. [57] If there is a strong
positive charge on the delivery systems, gene complexes non-specifically interact with
ECM, cell surfaces and plasma proteins due to their negative charges. If there is a strong
negative charge on the gene complexes, they are removed by phagocytosis via the
macrophage polyanion receptor. Steric stabilization of nonviral complexes has been
studied by creating a hydrophilic layer in the polymer chain or on the particles, which
diminishes non-specific interactions with molecules from environment. After uptake of
nonviral systems into the cells, gene complexes are fused with endosomes. Degradation
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of the vector may occur in the lysosome unless the endosomal membrane is destabilized
by pH-sensitive molecules or osmotic disruption by chloroquine after ion trapping after
its protonation [65], which lowers the amount of DNA being delivered into nucleus. Even
though some amounts of surviving complexes reach the nucleus, lipoplexes, polyplexes
and pDNA all appear to be too large to enter the nucleus via the nuclear pore complexes.
[5, 38] Therefore, nonviral gene delivery is highly dependent on cell division and nuclear
membrane breakdown, resulting in a more space for those molecules to enter.
2.1.4. Systemic gene delivery [30, 66]
The most widely investigated application of systemic gene therapy has been
cancer treatment. When the target tissue cannot be reached directly, systemic delivery is
conducted by the injection of viral or nonviral vector-DNA complexes into the
bloodstream, thus distributing the complexes to tissues throughout the body. However,
this approach has encountered limitations due to a low specificity of gene expression, in
vivo instability, toxicity and low transfection efficiency. [67] Many gene therapy
approaches involve the expression of growth/trophic factors that may have detrimental
side-effects in non-target tissues. For systemic administration, delivery systems should be
prepared at a high concentration sufficient to bear the loss that will occur in the
bloodstream. PLL-DNA complexes were rapidly cleared from the bloodstream within 30
min and accumulated in the liver. [17, 68, 69] While repeated injection might increase the
period of gene expression, if a vector is based on the viral vector and gene therapy is
repeatedly administered through its complex, the vector itself causes the severe problems
to host cells, for instance, toxicity or immune responses. [70, 71] Circulating antibodies

21

and the complement system recognize viral vectors in the bloodstream as pathogens and
neutralize them rapidly. In addition, other immune effectors can neutralize the viral
vectors and cells which have been transduced as well. In the case of nonviral vector
delivery, electrostatic interactions of cationic gene complexes with salts and anionic
proteins in serum (e.g., albumin, fibronectin) results in rapid aggregation. One major
concern of using nonviral vectors is their toxicity after the systemic application. For PEI
complex, the electrostatic condensation method with PEI generated about 86% free
residual PEI, which induced the cytotoxicity. [72, 73] When free 25kDa PEI was directly
added to PC-3 cells, cell viability was significantly lower than the other complex groups
such as PEI-DNA (N/P=10) and PLL-DNA complexes. Chollet reported that increasing
the quantity of L-PEI complex induced liver necrosis and death of mice (4weeks, Swiss
nude and C57/black6). In addition, older animals were more sensitive to this complex.
[14] Moreover, the results after injection indicated that PEI alone or complexed with
DNA can induce inflammatory and innate immune responses including an increase in the
number of monocytes, granulocytes, natural killer cells, B lymphocytes and T killer cells.
[14] Systemic administration of lipoplex also induces the rapid innate immune response.
[69] A series of these reductions of gene complexes finally affect the transfection
efficiency at target site. There are strategies for overcoming some of these barriers,
including the use of certain immune cells such as macrophages, and T cells, transduced
with viral vectors to encode therapeutic genes, and the modification of traditional
nonviral vectors with hydrophilic polymers for their stability against salt and serum. [66,
74] However, the application of systemic delivery is limited only to vascularly accessible
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tissue or tissue that has the discontinuous endothelial wall such as liver, spleen, and bone
marrow. [12] Unless enhancing the vascular permeability, systemic administration may
be inapplicable to many tissues.
2.1.5. Local gene delivery
2.1.5.1. Ex vivo gene therapy
Localized therapeutic gene expression may be achieved by ex vivo and in situ
delivery. For ex vivo, this approach requires the transplantation of cells that have been
previously transfected in vitro. This method provides the ability to select successfully
modified cell populations before in vivo transplantation and may provide long-term
transgene expression if the cells are transfected using appropriate viral vectors. Also, this
approach can achieve immunocompatability if autologous cells are used. There are a
couple of drawbacks including the time-consuming processes to identify, purify and
expand the transfected cells, the lack of cell survival and bioactivity after transplantation,
tumorigenesis by the implantation of genetically modified cells, the high cost associated
with all the necessary procedures. [70]
2.1.5.2. In vivo gene therapy
In vivo gene therapy modifies host cells genetically by direct in situ vector
delivery either by injection or implantation of materials that carry genetic materials. In
vivo gene therapy is simple to apply to the body, requiring only the in vivo small volume
injection, minimally invasive injection (e.g., several microliters) of a transgenic vector
and avoiding the risk of introducing ex vivo transfected cells that have potential
tumorigenicity. In addition, pDNA or a virus which is incorporated into a polymer
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scaffold may enhance gene transfer at the implant site, providing sustained delivery,
localized gene expression and extending opportunities for internalization. [75] Increasing
the concentration of DNA in the local cellular microenvironment can increase
transfection. [76, 77] However, transfection efficiency introduced by nonviral vectors via
in vivo gene delivery is too low to be clinically useful. The nonspecific interaction of
extracellular proteins with vectors can be one of reasons to reduce the number of active
gene complexes.
2.1.6. Current problems of nonviral-mediated local gene delivery
2.1.6.1. Cellular responses
In vivo gene therapy is an alternate approach to systemic gene delivery, used to
reduce the chance of vectors to transfect nontargeting cell/tissue nonspecifically via
circulation. However, similar to observations in systemic delivery applications, nonviral
vectors, which are locally introduced, can cause cytotoxicity at the applied site. PEI-DNA
complexes have a similar toxic effect where the cells adopt a rounded morphology,
indicative of a loss of adherence. [78] Moghimi and colleagues demonstrated that both BPEI (25kDa) and L-PEI (750kDa) induced membrane damage and apoptosis in various
human cell lines. [15] A decrease in the level of free PEI in the transfection solution can
be of benefit to cell survival and transfection. An ultrafiltration method proposed by
Finsinger and others is one simple solution addressing the elimination of free PEI
molecules. [72] This method removes about 30% of the free PEI. However, this method
was attributed to stability of PEI-DNA complexes, resulting in a significant decrease of
the surface charge. Any shear forces by centrifugation or homogenizing caused damage
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to DNA. [79] Electrophoretic purification was also introduced as a simple and quick
method for the purification of polyplexes. This method was able to purify about 60% of
free PEI and PEI conjugates like PEGylated PEI independent of their size associated with
N/P ratio. [80] Cationic liposomes induced the innate immune response and tissue
damages as well. Lipoplex triggered the innate immune response to unmethylated CpG
motifs of pDNA via recognition by toll-like receptors (TLRs), leading to the production
of inflammatory cytokines and interferons (IFNs). [13] To reduce inflammatory toxicity
caused by lipoplexes, the sequential injection method (cationic liposome first, and then
DNA injection) with an optimized interval time was effective in inhibiting the induction
of inflammatory cytokines (e.g., TNF-α, IFN-γ, IL-12) except removal of CpG motif of
pDNA. However, this method was only able to benefit certain types of liposome vectors
such as DOTAP/Chol and DOTMA/Chol. [69]
2.1.6.2.Environmental interactions
For both in vitro and in vivo applications, gene complexes mediated by nonviral
vectors interact with serum proteins in the cell culture media or the extracellular
environment within the tissue before binding to the cell surface. In in vitro studies, the
introduction of either lipoplex (e.g., Lipofectamine) or polyplex (e.g., polyethylenimine,
PEI) resulted in only 20-50% internalization of initial pDNA. [81-84] Complexes
between either lipoplexes or polyplexes and pDNA are typically prepared by electrostatic
interactions between the positive charges of either the cationic lipid headgroups or the
cationic polymers and the DNA phosphate groups. It has been accepted that slightly
positive lipoplexes and polyplexes achieved higher transfection efficiency because their
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net positive charge allowed more efficient binding with the negatively charged cell
surface. [12, 76, 77, 85] However, a positively charged complex is also likely to interact
with extracellular proteins in the physiological fluid, which may induce the aggregation
of complex itself or dissociation of the complexes. [17] These serum barriers may
directly or indirectly reduce the number of gene complexes via either their electrostatic
interaction with gene complex or subsequent gene complex self-aggregation neutralized
by proteins, respectively, which was proposed as one of the reasons for lipoplexes or
polyplexes exhibiting low transfection efficiency. Luo in 2000 tried to overcome low
transfection efficiency by simply increasing a number of gene complexes at the surface of
cell monolayer. Briefly, silica nanoparticles bound with gene complexes were settled
over cellular membranes in gravity, which resulted in an increase in the concentration of
DNA at the cell surface and gene expression. [76] In conclusion, an increase in the
number of gene complexes at the cell surface increases the opportunity for cellular
internalization and eventually transfection. Several studies attempted to enhance cellular
internalization of gene complexes via the addition of receptor ligands to the vector, the
modification of vectors with PEG groups, etc. [86] Alternatively, degradable biomaterials
provided a continuous infusion of DNA or gene complexes into the targeting tissue and
some of them resulted in significantly greater physiological responses compared with
application of a bolus delivery. [19] Biomaterials can be fabricated in various forms, such
as scaffolds, hydrogels, and nanospheres, and can potentially protect vectors and DNA
from the extracellular serum barriers.
2.2.

Conclusions
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Gene delivery provides new approaches for treating and controlling diseases. The
major barrier to the success of gene delivery is transfection efficiency. Although a greater
efficiency of transgene expression has been achieved with viral vectors, their
immunogenicity and carrying capacity remain significant challenges. Due to the safety
issue of viral vectors, nonviral vectors have been widely investigated as an alternative
approach. However, their low transfection efficacy has limited the ability for clinical
therapies. The successful in vivo application of nonviral vectors will depend on
understanding and overcoming the environmental and intracellular barriers to gene
delivery. Since it is difficult to fully control the intracellular mechanisms, the method to
increase the concentration of gene complexes at the cell membrane to achieve increased
internalization may be the most direct and practical approach. Encapsulation within
biomaterials was developed to shield the vector from the extracellular environment and
localize DNA release. Sustained release systems facilitated by degradable biomaterials
may provide a means of overcoming transient gene expression and low transfection
efficiency without repeated injections.
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CHAPTER THREE
BIOMATERIAL MATRICES FOR LOCALIZED GENE DELIVERY

3.1. Introduction
Biodegradable and biocompatible polymeric materials have been widely studied
in tissue engineering as matrices to provide space for induced tissue development and
delivery of cells and/or biologically active molecules to specific sites. [87, 88] The
incorporation of pDNA into biomaterial matrices and subsequent transfection of
endogenous or transplanted cells offers an attractive approach to localized, sustained
delivery of therapeutic proteins such as growth factors because the major limitation of
protein therapy has been the necessity to maintain therapeutic concentration sufficient to
induce the desired therapeutic response for the desirable length of time. [23, 24] Matrixbased gene transfer can provide retention of pDNA as well as therapeutic protein
produced by delivered pDNA within the target tissue. In addition, this local delivery
system can overcome low levels of transfection following systemic plasmid injections as
well as prompt degradation of naked DNA in the circulation.
Matrix-based approaches to gene delivery have been categorized into two
mechanisms: polymeric encapsulation and substrate-mediated delivery. [25] In
encapsulation systems, vectors are generally homogeneously incorporated throughout the
3D structure of the matrix during fabrication. [19] Vector release is controlled by
diffusion, hydrolytic/proteolytic degradation, or a combination of both mechanisms
depending on the physical and chemical properties of the vector. In the substrate-
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mediated approach, vectors are immobilized to the surface of the matrix after fabrication.
[17, 26] Both approaches have shown improved transfection efficiency, transgene
expression, and therapeutic efficacy relative bolus administration. However, combination
strategy combining both methods should be considered for the ultimate application to
create complex tissue structures.
3.1.1. Vector encapsulation systems
The main potential of encapsulation systems is the ability to provide continuous
vector release and uptake by the target cells and to increase the local vector concentration
retained within the target tissue relative to intravenous injection or bolus administration.
[89] Biomaterial matrices for gene delivery can be divided into two classes: hydrogels
and porous sponges. Hydrogels are prepared in aqueous solution by physical, ionic or
chemical crosslinking of hydrophilic polymers at ambient temperature for relatively short
times, which allows pDNA or vector complexes to be homogeneously incorporated
during gelation under physiological conditions. Hydrogel degradation may occur by
cellular proteolytic activity or chemical hydrolysis. Due to the relatively large size of
pDNA and lipoplex/polyplex vectors compared to the mesh size of most hydrogels,
degradation generally has a strong influence on the vector release kinetics and may be
influenced by changes in network crosslinking density, polymer molecular weight,
concentration, etc. Hydrogels have been particularly attractive for vector encapsulation
based on their ability to be injected by minimally invasive methods and crosslinked in
situ, allowing the matrix to conform to irregularly sized defects.
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On the other hand, porous scaffolds fabricated from relatively hydrophobic
degradable polyesters have also been considered as useful vector encapsulation systems.
These materials offer an increased range of mechanical properties and can support rapid
colonization of endogenous cells throughout the 3D structure. [90-92] Although a variety
of techniques are available for fabrication of porous sponges, the gas-foaming method
developed by Mooney’s group that can be performed at room temperature without the use
of organic solvents has been almost exclusively used for gene delivery applications. [93,
94]
3.1.1.1. Natural polymer hydrogels
Natural polymer matrices formed by collagen, gelatin, alginate, or recombinant
silk-elastinlike proteins have been of interest in the application of gene delivery because
of their generation in mild crosslinking conditions and their intrinsic degradability by
cellular proteolytic enzymes. [95] Bonadio and colleagues first described matrix-based
gene delivery using collagen gels loaded with naked pDNA, terming these constructs
gene activated matrices (GAMs). [18, 96] GAMs loaded with pDNA encoding bonegrowth promoting proteins such as bone morphogenetic protein-4 (BMP-4) and
parathyroid hormone (PTH) were implanted in critical size defects in the adult rat femur
and shown to promote significantly increased bone formation relative to control matrices
without pDNA. This paradigm (naturally-derived hydrogel/naked pDNA) has been
replicated and shown to be effective in several other in vivo models including dermal
wounds, ischemic ulcers, and skeletal muscle injury. [97-99] Ochiya used PCR to
demonstrate that pDNA injected intramuscularly with atelocollagen remained
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predominantly localized at the site of administration and was only minimally detected in
other tissues. [100] Although naked pDNA is essentially ineffective for in vitro
transfection, GAMs using naked pDNA have been effective in this and other in vivo
studies. However, it is important to note that relatively high (0.5-1mg/matrix) loading
concentrations were required as shown in Table 3.1. Although prolonged transgene
expression ranging from a few weeks to months has been achieved using GAMs, the
release property of collagen-based GAMs has seldom been investigated. So, it is unclear
how their release kinetics influences the level and period of transgene expression. A few
studies reported that 20% burst release of the initial, loaded DNA amount was observed
within 30min in the case of collagen matrix at the low concentration. [98, 100, 101]
To reduce the amount of DNA required within GAMs and optimize release
kinetics, several studies employed viral or nonviral vectors to protect naked pDNA from
rapid degradation by nucleases as well as to provide sustained delivery of pDNA. The
complexation with vectors was expected to reduce the initial loading quantity of DNA by
increasing transfection efficiency. In fact, those studies used relatively small amounts of
pDNA, for example, using PLL as a nonviral vector enabled successful, localized
transfection with DNA loading ranging from 2.5-7.5µg per matrix (1-2mg collagen).
[102] However, a high initial burst (>50%) was still observed regardless of the effort to
make vector-mediated gene complex. [92]
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Table 3.1. Collagen GAMs applications
Materials
Bovine tracheal
collagen
Type I bovine
collagen

Matrix size

Type of pDNA

pDNA per
matrix

10mg collagen

pDNA encoding
BMP-4, PTHa

0.5-1mg

pMat-1b

1-100mg

Atelocollagen

Ø=0.6mm,
L=10mm
(rod=minipellet)

pCAHST-1, cDNA
fragment of the
HST-1/FGF-4 gene

50-100µg

Type I bovine
collagen

50µg collagen

pPDGF A,Bc

1-3mg

Type I bovine
Collagen

400µl (500µg
collagen)

pGFP, sense and
antisense TSP2d
cDNA

0.5mg

Application method
Implantation into bone
gaps [96]
Implantation into bone
gaps [18]
Intramuscular
implantation [100, 103]
Subcutaneous
Implantation [97]
Matrix coating or
impregnation into PVA
sponge, followed by
subcutaneous
implantation [104]

a

bone morphogenetic protein-4 and parathyroid hormone
plasmid DNA encoding hPTH1-34 peptide
c
platelet-derived growth factor A or B
d
thrombospondin 2

b

Gelatin, a type of natural polymer, has been tested as a gene carrier. Tabata’s
group focused on cationized gelatin hydrogel as a controlled gene delivery system. [105108] The positively charged gelatin can electrostatically bind pDNA, and the in vivo
degradation is mediated by proteolysis and its rate controlled by varying the
concentration of glutaraldehyde crosslinker. For example, less crosslinked gelatin
hydrogel (denoted as hydrogels with 99.7 wt% water content) exhibited faster
degradation than hydrogel with higher crosslinking density (denoted as hydrogels with
96.4 wt% water content). [105] The in vivo degradation period of gelatin hydrogels was
controlled over the time from 7 to 21 days. [105, 106] For cartilage regeneration, gelatin
was blended with chitosan to improve its mechanical properties as well as provide a
favorable environment to chondrocytes, then incorporated with pDNA encoding TGF-β1.
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[109] According to the results of the release test, an initial burst release was observed
within 3 days and then the DNA release decreased. This release profile probably
influenced TGF-β1 expression, resulting in a peak value at 8 days of cell culture. Overall,
pDNA release was well controlled by the degradation of the gelatin or gelatin-chitosan
scaffold, but this system was only capable of achieving gene expression over a 2 week
time period due to the rapid degradation of the matrix.
pDNA has also been incorporated with recombinant silk-elastinlike polymers,
made of silk-like (Gly-Ala-Gly-Ala-Gly-Ser) and elastin-like (Gly-Val-Gly-Val-Pro)
blocks, that undergo an irreversible sol-to-gel transition with a change in temperature
from room temperature to 37°C. DNA release was controlled by varying the condition of
preparing hydrogels including a change in cure time and polymer concentration. [110112] This hydrogel matrix showed controlled delivery of pDNA for over 28 days. In the
case of hydrogel prepared with low concentration and short gelation time, burst release
was observed so that less than 70% of initial loaded DNA was lost within 5 days and
following DNA release was decreased. [110] Interestingly, the levels of transfection
within the tumor were higher than skin transfection and release kinetics became more
linear as increasing the polymer concentration and crosslinking time. [112] Although the
silk-elastinlike polymer gels were capable of entrapping viral gene complex as well as
localizing gene transfer, this type of genetically engineered biomaterial requires high cost
for production. [112]
An injectable, agarose-based carrier was able to deliver PLL-DNA complexes to
skin for wound healing. Gene expression, following the injection of gene complexes in
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solution, was detected for only 5-7 days, whereas one of the compacted DNAs from the
agarose hydrogel was prolonged for at least 35 days. [113] Recently, fibrin-based gels
were tested as delivery matrices in vitro. NIH 3T3 fibroblasts both encapsulated with
gene complexes and cultured on the fibrin gels, showed prolonged transfection for at least
10 days. [114] However, burst release still remained an issue, for example, an initial
burst of 21% and 22% was observed after 4h for pDNA and lipoplexes, respectively. In
contrast, Kong and colleagues reported well sustained pDNA delivery without an initial
burst using biodegradable alginate hydrogels. [115] Three different calcium cross-linked
alginate hydrogels were prepared with varying crosslinking segments of polymers,
resulting from the introduction of oxidation into alginate chains. Oxidation opened the
sugar ring of mannuronic acid to form acetal linkages, which were susceptible to
hydrolysis, and led to a decrease in the MW of alginates. When oxidized alginate
molecules of different MWs were calcium crosslinked, the resulting hydrogels were
composed of crosslinks between guluronic acid blocks in the different lengh of alginate
molecules. The resulting hydrogels contained various crosslinking densities and different
swelling ratios, and exhibited various degradation rate related to the crosslinking density.
The DNA release rate was related to the hydrogel degradation rate via concurrent
physical dissociation via ion-exchange and degradation via hydrolysis. This study
showed successful revascularization within the connective tissue and muscle in ischemic
hindlimbs of mice using the most rapidly degradable alginate hydrogel that incorporated
PEI-pDNA encoding VEGF. Overall, it should be noted that DNA release kinetics was
well controlled by manipulating two different degradation processes of biomaterials and
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in vivo gene expression was successful with a relatively small amount of pDNA (100µg
pDNA/ml hydrogel).
Hydrogels of naturally-derived polymers, with the exception of gelatin-based
GAMs have demonstrated sustained gene delivery as gene-activated matrices and
achieved long-term gene expression up to a few months. However, many of these studies
resulted in an initial burst release and, when using naked DNA, required high loading
amounts of DNA to induce the desired therapeutic response for the prolonged period.
Also, due to the nature of the polymers, degradation of matrices composed of natural
polymers is only mediated by proteolytic enzymes, which limits the ability to regulate the
release profiles.
3.1.1.2. Synthetic polymer hydrogels
The fabrication of synthetic hydrogels has received much attention due to their
reproducibility, availability, and ease of tailoring the hydrogel physical/chemical
properties to desired applications. One common strategy for the creation of synthetic
hydrogels has been the modification of water soluble polymers such as poly (ethylene
glycol) (PEG) and poly (vinyl alcohol) (PVA) with vinyl end groups and their subsequent
crosslinking by photo- or redox-initiated free radical polymerization. The degradation
rate of these hydrogels was controlled by a change in variation crosslink density within
network, polymer MW, the chemical composition, the degree of polymerization of the
polyester blocks, and polymer concentration. As a result of hydrogel degradation, DNA
release was sustained and controlled. [116, 117] Quick and Anseth first proposed the
potential of a photopolymerized hydrogel as a gene carrier. [118-120] This hydrogel was
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first introduced by Sawhney and Hubbell, which consisted of a hydrophilic PEG center
block copolymerized with polylactic acid (PLA) or polyglycolic acid (PGA) and endcapped with acrylate groups which provide crosslinkable residues. [93, 116] The control
of DNA release was mediated by a change in polymer type, composition and MW.
Unfortunately, the reactive free radicals generated by photocrosslinking process
significantly damaged DNA under typical photoinitiating condition. (Figure 3.1)
Protection of plasmid DNA from radical attack by condensation with nonviral vectors as
well as addition of vitamin C as a radical scavenger was investigated. These treatments
improved percent of DNA detected, especially in the case of DNA protected by either
protamine sulfate or PEI in the presence of 0.85mM vitamin C. [118, 119] However,
addition of a radical scavenger affected photopolymerization mechanism, resulting in less
crosslinking density within hydrogel network. So, the optimization of vitamin C
concentration was an issue.

Figure 3.1. Photograph of agarose gel electrophoresis showing conformations of
plasmid DNA released from dimethacrylated poly(lactic acid)-b-poly(ethylene
glycol)-b-poly(lactic acid) (PEG-PLA-DM) with 8.5 LA/PLA block hydrogels in the
absence of protective additives. First lane is non-encapsulated DNA in a solution of
degraded polymer, second lane is the released, encapsulated DNA.
[Reprinted from Journal of controlled release 96 (2004) 341-351, Deborah J. Quick,
Kristi S. Anseth, DNA delivery from photocrosslinked PEG hydrogels:
encapsulation efficiency, release profiles, and DNA quality, Copyright (2004) with
permission from Elsevier B.V.]
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Hydrogels photocrosslinked with methacrylated hyaluronic acid (HA) and
acrylated PEG-derivatives were also investigated. [121, 122] These hydrogels allowed
release of nonviral gene complexes with various degradation rates influenced by
hydrolysis and enzymatic degradation (hyaluronidase). DNA release showed a burst
release up to 80% within 2 days, and then dramatically decreased. Chun and colleagues
increased UV curing time to reduce this event. However, a long exposure to UV
irradiation damaged DNA, resulting in a change in DNA conformation. [122] In contrast
to naked pDNA, PEI-DNA complexes incorporated into these hydrogels were retained
within the hydrogel during release test. However, the quantity of released DNA reached
only 14% of the initial loaded DNA at most, while the activity of the complexes was still
maintained to transfect MCF-7/WS8 cells in vitro. [121] (Figure 3.2) It was assumed that
there was non-specific interaction of PEI-DNA complexes with the hydrogel. However,
no further investigation was performed.
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Figure 3.2. Representative release profiles for cumulative release of DNA complexes
from HA-PEG gels. Release studies performed in the presence of PBS (a) or
150U/ml HAase (b). The percentages of PEG and HA in the hydrogel are;
PEG6:HA1(■), and PEG8:HA1(▲) for mechanically stable gels and PEG2:HA1 (□),
PEG4:HA2(○), and PEG4:HA4 (∆) for fully degradable gels
[Reprinted from Journal of controlled release 120 (2007) 233-241, Julie A. Wieland,
Tiffany L. Houchin-Ray, Lonnie D. Shea, Non-viral vector delivery from PEGhyaluronic acid hydrogels, Copyright (2004) with permission from Elsevier B.V.]

Mikos’s group has developed a number of synthetic materials based on fumaric
acid. [123, 124] These biodegradable materials include poly(propylene fumarate-coethylene glycol) (p(PF-co-EG)), and oligo(poly(ethylene glycol) fumarate) (OPF), either
one of which can be applied as an injectable liquid and crosslinked in situ to form a
crosslinked network using radical initiators with a poly(ethylene glycol) diacrylate
(PEGDA) crosslinker. [125, 126] Kasper and others tested DNA release from OPF
synthesized with the different MW of PEG, 3.5K or 10K. It was found that 80-81%
dsDNA out of the total loaded DNA was released in a sustained, linear fashion over 4562 days in vitro, depending on the degradation kinetics of hydrogels. [127] It was noted
that degradation kinetics of OPF was the mechanism controlling DNA release kinetics
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because the molecular size of pDNA is much larger than hydrogel mesh size (e.g.,
~13.6nm for OPF 10K hydrogel).
In conclusion, the kinetics of DNA release and transfection of intact released
DNA can be controlled temporarily depending on the degradation properties of
hydrogels. Controlled release of DNA from degradable polymer matrix over the
prolonged times can protect DNA from degradation as well as provide consistent or
elevated

levels

of

DNA

within

the

extracellular

environment.

However,

photopolymerization process was detrimental to DNA structural and functional integrity
and an initial burst was uncontrollable. Using nonviral vectors may be the solution to
protect DNA from UV exposure and change incorporation mechanism of DNA within
hydrogel network. However, unfavorable interaction of vectors with hydrogel during
crosslinking was problematic.
3.1.1.3. Scaffolds
Relative to hydrogels, porous scaffolds support increased cellular colonization
throughout the 3D structure and can provide increased mechanical properties required for
certain applications. Scaffolds offer the structural and functional replacement of damaged
tissues. In addition to these merits, the delivery of pDNA through localized polymeric
scaffolds may be an attractive approach to provide an opportunity to control local gene
expression directly in the tissue. Mooney’s group has incorporated pDNA alone or
polyplex into poly(lactic-co-glycolic acid) (PLGA) scaffolds, which were formed by gas
foaming techniques, in order to provide the sustained delivery of pDNA over a period
ranging from days to a month. [19, 128] In comparison to the delivery of uncondensed
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DNA encapsulated into scaffolds, implantation of PLGA scaffolds incorporating
condensed pDNA (β-galactosidase) via PEI into the subcutaneous tissue of rats resulted
in a high level of gene expression for the entire 15-week duration of the experiment. In
comparison to the highest expression level resulting from bolus delivery (direct injection)
of condensed DNA at the 2-week time point, the results from scaffolds incorporating
condensed gene complex clearly indicated the importance of a scaffold for sustained
delivery of condensed DNA with intensified and extended expression of transferred
genes. [128] Porous multiple channel bridges made from PLGA by the gas foaming
method, allowed cells to infiltrate through multiple channels as well as to be transfected
by release of incorporated DNA following bridge implantation when bridge loaded with
plasmid was implanted into rat spinal cord lateral hemisection. However, in vitro DNA
release study showed substantial burst release with approximately 75% of DNA within
the bridge was released during the first day. [129] Furthermore, Shea’s group coated this
porous multiple channelled PLGA scaffold with ECM components, for example, collagen
I, fibronectin and laminin I in order to improve cell adhesion and subsequent transgene
expression. [130] In this study, lipoplexes with Transfast were applied and incubated on
ECM-coated PLG surfaces, in contrast to the previous DNA encapsulation method.
Although higher levels of transgene expression overall were reported after spinal cord
implantation due to an increase in the number of cells adhered to the scaffold, the fast
release within an hour in a burst stage (about 69.3% release of lipoplexes) was still
observed and transgene expression lowered after one week. In fact, the release kinetics
for poly(α-hydroxy acids)-based scaffolds displayed an initial burst release and the acidic
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environment during scaffold degradation caused plasmid conformation change from the
supercoiled form to nicked and linear conformations over time. (Figure 3.3) [129, 131]

Figure 3.3. In vitro DNA release kinetics and agarose gel electrophoresis. (A)
Cumulative DNA release from scaffolds loaded with 200, 400, or 800µg of plasmid
(n=4 per dose) (B) Image of an agarose gel containing DNA released from a scaffold
at different times. Lane 1: molecular weight marker, Lane 2: unincorporated
plasmid, Lane 3-7:
7: DNA released at days 1, 3, 7, 14 and 21, respectively.
[Reprinted from Biomaterials 30 (2009) 394
394-401,
401, Christopher B. Rives, Anne des
Rieux, Marina
na Zelivyanskaya, Stuart R. Stock, William L. Lowe, Jr., Lonnie D.
Shea, Layered PLG scaffolds for in vivo plasmid delivery, Copyright (2008) with
permission from Elsevier Ltd.]

mediated delivery
3.1.2. Substrate-mediated
Substrate-mediated
mediated gene delivery or reverse transfection immobilizes pDNA or a
DNA complex to a substrate surface, which enables this system to directly deliver
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transgene to target cells that adhere to thesubstrate. [132] This delivery system can avoid
mass transfer limitations of bolus administrations. Novel cDNA microarrays for highthroughput transfection of adherent cells have been described based on this concept.
[133] There are two methods to immobilize gene complexes. One isspecific
immobilization and the other is nonspecific immobilization. [86, 134] Specific
immobilization was employed through the reaction between antigen and antibody or
biotin and avidin. Levy and colleagues investigated localized gene transduction from
collagen gels within a 50µm surrounding zone by use of the binding affinity between
avidin and biotin. [75] Basically, collagen gel was incorporated with avidin (avidincollagen gel) and adenoviral vector was incubated with biotinylated antihexon IgG, and
then two solutions were combined to produce the localized viral gene delivery system.
Although there is still a risk of viral vector use, this study addressed site-specific
localization and localized transgene expression in comparison to the bolus administration
which caused distal side-effects. [75] Not only binding of viral complexes but also
nonviral DNA complexes was developed, based on specific immobilization. Both
biotinylated polylysine and PEI formed complexes with plasmid encoding for luciferase,
and then they were tethered to the Neutravidin (NA)-containing surface. The
immobilization varied with the number of biotin residues per either vectors or complexes.
For polylysine complex, increasing the number of biotin groups present on polylysine
increased luciferase activity. [135] Furthermore, using spatially patterned NA-bound HAcollagen hydrogel with topographic features allowed binding of biotinylated complexes
as well as oriented cell growth. [56, 136] However, increasing the number of biotin
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residues on the complex induced strong avidin-biotin binding between the complex and
the surface, which interfered with gene complex release from the matrix, which lowered
transfection efficiency. [135]
In studies based on nonspecific immobilization, either lipoplexes or polyplexes
were immobilized by surface adsorption. The main issue with this approach is the affinity
of the DNA complex for the substrate that achieves a delicate balance between
immobilization and release. Shea’s group is one of the major groups to have focused on
DNA delivery via a substrate-mediated approach. To enhance cell attachment and DNA
cellular internalization, various serum and adhesive molecules such as fetal bovine serum
(FBS), bovine serum albumin (BSA), fibronectin, collagen and laminin were applied to
the polystyrene culture plate surface. [23, 134, 137] Substrate binding of DNA was
independent of the type of proteins except for laminin; however, fibronectin coating
supported the best cellular internalization and gene expression. [23] The type of gene
complex and molecular interactions between the complex and substrate also affect
transgene expression. For example, polyplexes with PEI increased gene expression on
serum-coated substrates, while lipoplex delivery with Lipofectamine exhibited equivalent
quantities delivered from the control group (no serum modification). These differences
may result from the different properties of vectors such as zeta-potential, size, chemical
composition, etc. [137] As continuing studies, the substrate-mediated delivery approach
via nonspecific complex immobilization and adhesive proteins coating was extended to
biomaterial scaffolds such as PLG. [138] Especially, patterned PLG substrates, which
were prepared with 50% FBS and pNGF-PEI complex immobilization, were employed to
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lead neurite extension (dorsal root ganglia) by co-culture over HEK293T cells transfected
on the PLG substrates. [139] In conclusion, DNA or gene complex-immobilized substrate
served to increase transfection efficiency and the number of transfected cells with a
relatively small amount of DNA required. Especially, the result of spatially patterned
surfaces suggested the selective transfection of cells adhered on the substrate which is
aligned along the patterns. However, in some cases, burst release was still observed
within a few hours. [138] In addition, although there was no significant difference in
quantities of DNA binding onto either hydrophilic or hydrophobic substrates, transfection
efficiency was significantly increased at the hydrophilic surfaces. [140, 141] Finally, the
substrate-mediated approach has not been widely studied in vivo, where exposure of
superficial DNA/gene complexes to enzymes in biological fluids may significantly affect
their activity.
3.2.

Conclusions
The incorporation of DNA into biomaterial matrices may provide an improved

alternative to bolus gene delivery. Both vector encapsulation systems and substratemediated systems have been developed to improve the transgene expression. Figure 3.4
summarizes the approach of two types of biomaterial matrices for localized gene
delivery. As vector encapsulation systems, hydrogels and porous scaffolds were
evaluated for their release kinetics and localization of gene expression. Overall,
encapsulation systems exhibit temporal control of DNA release kinetics depending on the
degradation properties of hydrogels whereas the initial burst release still remains an issue
to be solved. In natural polymer case, despite successful in vivo results, it still required
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high loading amounts of DNA to induce the desired therapeutic response for prolonged
periods. Also, enzymatic degradation can be another limitation to control DNA release
kinetics. On the other hand, synthetic polymer-based hydrogels can be prepared with
various types of polymerization/crosslinking in the presence of DNA, resulting in various
release profiles. However, DNA integrity can be damaged depending on the crosslinking
mechanism. Although poly(α-hydroxy acids)-based scaffolds are made of materials such
as PLGA already used in FDA-approved clinical applications and their preparation and
modification have been well known, the initial burst release and the acidic environment
produced by scaffold degradation are undesirable for gene delivery.
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(a)
(Continued)
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(b)
Figure 3.4. Schematic representation of biomaterial matrices for localized gene
delivery of DNA-based therapeutics using a nonviral DNA delivery vector: (a)
Vector encapsulation systems and (b) Substrate-mediated delivery
Following the substrate-mediated delivery mechanism, direct contact of DNA or
gene complex with cells adhered to the gene transfer substrate significantly improved cell
transfection by use of the small quantities of DNA, resulting from the elimination of the
undesirable interactions with ECM and serum proteins. Especially, the selective
transfection of cells adhered on the substrate which is aligned along the pattern suggests
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the potential of spatially controlled gene delivery. However, DNA release in the studies
to date was uncontrolled. Especially in the case of adsorption of DNA onto PLG scaffoldbased substrate, the porous scaffold-induced burst release observed within a few hours.
And it seemed that only 2D patterned structure has been studied. Taken together, gene
delivery system requires several factors including material composition and fabrication
compatible with pDNA, easily controllable degradation profiles avoiding the initial burst
release, and direct contact with targeting cell/tissue to remove the environmental barrier
to delivered DNA. The application of biomaterial matrices can potentially regulate the
time period of gene expression by manipulating the degradation rate of biomaterials. In
addition, this application can target tissue and organ sites to be transfected where the
biodegradable polymer matrix is implanted or injected. Furthermore, spatial patterning
combined with hydrogel controlled gene delivery system may be useful in regenerating
complex tissue structures such as central nervous system.
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CHAPTER FOUR
METHODS FOR GENE COMPLEX STABILIZATION DURING
LYOPHILIZATION AND pDNA QUANTITATION

Abstract
The investigation of matrix-based gene delivery requires effective methods for: 1)
concentrating gene complexes without causing DNA damage or reducing transfection
efficiency and 2) measuring the concentration of pDNA after polyplex/lipoplex
formation. The first set of studies reported in this chapter examined the effects of varying
polyethyleneimine (PEI) N/P ratio, sucrose/glucose cryoprotectants, and sugar/DNA
mass ratio on the transfection efficiency of PEI (polyplex) and XtremeGene (XG,
lipoplex) nonviral vectors after lyophilization. In order to measure pDNA release from
hydrogel matrices, it was essential to develop a decomplexation method that enabled
recovery of DNA condensed by nonviral vectors. The efficacy of various decomplexation
reagents such as pH12 TE buffer or 120mg/ml sodium tripolyphosphate (STP) was
investigated. STP treatment was shown to provide the highest pDNA detection levels
(relative to non-complexed controls) from both PEI and XG complexes. Finally, a reverse
transfection study was performed to provide initial proof of principle for the transfection
efficacy of hydrogel-encapsulated nonviral vectors in the presence of serum.

Keywords: cryoprotectant, decomplexation, lyophilization, N/P ratio, reverse
transfection, transfection efficiency
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4.1.

Introduction
Since the capability of lipoplexes and polyplexes for DNA delivery has attracted

attention, one major concern is to maintain their long-term physical stability because
these nonviral vectors readily aggregate in liquid, resulting in reduced transfection
efficacy. [142, 143] Early studies in systemic gene delivery demonstrated that unless the
injection was performed immediately after the complex preparation, it was necessary to
develop a stabilization method, maintaining transfection efficiency after long-term
storage. When biomaterial matrices such as hydrogels incorporate or encapsulate DNA or
a gene complex, the gene complexes must be concentrated in order to obtain suitable
loading amounts. A lyophilization process was developed to provide the prolonged
stability of DNA or DNA complex. [144, 145] The process is an economical approach to
maintain the efficacy of DNA-based therapeutic products during transportation and
storage. The lyophilization process involves freezing and drying stresses that may cause
damage to DNA. Naked DNA, without protection by cationic lipid or polymer vectors,
was degraded upon freezing, called cryolysis, resulting in DNA strand breaks. [146]
Condensation of DNA with cationic lipid or polymer seemed to maintain the complex
stability better than naked DNA during a rapid cooling process, for example, snapfreezing in liquid nitrogen or ethanol and dry ice. However, DNA strand breakage was
still observed as well as an increase in size of complexes due to aggregation, which
resulted in a decrease in transfection efficiency. [147] Therefore, the addition of a
stabilizing component or cryoprotectant, for instance, sugars, was investigated to prevent
aggregation during freezing and to provide protection during dehydration. [148]
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Sugar protection can be explained by three mechanisms; glassy matrix formation,
particle isolation during the freezing process, and water replacement by sugars. [144, 145]
As a cooling process lowers the temperature, sugars readily form a glassy structure able
to immobilize complexes within this matrix and eventually prevent complex aggregation.
The glass transition temperatures (Tg) of various sugar types showed that sugars
possessed high Tg values in the range of approximately 60 °C to 78°C except for glucose,
which explained the glassy state during freeze drying. (Table 4.1) [149] However,
glucose fully protected transfection activity and size even though it is in the rubbery state.
Also, a change in the disaccharide concentration affected the preservation of transfection
activity, despite both samples maintaining the glassy state. So, glassy matrix formation
alone was not sufficient to explain the protective mechanism. Since transfection
efficiency is related to complex particle size, the prevention of aggregation is critical
during the lyophilization process. Aggregation can happen during freezing because gene
complexes are concentrated into the unfrozen fraction of a solution. It may be essential to
isolate different components within a sugar matrix. [150] For example, although PEG
does not have a measurable Tg [149] and is known to crystallize during lyophilization, 5%
PEG (MW8000) was shown to preserve relatively small gene complex sizes and high
transfection efficiency among the tested conditions. (Table 4.1) [149] The effect of PEG
on the particle size was extended to the study of PEGylation effects on the complexes.
[151] The water replacement mechanism can be explained by hydrogen bond formation
between sugars and lipoplexes. The water replacement hypothesis was studied by John
and Lois Crowe over more than two decades; demonstrating that sugars serve as a
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substitute for structural water associated with lipoplex surfaces during dehydration. [148,
152, 153] Regardless of the relative contributions of these mechanisms, evidence to date
suggests that lyophilization with an optimal amount of cryoprotectant might be applicable
to the stable concentration of gene complexes. However, the choice of cryoprotectants
would be critical due to the different protection properties. Furthermore, it was found that
the sugar/DNA ratio appeared to be the critical factor and an isotonic sugar solution
should be prepared at the concentration only sufficient to protect, for examples, 5%
glucose, 5% dextrose, 10% sucrose, etc. [150] Hydrogel compositions for gene delivery
in this study is based on matrix-based gene delivery, which requires the effective method
to concentrate the desirable amount of DNA without damage to DNA as well as a change
in transfection efficiency. Since lyophilization with 5% glucose or 10% sucrose showed
the potential to stabilize gene complexes for a long-term period, the influence of those
cryoprotectants on the transfection efficiency and DNA stability of initial nonviral gene
complexes should be considered before the investigation of transfection efficacy of genes
mediated by a hydrogel matrix. Therefore, the first objective of these studies was the
development of a lyophilization method for PEI (polyplex) or X-tremeGene (lipoplex)
vectors incorporating a plasmid encoding green fluorescent protein (pGFP) as an easily
assayed gene product. The condensation of DNA during complexation with cationic
materials also substantially reduces its accessibility to DNA binding dyes required for
pDNA quantitation. In fact, signal reduction from DNA-binding dyes has commonly
been used in the gene therapy literature as an assay for the efficacy of complex formation.
In order to effectively measure concentrations of nonviral gene complexes (particularly
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following release from matrices), various strategies for decomplexation were investigated
including treatment with heparin, addition of sodium tripolyphosphate or SDS. [118, 154]
The PicoGreen DNA-binding dye that exhibits fluorescence enhancement selectively
after binding double stranded DNA was used to measure the efficacy of decomplexation
relative to naked DNA controls. Finally, as proof of principle, a preliminary “reverse
transfection” experiment was performed in which the transfection efficiency of PEI-based
polyplexes lyophilized on the culture substrate was compared to conventional bolus
addition of vector to the culture medium in the presence of serum.
Table 4.1. Glass transition and crystal melt temperatures for DMRIE-C-DNA
complexes lyophilized with various additives
Concentration
Additive
Tg (°C)
Tm (°C)
(%, w/v)
1
55.0
PEG 8000
5
55.7
1
75.2
Hydroxyethyl starch
5
71.2
1
161.8
Mannitol
5
162.4
1
59.9
Sucrose
5
61.8
1
67.1
Trehalose
5
69.5
1
67.1
Lactose
5
77.5
1
2.2
Glucose
5
7.0
[Reprinted from Journal of pharmaceutical sciences 89 (2000) 682-691, S. D. Allison,
T. J. Anchordoquy, Mechanisms of protection of cationic lipid-DNA complexes
during lyophilization, Copyright (2000) with permission from Wiley-Liss, Inc. and
the American pharmaceutical association]

4.2.

Materials and methods

4.2.1. Materials
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Branched PEI (b-PEI; Aldrich, MW 25kDa), fibronectin (0.1% solution from
bovine plasma), and paraformaldehyde and antibiotics (10000I.U. penicillin- 10000µg/ml
streptomycin solution) were purchased from Sigma-Aldrich Co (St. Louis, MO). b-PEI
was diluted in water and syringe-filtered. Tryptone, yeast extract, agar, D(+)-sucrose
(biochemical grade), D(+)-glucose (anhydrous), ethidium bromide (EtBr), and water
(DNase-, RNase- and Protease-free) were obtained from Acros Organics (NJ, USA).
Sodium chloride, sodium tripolyphosphate (STP) and sodium dodecyl sulfate (SDS) were
from Fisher Scientific (NJ, USA). A plasmid vector encoding Monster Green Fluorescent
Protein under a CMV enhancer promoter and an ampicillin resistance gene (pGFP),
Triton® X-100 (molecular biology grade), agarose (LE, analytical grade), blue-orange 6x
loading dye, and 1kb DNA ladder were purchased from Promega Corp (Madison, WI).
DMEM/F12 (50/50, 1x) and 10000I.U. penicillin/10000µg/ml streptomycin stock
solution were obtained from Mediatech. Bovine growth serum (BGS) was from Hyclone
(Logan, UT). Opti-MEM (Gibco®), fluorescein diacetate (FDA), propidium iodide (PI)
and 4'-6-Diamidino-2-phenylindole (DAPI), and DH5αTM chemically competent E. coli
were obtained from Invitrogen Corp. EndoFree plasmid Maxi and Mega kits were
purchased from Qiagen. (Valencia, CA) X-tremeGene (XG) was donated by Roche
molecular biochemicals (IN, USA) and served as a model cationic lipid. XG is designed
and optimized for transfection and high-level protein expression in HeLa, NIH 3T3, Hek
293 cells, or other mammalian cells.
4.2.2. Transformation of plasmid into chemically competent E. coli and DNA
purification
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pGFP was transformed into DH5α chemically competent E. coli by heat shock
according to the manufacturer’s protocol. Transformed E. coli was spread on pre-warmed
LB-agar plates (15g/l agar) containing 100µg/ml ampicillin (LB media: 1% Tryptone,
0.5% yeast extract, and 1% sodium chloride, autoclaved) by use of a metal spreading bar
that was cleaned with ethanol and flame-sterilized between each use. As a control , nontransformed E. coli were also plated on LB-agar plates without ampicillin to ensure that
only transformed cells grew in the ampicillin environment. After overnight incubation in
a 37°C incubator, a single colony was picked from a freshly streaked selective plate and
inoculated in a 4ml or 8ml LB starter culture containing the 100µg/ml ampicillin for
EndoFree plasmid Maxi or Mega kits, respectively. Larger scale cultures were inoculated
and plasmid purified using either EndoFree plasmid Maxi or Mega kits according to the
manufacturer’s instructions depending on the required yield of purified DNA. DNA
concentration

was

quantified

by

UV

absorbance

(Beckman,

DU®640B

spectrophotometer) at 260 nm. Agarose gel electrophoresis and the A260/280 ratio were
used to verify DNA purity and quality.
4.2.3. Optimization of conventional transfection
To determine the optimal condition for gene complex formation, the transfection
efficiency of freshly prepared complexes of pGFP with either b-PEI or XG was
investigated. For PEI complexes, transfection efficiency was compared between
complexes prepared at N/P ratios of 5 and 7.5. For conventional bolus transfection, PEI
was gently mixed with 2µg pGFP, in sterile, deionized water (70µl total volume) at
nitrogen-to-phosphate (N/P) ratios of 5 and 7.5. The calculation of N/P ratio is described
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in Appendix A. After mixing, the complex solution was incubated for 30 min at room
temperature. XG served as a model cationic lipid. It was used for transfection according
to manufacturer’s protocol. Briefly, two separate suspensions of XG reagent and 2µg of
pGFP were prepared in Opti-MEM and then mixed together. The mass ratio of XG
reagent to DNA was kept at 5:1. NIH 3T3 fibroblasts were routinely cultivated in
DMEM/F12 with 10% bovine growth serum (BGS) and 1% antibiotics. 1×105 cells per
well of NIH 3T3 fibroblasts were seeded in 12-well plates one day before the transfection
experiment to achieve the optimal cell density (50-70 % confluence) for transfection.
Serum-containing culture medium was replaced with fresh serum-free media, after two
rinses with serum-free media. After addition of each complex, the plates were incubated
for 6 hours, then the medium exchanged with serum-containing culture medium. At 24
and 48 hours post-transfection, the cells were fixed with 4% paraformaldehyde and
stained with DAPI to identify all cell nuclei. Digital fluorescent image analysis was
performed to quantify transfection efficiency as the ratio of GFP+ to total cells.. Freshly
prepared complexes with PEI and XG were designated FC PEI and FC XG, respectively.
4.2.4. Effect of various cryoprotectants on the in vitro transfection efficiency
Both 10% w/v sucrose and 5% w/v glucose were evaluated as cryoprotectants in
this study and the volume of cryoprotectant to be added was fixed to 10% v/v of total
complex volume. Briefly, PEI (N/P=5 and 7.5) was mixed with 2µg pGFP in sterile,
deionized water (90% of total volume=63µl) and incubated at 37°C for 25 minutes. After
complexation, 7µl of cryoprotectant solution was added (total volume=70µl) and
incubated at 37°C for 5 minutes. In this case, either 7mg sucrose or 3.5mg glucose were
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added to each complex, respectively. Since XG complexes were prepared in different
volume from PEI complexes, two different addition methods were compared; one method
was the addition of cryoprotectant at the same sugar/DNA ratio as used for PEI/pGFP
complexes. That is, either 7mg sucrose or 3.5mg glucose were added to each complex.
On the other hand, either 10% w/v sucrose or 5% w/v glucose were evaluated, for
example, either 20mg sucrose or 10mg glucose were added to each complex sine the total
volume of XG complex was 200µl. Complexes were rapidly frozen in dry ice/ethanol and
immediately

lyophilized.

For

transfection

experiments,

lyophilized

complexes

(designated LC PEI and LC XG) were resuspended in the same volume of sterile,
deionized water for PEI complex and Opti-MEM for XG complex as before drying and
used to transfect fibroblast cultures as described above. Complexes lyophilized without
the addition of a cryoprotectant were prepared as negative controls. Transfection
efficiency was analyzed as described above.
4.2.5. Gel retardation assay
To demonstrate efficient and stable complexation, a gel retardation assay was
performed. The complexes were electrophoresed on a 1% (w/v) agarose gel containing
0.5µg/ml of EtBr. DNA was visualized with a UV illuminator (Alpha Innotech
FluorChemTMSP) and Alpha Ease FC software (version 4.1).
4.2.6. Decomplexation of gene complex
The condensation of DNA with nonviral vectors blocks interactions with DNAbinding dyes and interferes with quantifying the amount of DNA. Since there was no
optimal decomplexing method, various reagents such as pH12 TE buffer, and STP
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(120mg/ml) were compared to dissociate DNA from either PEI or XG complexes. In
addition, 0.2mM, 20mM, 34.7mM (1%) and 1M SDS and 0.1% Triton X-100 were
evaluated as decomplexing agents only for the XG complexes. Increasing pH causes
deprotonation of nonviral vectors and their dissociation from DNA. [55] Excessive
amounts of STP and SDS electrostatically interact with cationic vectors, which results in
the dissociation of DNA. Triton X-100 is a well known detergent and lysis buffer, which
solubilizes lipids. A volume of 50 µl of gene complex solution and each decomplexing
solution were mixed and incubated at room temperature for 30 minutes. The amount of
DNA was measured by PicoGreen assay.
4.2.7. PicoGreen quantification of DNA
PicoGreen® is a fluorochrome that selectively binds dsDNA and allows efficient
DNA quantitation with high sensitivity. A standard curve encompassing the range of
expected sample concentrations was prepared from a stock solution of naked pGFP.
Standards and decomplexed samples were assayed according the manufacturer’s protocol.
Briefly, 100µl samples of pDNA/decomplexation agent were mixed with 100µl
PicoGreen working stock and analyzed with a Bio-TEK synergy HT multimode
microplate reader with KC4 software using 480 nm excitation and 520 nm emission
wavelengths. Duplicate or triplicate samples were averaged and normalized for
background readings obtained from samples without pDNA.
4.2.8. Reverse transfection in the presence of serum
Transfection complexes containing PEI (N/P 7.5) or XG with 2µg pGFP were
prepared in the same manner as the lyophilized complex. The resulting complexes were
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pipetted onto the fibronectin (25µg/ml)-coated or uncoated lab-made wells (about 24well
size) on the Petri dish for bacteria culture. After addition of complexes, the Petri dish was
snap-frozen with dry ice and ethanol bath and freeze-dried overnight. After lyophilization,
NIH 3T3 fibroblasts were seeded on the wells on the Petri dish (1×105 cells/well) and
transfection was carried out in the presence of 10% BGS without any treatments nor
medium renewals. Two days after transfection, samples were stained with 1 µM
fluorescein diacetate/2.5 µM propidium iodide (FDA/PI), rinsed with PBS, visualized by
fluorescence microscopy (Zeiss Axiovert 200), and digitally imaged to assess cell
viability and morphology. Transfection efficiency was compared with conventional
transfection performed by the direct addition of resuspended lyophilized complexes to
pre-seeded cells in the presence of serum.
4.2.9. Statistical analysis
Statistical analysis was performed by single factor ANOVA using Tukey's HSD
method for post hoc comparisons, where p values <0.05 were considered to be
statistically significant. All results were expressed as mean ± standard deviation.
4.3.

Results

4.3.1. Optimization of transfection condition
Figure 4.1 shows the transfection efficiency of of freshly prepared and lyophilized
complexes of pGFP with b-PEI. Overall, PEI complexes prepared at N/P 7.5 exhibited
significantly better transfection than at N/P 5, resulting in more than threefold increase in
the percentage of GFP+ cells. Relative to freshly prepared complexes at both N/P ratios,
lyophilization caused a significant decrease in transfection for all conditions, resulting in
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3.14% (±1.9), 9.47% (±3.44) and 9.99% (±3.54) for N/P5 PEI, N/P7.5 PEI and XG
complexes at 10% w/v sucrose condition. Although there was no significant difference in
transfection efficiency of LC PEI at N/P 7.5 prepared with 5% glucose and 10% sucrose,
lyophilized complex with 10% w/v sucrose exhibited higher average values of
transfection efficiency.

Figure 4.1. Comparison of transfection efficiency of PEI-pGFP complexes at various
N/P ratios; freshly prepared complex (= FC), lyophilized complex with 5% w/v
glucose (= LC, 5% glucose), lyophilized complex with 10% w/v sucrose (= LC, 10%
sucrose), p<0.05, letters represent the significant difference between groups

The transfection efficiency of XG complexes under two conditions was shown in
Figure 4.2. In one condition, maintaining constant sugar:DNA mass ratio was maintained,
while in the other condition a final sugar concentration comparable to the conditions used
for PEI-based complexes was used. Lyophilization had no significant influence on the
transfection efficiency of XG complexes. As a result, although freshly prepared PEI

60

complexes at 7.5 N/P ratio provided significantly higher transfection of 16.54% (±3.55)
than XG (10.34±3.42%), XG-based complexes achieved similar transfection efficiencies
after lyophilization to freshly prepared one.

Figure 4.2. Transfection efficiency of XG-based complexes with various preparation
conditions; freshly prepared XG-pGFP complex (= FC XG), lyophilized XG-pGFP
complex with 3.5mg glucose (= LC XG, 3.5mg glucose), LC XG with 5% w/v glucose
(10mg) (= LC XG, 5% glucose), LC XG with 7mg sucrose (= LC XG, 7mg sucrose),
and LC XG with 10% w/v sucrose (20mg) (= LC XG, 10% sucrose)
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Figure 4.3. Relative transfection efficiency of lyophilized complexes over freshly
prepared complexes, p<0.05, * represents significant difference in comparison with
freshly prepared complex
Under our conditions, N/P=7.5 PEI complexes and XG complexes lyophilized
with 10% w/v sucrose exhibited the closest transfection efficiency relative to freshly
prepared complexes. However, LC PEI retained only 57.26% of FC PEI transfection
efficiency and was not as efficient as LC XG in fibroblast transfection. (Figure 4.3)
Representative photomicrographs of fibroblasts transfected with these polyplexes and
lipoplexes both freshly prepared and lyophilized are shown in Figure 4.4.

62

(a)

(b)

(c)

(d)

(e)

(f)
(Continued)
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(g)

(h)

Figure 4.4. Transfection of NIH 3T3 fibroblasts after administration of freshly
prepared (a, b) PEI-pGFP complex and (c, d) XG-pGFP complex, and lyophilized
(e, f) PEI –pGFP complex and (g, h) XG-pGFP complex with 10% w/v sucrose;
Green fluorescent images of pGFP transfected fibroblasts on the left and blue
fluorescent images of DAPI nucleic acid stained fibroblasts on the right

4.3.2. Decomplexation of gene complex
The result of the efficacy of pH12 TE buffer and 120mg/ml STP for
decomplexation is shown in Figure 4.5. When assayed in pH 7.4 TE buffer without
decomplexation, less than 10% of the original amount of DNA could be detected in both
PEI and XG complexes. Following exposure to pH12 TE, 77.74 % (±8.44) and 77.94 %
(±8.30) of initial DNA was measured from FC PEI and LC PEI, respectively. However,
in the XG complex case, 44.33 % (±5.99) and 40.92 % (±3.37) of initial DNA was
detected from FC XG and LC XG, respectively. In comparison with pH12 TE treatment,
120mg/ml STP treatment exhibited significantly better decomplexation, especially, 93.03 %
(±2.06) and 92.65 % (±0.41) detected amount from FC PEI and LC PEI, respectively.
Although there was significant improvement in decomplexing DNA from XG complexes,
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DNA amounts detected were still lower than the amounts from PEI complexes, 66.18 %
(±4.64) and 55.14 % (±1.09) of initial DNA from FC XG and LC XG, respectively.

Figure 4.5. The percent amount of DNA measured over the naked DNA at pH7.4 as
control after the various decomplexation treatment, 30 min incubation for
decomplexation, p<0.05, * and # represent significant difference of each complex
between pH12 TE treatment and 120mg/ml STP treatment, and significant
difference between complexes treated with 120mg/ml STP, respectively

The results of agarose gel electrophoresis are shown in Figure 4.6. When the
complexes were treated with pH12 TE, no appearance of retarded DNA bands was
observed. In the case of STP treatment, DNA dissociated from both PEI and XG
complexes still remained in the supercoiled conformation. However, the majority of
DNA dissociated from both FC PEI and LC PEI was retained in or near the gel well and a
very small portion of the supercoiled conformation was detected. Although PEI
effectively transfected NIH 3T3 fibroblasts in Figure 4.4, LC PEI exhibited 57.26% of
FC PEI transfection efficiency in Figure 4.3.
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(a)

(b)

Figure 4.6. Images of an agarose gel electrophoresis to show stability of plasmid
DNA before and after decomplexation with (1) pH12 TE treatment for 30minincubation and (2) 120mg/ml STP treatment for 4 hour-incubation; Decomplexation
of (a) PEI-pGFP complexes and (b) XG-pGFP complexes, Lane 1: 1kb DNA ladder

To improve the decomplexation method and recover more DNA dissociated from
XG complex, the decomplexing efficacy of various concentrations of SDS and 0.1%
Triton X-100 were investigated. (Figure 4.7) Unfortunately, neither method worked as
efficiently as 120mg/ml STP solution. DNA was able to be detected only when 0.2mM
SDS was employed. None of the other concentrations of SDS resulted in DNA
dissociation.
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Figure 4.7. The efficiency of various decomplexation methods for XG-mediated
complexes, 30 min incubation for decomplexation, p<0.05, letters represent the
significant difference between treatments

As shown in Figure 4.7, under our experimental condition, 120mg/ml STP was
the most efficient decomplexation method while the detected DNA amounts were only
about 66% and 55% for FC XG and LC XG, respectively. To improve its decomplexation
efficacy, various incubation times were employed. As shown in Figure 4.8, increasing
incubation time helped to dissociate DNA and increased DNA amount detected by
PicoGreen assay. Especially, almost 90% DNA were recovered from both FC XG and LC
XG at 4 hour incubation of XG complexes.
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Figure 4.8. The effect of incubation time on decomplexation of XG-mediated
complex with 120mg/ml STP, p<0.05, * and # represent significant difference
relative to 0.5 hr incubation FC XG and LC XG, respectively

4.3.3. Reverse transfection
In reverse transfection with LC PEI, transfection and GFP expression

was

observed even in the presence of 10% serum whereas conventional bolus addition of
complexes to the culture medium achieve minimal transfection or GFP expression. Cells
cultured over LC PEI adsorbed dish showed transfection for one day while the
conventional delivery of LC PEI exhibited almost zero transfection. Transfected cell
images by LC PEI in the reverse and conventional delivery methods were shown in
Figure 4.9.
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(a)

(b)

Figure 4.9. NIH 3T3 fibroblasts transfected by PEI complex (a) in the conventional
delivery method and (b) in the reverse transfection method in the presence of 10%
bovine growth serum, cells were cultured on the substrate without fibronectin

In reverse transfection with XG complex, fibronectin coating was applied to the
Petri dish surface to ensure consistent cell attachment. Uncoated substrate was studied at
the same time. Relative transfection efficiency of both conventional bolus transfection
and reverse transfection is shown in Figure 4.10. Without fibronectin coating, slight
increased cell transfection values were shown in reverse transfection despite no
significant difference. The presence of fibronectin improved cell attachment to the
surface and significantly affected transfection efficiency. Reverse transfection of LC XG
achieved a fourfold increase in the percentage of GFP+ cells on fibronectin-coated
substrates than conventional transfection with LC XG.
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Figure 4.10. Comparison of the transfection efficiency between conventional bolus
method and reverse transfection method, performed in the presence of 10% BGS,
p<0.05, * represents significant difference in comparison with conventional bolus
transfection with fibronectin (FN) coating on the Petri dish surface

4.4.

Discussions
In these studies, two different N/P ratios of PEI complexes were compared and

the higher ratio (7.5) found to yield significantly higher transfection efficiency. (Figure
4.1) The N/P ratio is well known as a critical factor influencing both transfection
efficiency and cell cytotoxicity. Ratios ranging from 5 to 13.5 have been presented in the
literature, although the optimal ratio commonly differs among investigators and
applications. Ferrari and others reported better transfection efficiency in vitro by use of
linear PEI (ExGen 500) at a 5 ratio that resulted in neutral particle charge, while Boussif
and colleagues indicated maximal transfection efficiency in the range of 9 to 13.5 ratios.
[155-157] Overall, when PEI complexes were prepared at higher ratios and with
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increasing positive charge, greater levels of cytotoxicity were observed. In the present
studies, increasing the N/P ratio to 10 resulted in severe cytotoxicity (data not shown).
Overall, the choice of cryoprotectant did not significantly affect the transfection
efficiency of lyophilized N/P 7.5 PEI complexes and XG complexes. (Figure 4.1 and 4.2)
Various studies have investigated the feasibility of lyophilization to physically stabilize
nonviral vectors. [158, 159] Lyophilization requires the addition of cryoprotectants and
sucrose has been the most widely studied cryoprotectant in the literature. [144, 145, 147,
149, 150] The addition of sucrose to nonviral gene complexes such as PEI-DNA gene
complex and various lipoplexes prevented complex aggregation and helped to maintain
transfection. However, lyophilization process induced the activity loss of each complex
even in the presence of cryoprotectants in this study. While cryoprotection effectively
preserved XG complex bioactivity, the transfection efficiency of PEI-based complexes
was significantly reduced by lyophilization under all conditions. As shown in Figure 4.6,
reduced amount of supercoiled conformation might affect transfection efficiency of LC
PEI.
The protective mechanism of cryoprotectants is still unclear and the preservation
of transfection is controversially discussed in the literature. Some studies have reported
an increase or preservation in transfection efficiency after lyophilization, while more than
30% of transfection activity was lost following simple dehydration. [147, 149] Allison
and others investigated mechanisms of cryoprotection of nonviral complexes during
lyophilization. [149] Although glucose had low Tg values (Table 4.1) and complexes
dried with glucose seemed to be collapsed during drying, their results showed that the
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particle size and transfection efficiency were well preserved. However, the lowest
transfection activity with 5% w/v glucose was observed in the present studies. The
sugar/DNA ratio has been discussed as a critical parameter. [159] Figure 4.2 showed that
the transfection efficiency after lyophilization slightly increased with an increasing
amount of cryoprotectant, although the changes were not statistically significant. This is
inconsistent with the outcome reported by Brus and others that smaller amounts of
cryoprotectant were required to maintain the particle size and fully recover transfection
efficiency. [159] Also, Anchordoquy and others reported 1% w/v of disaccharide to the
complexes reduced particle aggregation and helped preserve transfection. [145] In
contrast, Molina and colleagues reported that sucrose/DNA mass ratios of 7500
effectively preserved particle size of PEI complexes despite lowering transfection
efficiency. [158] On the other hand, Talsma and others used higher mass ratio (10000) of
sucrose to DNA and showed well preserved transfection efficiency. [160] Again, the
protection mechanism of cryoprotectants is still unclear and is requires further study.
Decomplexation is an important step for gene delivery analysis. In these studies,
120mg/ml STP was the most effective method to decomplex DNA from nonviral vectors,
which indicated that interaction of negatively charged small molecules with positively
charged PEI or XG was more effective for dissociation of DNA than vector
deprotonation by alteration of buffer pH. (Figure 4.5) The result of agarose gel
electrophoresis as shown in Figure 4.6 supported a choice of STP treatment for
decomplexation because there was no appearance of DNA bands after pH12 TE treatment
although the reason for this outcome is unclear. In order to attempt to improve DNA
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detection, EtBr was also added directly to the samples in the loading buffer rather the
incorporation within the gel. Unfortunately, this method did not help to improve DNA
detection (data not shown). Although several other agents were investigated for XG
decomplexation, none was as effective as STP. It was finally discovered that the
incubation time of samples with STP solution was the critical factor. (Figure 4.8) As
composition of XG is not provided by the manufacturer due to confidentiality, we can
only guess that long nonpolar tails of lipids may act as steric barrier to the approach of
STP molecules.
As expected, a “reverse transfection” strategy in which vectors were localized on
the substrate surface and thereby concentrated near the cell surface achieved a dramatic
increase in transfection efficiency in the presence of 10% serum relative to conventional
bolus vector delivery for which transfection was very low. (Figure 4.9 and 4.10) Relative
gene expression of LC XG in reverse transfection was fourfold higher than in bolus
transfection. The same experiments were conducted with LC PEI without fibronectin
coating and reverse gene delivery method improved gene expression as well. However,
we were unable to calculate transfection efficiency from this experiment due to cell
detachment. Although it was reported that PEI complex itself was sufficient for cell
immobilization at regular tissue culture polystyrene (TCPS) plates, this did not appear to
be the case for bacterial Petri dish. [161] Under out experimenetal conditions, excess PEI
charge helped cell adhesion in comparison to without complex at the surface only for one
day. Reinisalo and others performed the similar studies, employing reverse transfection
with various MW PEI complexes on the PLL/laminin treated 48-well plates. [161] They
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compared the data from conventional transfection with serum-free media with reverse
transfection in the presence of serum. Reverse transfection exhibited 80-100% of
transfection via conventional transfection. Furthermore, the reverse transfection-based
system provided the long-term stability of transfection activities.
4.5.

Conclusions
In these preliminary studies, factors critical to effective lyophilization and

decomplexation were evaluated and optimized. All XG formulations and N/P 7.5 PEI
complex lyophilized with 10% sucrose exhibited similar transfection efficiencies
following lyophilization. Because XG is a proprietary material of undisclosed
composition, N/P 7.5 PEI was selected for future studies (Chapter 7) 120 mg/ml STP
treatment was identified as the most effective decomplexation solution and selected for
use in future studies for measuring amounts of released PEI/pDNA complexes from
hydrogels. As a pilot study, the dramatic improvement of transfection efficiency by
reverse transfection in the presence of serum suggests that hydrogel-based delivery of
nonviral vectors may concentrate vectors near the surface of adherent cells in a similar
manner and also achieve improved transfection efficiency. Relative to substrate-mediated
reverse transfection approaches, it is expected that encapsulation of vectors within a
hydrogel matrix may provide improved vector stability.
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CHAPTER FIVE
A NOVEL SYNTHETIC ROUTE FOR THE PREPARATION OF
HYDROLYTICALLY DEGRADABLE SYNTHETIC HYDROGELS
(Adapted from Journal of Biomedical Materials Research, Part A,
2009. 90(4): p.1073-82)

Abstract
Synthetic hydrogels offer a number of advantages as matrices for gene delivery
including reproducibility, tailoring of adhesive properties to target desired cell
populations, and the controlled variation of degradation rate and mechanical properties.
These studies describe the development of a novel, two-step synthetic route for the
preparation of hydrolytically degradable, crosslinkable PEG-based macromers based on
chemical intermediaries that form ester linkages with variable alkyl chain length.
Through variation in the alkyl chain length of the chemical intermediary, variable
degradation times ranging from weeks to months were achieved, while consistent
swelling properties were maintained. Macromer solutions were coated on CCP fibers and
crosslinked by photo-initiated polymerization. However, the resulting hydrogel coatings
were unstable and exhibited rapid delamination upon exposure to aqueous solutions.

Keywords: controlled release, crosslinkable, hydrogel coating, hydrolytically degradable,
polyethylene glycol, synthetic hydrogel

75

5.1.

Introduction
Hydrogels have been widely investigated for biomedical applications, including

drug/protein/DNA delivery systems and matrices for cell encapsulation as well as
transplantation. [162-164] Among their beneficial properties, aqueous solutions of
monomers/macromers can be delivered by minimally invasive surgical techniques and be
formed in-situ under relatively mild conditions. The resulting hydrophilic, crosslinked
structures form highly water swellable, yet insoluble polymer networks with similar
physical properties to many soft tissues. Hydrogels can be formed from both biologicallyderived and synthetic polymers. While biologically-derived hydrogels, such as chitosan,
fibrin, collagen, and gelatin are intrinsically cell adhesive and degradable by cellular
proteolytic enzymes, synthetic hydrogels offer advantages in reproducibility, availability,
and tailoring of physical/chemical properties to desired applications. [107, 165-168]
One common strategy for the creation of synthetic hydrogels has been the
modification of water soluble polymers such as poly (ethylene glycol) (PEG) and poly
(vinyl alcohol) (PVA) with vinyl end groups and their subsequent crosslinking by photoor redox-initiated free radical polymerization. Due to the non-degradable nature of the
polymer backbone and the limited degradation of vinyl esters following free radical
polymerization, considerable effort has been directed toward the modification of these
polymers with hydrolytically degradable groups. Sawhney and Hubbell first described the
synthesis of hydrolytically degradable, crosslinkable synthetic copolymers, which
consisted of a hydrophilic PEG center block co-polymerized with poly (lactic acid)
(PLA) or poly (glycolic acid) (PGA) and end-capped with acrylate groups. [116] They

76

showed that the hydrogel degradation properties could be controlled through variation of
PEG molecular weight, and the chemical composition and degree of polymerization of
the polyester blocks. Later, Metters and colleagues developed a mathematical model that
predicted the network mass loss of PLA-b-PEG-b-PLA based on several fundamental
parameters, including the hydrolysis rate of the degradable linkages, polymer
concentration, and the crosslink density. [117]
In recent years, a variety of alternative chemistries have been investigated for the
creation of hydrolytically degradable, crosslinkable synthetic macromers. Anseth and coworkers developed degradable, crosslinkable PVA networks by grafting of methacrylateterminated PLA oligomers and showed that degradation was controllable through
variation of polymer molecular weight and degree of functionalization. [169-171] Wang
et. al. reported the modification of PEG with a hydrolytically degradable phosphoester
linkage and terminal methacrylate groups. [172] Mikos and co-workers synthesized
novel oligo(PEG fumarate) (OPF) oligomers by the reaction of PEG with fumaryl
chloride, generating multiple ester and double bonds in the polymer chains, which were
crosslinked by photo- and redox-initiated radical polymerization. [124] Variation of PEG
molecular weight provided control of gel swelling, mechanical properties and
degradation rate. [125, 126]

Hubbell and co-workers have recently described the

crosslinking of acrylated multi-arm PEGs with multi-functional thiol compounds by
Michael-type addition, yielding networks with varying rates of hydrolytic degradation as
a function of polymer concentration and functionality. [173, 174]
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Many of the methods described above achieve variable degradation through
changes in macromer concentration, functionality, and molecular weight that produce
corresponding changes in the network physical properties such as equilibrium swelling
and elastic modulus. Vyavahare and colleagues described the synthesis of a degradable
hydrogel crosslinker, 2-hydroxyethyl glycolate dimethacrylate, by conjugating two
hydroxylethyl methacrylate groups with a difunctional chemical intermediary,
chloroacetyl chloride. [175] These studies describe the adaptation and expansion of this
method for the preparation of hydrolytically degradable as well as crosslinkable
macromers based on water soluble, hydroxyl-terminated polymers such as PEG. In this
chapter, hydrogels with consistent physical properties and variable degradation rates
ranging from weeks to months were obtained through variation of the alkyl content of the
chemical intermediary. The feasibility of fiber coating by use of newly developed
hydrogels was evaluated.
5.2.

Materials and Methods

5.2.1. Materials
Polyethylene glycol (PEG) and chloroacetyl chloride were purchased from Fluka
(Buchs, Switzerland). 2-chloropropionyl chloride, 4-chlorobutyryl chloride, sodium
acrylate, triethylamine (TEA), 4-methoxyphenol, poly(ethylene glycol) diacrylate
(PEGDA, Mn258, inhibited with 100ppm MEHQ) and inhibitor remover column
(disposable column for removing hydroquinone and MEHQ) were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Inhibitor from PEGDA was removed by remover
column and the filtered product was stored at 4°C, avoiding light. Anhydrous sodium
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sulfate and ethyl ether were from Fisher scientific (NJ, USA). Irgacure 2959 (2-hydroxy1-[4-(hydroxyethoxy) phenyl]-2-methyl-1-propanone, I-2959) was obtained from Ciba®
Specialty Chemicals (Basel, Switzerland) and prepared as a 10% stock solution in 70%
ethanol. Dichloromethane (HPLC grade), anhydrous dimethylformamide (DMF), sodium
bicarbonate and CDCl3 were obtained from Acros organics (NJ, USA). Dichloromethane
was dried with calcium hydride and stored over molecular sieves (3A). All other
chemicals were used as received. Adult normal human dermal fibroblasts (NHDF, CC2511) obtained from a 39-year-old female were purchased from Biowhitaker (Rockland,
ME). DMEM F-12 50/50, 1x with L-glutamine, 15 mM HEPES/trypsin EDTA (0.05%
trypsin/0.53 mM EDTA in HBSS), and 10000I.U. penicillin and 10000µg/ml
streptomycin were obtained from Mediatech (VA, USA). Bovine growth serum was
purchased from Hyclone (Logan, UT). The PLLA CCP fiber bundles were donated by
Fiber Innovation Technologies and the cross-section of a single fiber was shown in
Figure 5.1. Hexane and isopropanol were obtained from Fisher scientific. The fiber spin
finishing was removed by serial washes with hexane and isopropanol. Briefly, a bundle
of fiber was washed in order of 100% hexane, 50/50 hexane/isopropanol mixture and
100% isopropanol for an hour at each step. Extra chemicals were rinsed off with water
twice while sonicating. The final fibers were dried under vacuum. Dichloromethane was
dried with calcium hydride and stored over molecular sieves (Grade 514, Type 4A). All
other chemicals were used as received. Loctite® 3311TM light cure adhesive were from
Henkel Loctite Americas (SC, USA). Capillary tubes (I.D. 1.1-1.2mm, wall 0.2±0.02mm,
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length 75mm) were from Chase scientific glass Inc (TN, USA) and were used as a glass
frame for supporting fibers.

Figure 5.1. Cross-section
section of a single PLLA capillary channel polymer (CCP
CCP) fiber
5.2.2. Synthesis of photopolymerizable, degradable, and crosslinkable PEG
macromers
PEG-diacrylate
diacrylate macromers with hydrolytically degradable ester bonds were
synthesized by a two-step
step reaction as shown in Figure 5.2.

Figure 5.2. Synthetic route for preparation of degradable, crosslinkable PEG-bisPEG
acrylate macromers

80

5.2.2.1. Preparation of PEG-bis-(chloroacetate), PEG-bis-(2-chloropropanoate), and
PEG-bis-(4-chlorobutyrate)
PEG-bis-chloroacetate was prepared by reaction of the PEG terminal hydroxyl
groups with chloroacetyl chloride. All glassware was dried in a vacuum oven and fully
purged with argon before use. 3.75 mmol PEG (MW 4000) was dissolved in 120mL of
dry dichloromethane in a 250-mL round-bottom flask under an argon atmosphere. Once
the PEG was completely dissolved, 6.75 mmol TEA was added and the reaction flask was
cooled on an ice bath. Chloroacetyl chloride (15 mmol) in 30mL of dry dichloromethane
was added dropwise with an addition funnel over 2 h. The ice bath was removed after 2
h, and the reaction was allowed to continue at room temperature for 24 h. The reactant
was filtered to remove TEA-HCl salt, and then concentrated by rotary evaporation (Buchi
Rotavapor®, Switzerland) to reduce the solvent amount to 1/10th of its initial volume.
The residue was precipitated in 200mL of cold ethyl ether (-20°C), recovered by
filtration, and dried under vacuum for a few hours. The product was redissolved in dry
dichloromethane (150mL) and washed repeatedly with 15mL of 10% sodium bicarbonate
solution until the pH of the solution was neutral, followed by 3 washes with water (15mL
each) and dried with anhydrous sodium sulfate. The solution was concentrated by rotary
evaporation, the residue was precipitated in 200mL ethyl ether (-20°C), and was washed
3 times with cold ethyl ether. The final product was recovered by filtration and stored in a
vacuum desiccator.
PEG-bis-(2-chloropropanoate) and PEG-bis-(4-chlorobutyrate) were prepared by
the same procedures using 2-chloropropionyl chloride, 4-chlorobutyryl chloride,
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respectively. The structure of all products was determined by 1H-NMR (Bruker Avance300 MHz) using CDCl3 solvent. Conversion efficiency was calculated based on the ratio
of the integrals of the PEG back bone (δ = 3.5-3.7) and the terminal PEG methylene
peaks (δ = 4.3).
5.2.2.2. Preparation of PEG-bis-(acryloyloxy acetate)[PEG-bis- AA], PEG-bis(acryloyloxy propanoate) [PEG-bis-AP], and PEG-bis-(acryloyloxy
butyrate)[PEG-bis-AB]
PEG-bis-AA was prepared by the reaction of PEG-bis-chloroacetate and sodium
acrylate. Dried PEG-bis-chloroacetate (2.5 mmol) was dissolved in 100mL DMF in a
250mL 3-neck flask, with 0.01 g 4-methoxyphenol. Sodium acrylate (12.5 mmol) was
added to the reaction flask under an argon atmosphere. The reaction proceeded for 30 h at
50°C, and then the reactant was cooled to room temperature and filtered through a
cellulose filter (Grades 4, Whatman®) to remove unreacted sodium acrylate. DMF was
removed by rotary evaporation and the residue was precipitated and washed with 200mL
of cold ethyl ether (-20°C) three times. The final product was recovered by filtration and
stored in a vacuum desiccator. PEG-bis-AP and PEG-bis-AB were prepared by the same
procedure under reflux at higher temperatures from PEG-bis-(2-chloropropanoate) (85°C)
and PEG-bis-(4-chlorobutyrate) (100°C). The final structure of all products was
determined by

1

H-NMR (CDCl3 solvent). Product acrylation efficiency (%) was

calculated based on the ratio of the integrals of the PEG back bone (δ = 3.5-3.7) and the
acrylate peaks (δ = 6.4).
5.2.3. Hydrogel preparation
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Macromers were dissolved at varying concentration (% w/v) in deionized water
with 0.1% I2959 (w/v) and syringe-filtered (0.2 µm, Nalgene®). These solutions were
pipetted between two slide glasses, separated by 1 mm Teflon spacers and clamped
together with binder clips. The photopolymerization was allowed to proceed for 5 min
per each side under UV light (Model B 100 AP of Blak-ray®; wavelength: 365 nm;
intensity: 15 mW/cm2). Gel discs were cut with a hole-punch (5/16 in.).
5.2.4. Degree of gelation and swelling behavior
After photopolymerization, the hydrogel discs were freeze-dried (FreeZone® 4.5
Benchtop freeze dry systems of ©Labconco; RV5 rotary vane pump of BOC Edwards),
weighed (Wd1), and then was allowed to swell in distilled water for 24 h to remove any
uncrosslinked residual macromer. Excess water on the surface of gels was blotted
moderately with a piece of Kimwipe paper and the wet weights of gels (Ww) were
measured. The discs were completely dried under vacuum at 60°C for 3 days and
weighed (Wd2). The gel content was calculated as

Gelcontent(%) =

Wd 2
×100
Wd1

The equilibrium water content (EWC) was calculated as:

EWC(%) =

(Ww − Wd 2 )
Ww

×100

5.2.5. Hydrogel degradation
Photopolymerized hydrogel discs were swelled in water overnight to remove any
unreacted macromer, freeze-dried, weighed (Wd0) and incubated in 4mL of PBS (pH 7.4)
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at 37°C on a shaker plate. At specified time points, gel discs (n = 5/time point) were
taken from each group, rinsed with water, and then freeze-dried to determine their final
mass (Wdt). The percent mass loss of each sample was determined using the following
equation:

Massloss (%) =

(Wd 0 − Wdt )
Wd 0

×100

5.2.6. Cytocompatibility
Acrylate-PEG-GRGDS was synthesized as described, [176] prepared as a stock
solution in 1×PBS (10 µmol/ml), and sterile filtered. For hydrogel encapsulation studies,
macromer solutions were prepared containing 10% w/v sterile filtered PEG-bis-AA in
PBS, 2.5 µmol/ml acrylate-PEG-GRGDS, 0.1% I2959, and NHDF at 4×105 cells/ml.
Sample volumes (100µL) were photopolymerized as described earlier and cultured in
DMEM/F12 with 10% serum and 1% antibiotics in 12 well plates for 7 days. For surface
seeding studies, 10% PEG-bis-AA solutions containing acrylate-PEG-GRGDS and I2959 as above were photopolymerized, placed in 12 well plates with 2mL medium,
seeded with 8×104 NHDF, and cultured 5 days. To assess cell viability and morphology,
samples were stained with 1 µM fluorescein diacetate/2.5 µM propidium iodide (FDA/PI),
rinsed with PBS, visualized by fluorescence microscopy (Zeiss Axiovert 200), and
digitally imaged.
5.2.7. Controlled release of IgG
40% w/v solutions of PEG-bis-AA, PEG-bis-AP, and PEG-bis-AB containing 2.5
mg/ml human IgG were prepared in PBS. 100µL samples (250 µg initial protein content,
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n = 4/group) were photopolymerized as described earlier and then incubated in 2.5mL of
PBS (pH 7.4) at 37°C on an orbital shaker. At weekly intervals, the sample buffers were
collected and replaced. IgG release was measured by fluorescamine assay as previously
described.[177] Briefly, 150µL samples were mixed with 50µL fluorescamine stock
solution (3 mg/ml in acetone) and fluorescence was measured using a microplate reader
(Spectramax GerminiEM, Molecular Devices, Sunnyvale, CA) at 395 nm excitation and
475 nm emission wavelengths. IgG concentrations were calculated relative to a standard
curve prepared from known IgG concentrations.
5.2.8. Hydrogel coating
The PLLA CCP fibers were cleaned by ultrasonication, completely dried under
vacuum in advance, and then coiled around the glass frame. Both fiber ends were glued
to the glass frame by Loctite® 3311TM light cure adhesive via UV photocrosslinking.
Fibers were dipped in hydrogel coating solution, 20% w/v PEG-bis-AA, PEG-bis-AP,
and PEG-bis-AB with 0.1% I2959 (w/v) and then exposed to UV light (Model B 100 AP
of Blak-ray®; wavelength: 365 nm; intensity: 15 mW/cm2) for photopolymerization. To
obtain an air (or oxygen)-free environment, photopolymerization was also performed in a
box filled with argon gas.
5.2.9. Plasma surface modification
In order to improve hydrogel binding with fibers, plasma surface modification was
applied. Plasma treatment technology is one of the most common ways to introduce
chemically reactive groups on a material surface that can easily react with the contact
material. [178] Its process is very simple and the cost is rather low relative to other

85

surface treatments such as chemical modification by oxidation. [179] In this study,
oxygen plasma was applied by use of a Harrick plasma cleaner/sterilizer (PDC-001) to
modify the CCP PLLA fiber surface chemistry through abstraction of hydrogens from the
polymer chains, creating free radicals (peroxide groups). [180] Applied frequency was
13.54MHz. The pressure in the plasma chamber was reduced to 30mtorr, followed by
introduction of oxygen gas into the plasma chamber at 300mtorr for 5 minutes. Right
after plasma treatment, the modified fibers were dipped in low MW PEGDA for 30
minutes. The extra PEGDA was rinsed with water several times. After removal of water,
the resulting fibers were dipped in the hydrogel solution and then were moved under the
UV light.
5.2.10. Statistical analysis
Quantitative data for gel content, equilibrium water content, and mechanical
properties were compared by ANOVA using Tukey's method for post hoc comparisons. p
values < 0.05 were considered to be statistically significant. All data are presented as
mean±standard deviation.
5.3.

Results

5.3.1. Synthesis of degradable, crosslinkable PEG-based macromers
5.3.1.1. Preparation of PEG-bis-(chloroacetate), PEG-bis-(2-chloropropanoate), and
PEG-bis-(4-chlorobutyrate)
In the first step, the reaction between the PEG hydroxyl groups and the acid
chloride groups of the various chemical intermediaries resulted in the formation of ester
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bonds and terminal alkyl chloride groups separated by a variable alkyl spacer. 1H-NMR
peaks detected and representative spectra from each material are shown below.
PEG-bis-(chloroacetate) [Figure 5.3 (a)]: T= 3.5-3.7 (m, -(CH2CH2O)n-), 4.12 (s,
-OC(=O)CH2Cl), 4.3-4.4 (t, -CCH2OC(=O)-) ppm. Conversion efficiency: ~96%.
PEG-bis-(2-chloropropanoate) [Figure 5.3. (b)]: T= 1.65-1.75 (d, -CH3), 3.-3.7
(m, -(CH2CH2O)n-), 4.3-4.4 (t, -CCH2OC(=O)-), 4.4-4.5 (q, -OC(=O)CH(C-)Cl) ppm.
Conversion efficiency: ~94%
PEG-bis-(4-chlorobutyrate) [Figure 5.3 (c)]: T= 1.96 (m, -CCH2C-), 2.5-2.6 (t, OC(=O)CH2C-), 3.5-3.7 (m, -(CH2CH2O)n-, -CCH2Cl), 4.2-4.3 (t, -CCH2OC(=O)-)
ppm. Conversion efficiency: ~96%.

(a)
(Continued)
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(b)

(c)
Figure 5.3. Structure and 1H-NMR spectrum of (a) PEG-bis-(chloroacetate), (b)
PEG-bis-(2-chloropropanoate) and (c) PEG-bis-(4-chlorobutyrate)
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5.3.1.2. Preparation of PEG-bis-(acryloyloxy acetate)[PEG-bis- AA], PEG-bis(acryloyloxy propanoate) [PEG-bis-AP], and PEG-bis-(acryloyloxy
butyrate)[PEG-bis-AB]
Terminal acrylate esters were added to the intermediate products by nucleophilic
substitution reaction between the terminal alkyl chloride groups and sodium acrylate.
PEG-bis-(chloroacetate) also readily reacted with sodium methacrylate to produce
terminal methacrylate groups (data not shown). 1H-NMR peaks detected and
representative spectra from each material are shown below.
PEG-bis-AA: T= 3.5-3.7 (m, -(CH2CH2O)n-), 4.3-4.4 (t, -CCH2OC(=O)-), 4.74.8 (s, -OC(=O)CH2OC(=O)-), 5.9 and 6.4 (d, 2H, acrylic –CH2), 6.15 (q, 1H, acrylic –
CH) ppm. Acrylation efficiency: 95~98%.
PEG-bis-AP: T= 1.45-1.55 (d, -CH3), 3.5-3.7 (m, -(CH2CH2O)n-), 4.3-4.4 (t, CCH2OC(=O)-), 5.1-5.25 (q, -OC(=O)CH(C-)OC(=O)-), 5.9 and 6.4 (d, 2H, acrylic –
CH2), 6.15 (q, 1H, acrylic –CH) ppm. Acrylation efficiency: 86~87%.
PEG-bis-AB: T= 2.0 (m, -CCH2C-), 2.5-2.6 (t, -OC(=O)CH2C-), 3.5-3.7 (m, (CH2CH2O)n-), 4.15-4.25 (t, -CCH2OC(=O)-), 4.2-4.3 (t, -CCH2OC(=O)-), 5.9 and 6.4
(d, 2H, acrylic –CH2), 6.15 (q, 1H, acrylic –CH) ppm. Acrylation efficiency: 92~94%.
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(a)

(b)
(Continued)
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(c)
Figure 5.4. Structure and 1H-NMR spectrum of (a) PEG-bis-(acryloyloxy acetate),
(b) PEG-bis-(acryloyloxy propanoate) and PEG-bis-(acryloyloxy butyrate)

5.3.2. Gel content and swelling behavior
Aqueous solutions of the various acrylated macromers were crosslinked by
photopolymerization at 10 and 20% (w/v) concentration. The gel contents and the
equilibrium water contents of various photopolymerized hydrogels are shown in Table
5.1. Gel content was consistently high (around 95%) and not significantly affected by
variation in macromer chemical composition or concentration. Similarly, no significant
differences were detected in equilibrium water content among hydrogels prepared from
macromers of different chemical composition at fixed concentration. However,
significantly lower equilibrium water content was observed in all hydrogels prepared at
higher macromer concentration.
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Table 5.1. Gel Content and Equilibrium Water Content
Gel Content (%)
Equilibrium Water Content (%)
10% w/v
20% w/v
10% w/v
20% w/v
PEG-bis-AA
95.89±4.3
96.74±1.52
91.78±0.26
86.37±0.23a
PEG-bis-AP
94.61±4.5
95.86±3.26
92.47±0.55
87.64±0.38a
PEG-bis-AB
96.59±2.86
94.74±1.77
92.17±0.29
87.44±0.28a
a
represents the significant difference between two concentrations

5.3.3. Hydrogel degradation
Figure 5.5 shows an idealized schematic of hydrolytic degradation within the
hydrogel network and the expected degradation products, which include PEG, polyacrylic
acid (PA) and glycolic acid from PEG-bis-AA, lactic acid from PEG-bis-AP, 4hydroxybutanoic acid from PEG-bis-AB. The degradation characteristics of these gels
were expected to be bulk hydrolysis and the degradation times varied from 21 days to
months, depending on macromer concentration and the alkyl chain length of the chemical
intermediary used for synthesis.

Figure 5.5. Degradation mechanism of PEG-bis acrylates and expected products
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5.3.3.1.Influence of macromer concentration on degradation
First, the degradation behavior of hydrogels polymerized from solutions of
constant macromer composition (PEG-bis-AA) at varying concentration (10, 20, and 40%
w/v) was monitored (Figure 5.6). All of the hydrogels exhibited the small mass loss of
about 20-40% within two weeks. After the initial 20% mass loss, however, the rate of
degradation increased sharply. The time required for complete degradation increased with
increasing hydrogel macromer concentration. The 10% hydrogels completely degraded
by 21 days, followed thereafter by the 20 and 40% gels, which exhibited total mass loss
after 35 days and 42 days, respectively.

Figure 5.6. Mass loss of hydrogels polymerized from solutions containing different
concentrations of PEG-bis-AA macromers; 10% w/v (▲), 20% w/v (■), and 40%
w/v (♦)

5.3.3.2.Influence of macromer chemical composition on degradation
In a second set of experiments, the degradation of hydrogels prepared from the
three different PEG-bis-acrylates was compared at fixed polymer concentration (10%
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w/v). As the alkyl chain length of chemical intermediary used in the synthesis increased
from chloroacetyl chloride through 2-chloropropionyl chloride to 4-chlorobutyryl
chloride, the time required for hydrogel degradation increased (Figure 5.7). 10% PEGbis-AA hydrogels degraded by 3 weeks, whereas complete degradation of PEG-bis-AP
and PEG-bis-AB hydrogels was observed by 5 weeks and 9 weeks, respectively.

Figure 5.7. Mass loss of different PEG-bis-acrylate hydrogels at 10% w/v; PEG-bisAA (▲), PEG-bis-AP (□), and PEG-bis-AB (○)

5.3.4. Cytocompatibility
Cytocompatibility tests were performed using the most rapidly degrading
hydrogel formulation, PEG-bis-AA. Encapsulated fibroblasts maintained a rounded
morphology at both 1 and 7 days. (Figure 5.8(a) and (b)) At 1 day post-encapsulation,
fibroblasts exhibited high viability with minimal cell death, whereas increased numbers
of dead cells were observed by 7 days. Fibroblasts seeded on the surface of RGD-grafted
hydrogels attached, spread, and proliferated to reach near confluence by 5 days. (Figure
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5.8(c) and (d)) No evidence of cell death was observed in fibroblasts cultured on the
hydrogel surface.

(a)

(b)

(c)

(d)

Figure 5.8. Viability and morphology of human dermal fibroblasts encapsulated
within PEG-bis-AA hydrogels after 1 day (a) and 7 days (b) in culture and cultured
on the hydrogel surface for 1 day (c) and 5 days (d) (Scale bars = 100µm)

5.3.5. Controlled release of IgG
As a model high molecular weight solute, IgG release was compared among
hydrogels prepared from three different PEG-bis-acrylate compositions at fixed polymer
concentration (40% w/v). The release of IgG was primarily dependent on hydrogel
degradation. (Figure 5.9) All materials exhibited slow release within the first two weeks.
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Increased release from PEG-bis-AA, the most rapidly degrading formulation, occurred
between 2 and 5 weeks prior to reverse gelation at 6 weeks. Total IgG recovered from
PEG-bis-AA hydrogels was approximately 60% of the amount initially loaded. The
slower degrading PEG-bis-AP and PEG-bis-AB hydrogels maintained steady, low-level
release throughout the 6 weeks of the study.

Figure 5.9. Release of human IgG from 40% w/v hydrogels crosslinked from
macromers of varying chemical composition; PEG-bis-AA (▲), PEG-bis-AP (□),
and PEG-bis-AB (○)

5.3.6. Stability of hydrogel coating on the CCP fiber
20% w/v hydrogel was photopolymerized on the CCP fiber and all the samples
prepared with PEG-bis-AA, PEG-bis-AP and PEG-bis-AB were immersed in water.
Unfortunately, all hydrogels detached and were released from the channels very quickly
after exposure to water (Figure 5.10). Although fiber was modified by plasma treatment
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and PEGDA grafting on its surface, this did not improve hydrogel fixation within the
grooves. (Data not shown)

(a)

(b)

(c)

Figure 5.10. Hydrogel delamination from the capillary channel polymer (CCP)
fiber; 20% w/v PEG-bis-AA was coated and images were taken (a) before and (b, c)
after hydrogel swelling in water

5.4.

Discussions
Acrylated linear PEG-based polymer via simple 2 step synthesis was developed

for modifying hydroxyl-terminated polymers with discrete ester bonds and terminal
acrylate esters based on the use of difunctional chemical intermediaries. This approach
was based on the hypothesis that small changes in the alkyl spacer introduced through
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various chemical intermediaries [-(CH2)-: chloroacetyl chloride; -C(CH3)H-: 2chloropropionyl chloride; -(CH2CH2CH2)-: 4-chlorobutyryl chloride] could provide
significant changes in susceptibility to hydrolytic degradation while having minimal
impact on the final network physical properties. The reaction mechanisms attained high
degrees of conversion with final acrylation efficiencies of PEG-bis-AA and PEG-bis-AB
exceeding 90%. The slight reduction in acrylation efficiency of PEG-bis-AP likely
resulted from steric hindrance of the methyl group on 2-chloropropionyl chloride. A
similar synthesis was also attempted using 3-chloropropionyl chloride [alkyl spacer (CH2CH2)-]. However, a stable intermediate product could not be maintained and
converted to the desired final product by nucleophilic substitution due to a competing
elimination reaction (data not shown).
In general, hydrogel physical properties are highly dependent on the polymer
backbone chemistry, degree of functionalization, and network crosslinking density. As
shown in Table 5.1, the equilibrium water content of hydrogels crosslinked from the
various macromers was independent of macromer chemical composition and decreased
with increasing macromer concentration. These results suggest that the changes in
macromer chemical composition and molecular weight introduced by the various
chemical intermediaries are relatively small and the network physical properties are
primarily attributable to the PEG backbone and macromer concentration. The reduction
in equilibrium water content with increasing macromer concentration is consistent with
increased crosslinking density resulting from the higher concentration of vinyl groups in
the macromer solution.
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To promote biocompatibility, the final degradation products of the hydrogel
networks should consist of physiological metabolites and non-toxic water-soluble
polymers. Hydrolytic or enzymatic cleavage of ester bonds within the hydrogel networks
may be expected to yield PEG, polyacrylic acid, and various monomeric hydroxyl acids.
PEG and polyacrylic acid are readily eliminated from the body by renal clearance. [181]
The monomeric hydroxyl acids derived from the chemical intermediaries (glycolic acid,
lactic acid, and 4-hydroxybutanoic acid) are all naturally occurring metabolites. Human
fibroblasts encapsulated within or seeded on the surface of PEG-bis-AA hydrogels
exhibited high initial viability. Encapsulated cell viability decreased by 7 days, while
adherent cells proliferated and reached confluence. A recent study reported similar
observations of rounded fibroblast morphology and decreased viability following
encapsulation within PEG-bis-AP hydrogels. [182] Incorporation of small amounts of
native hyaluronic acid to form semi-interpenetrating networks resulted in increased cell
spreading that was dependent on cellular hyaluronidase activity and significant
proliferation over two weeks in culture.
To further investigate the effect of varying macromer chemical composition on
hydrogel degradation rate, two different experimental designs were examined. In the first
set of studies, variation in the solution concentration of a single macromer (PEG-bis-AA)
was shown to effectively vary hydrogel degradation rate, which decreased with
increasing macromer concentration. These results are consistent with previous studies
showing increasing macromer concentration increases polyacrylate chain length and
crosslinking density and reduces macromer cyclization resulting in reduced water content
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and kinetics of ester bond hydrolysis. [117, 183] It was noticed that increasing macromer
concentration resulted in more continuous mass loss of the material over time. The
degradation profile of 40% w/v PEG-bis-AA macromers appeared more close to surface
degradation/erosion. According to an increase in crosslinking density at higher
concentration, it can be explained that the in-diffusion of water within 40% w/v PEG-bisAA hydrogels was limited than the other groups, resulting in more susceptible to
degradation at part of the matrix in proximity to the surface unlike ideal bulk hydrolysis.
In the second set of studies, macromer concentration was held constant while chemical
composition was varied using macromers incorporating various chemical intermediaries.
Hydrogel degradation rate was found to decrease with increasing length of the alkyl
spacer derived from the chemical intermediaries. Schoenmakers and colleagues recently
reported a similar observation for the hydrolysis of drug-linked ester bonds. [184]
Paclitaxel was conjugated to PEG through hydrolysable ester linkers (3-sulfanylpropionyl
and 4-sulfanylbutyryl) containing two or three methylene groups, respectively. Drug
release kinetics decreased with increasing number of methylene groups in the linker.
These results were attributed to a decrease in the atomic charge on the carbon atom of the
ester carbonyl group with increasing number of methylene groups predicted by molecular
modeling.
Solute release from bulk degrading hydrogel networks such as those prepared in
this study occurs by a combination of diffusion and degradation. The relative contribution
of each mechanism is influenced by the size of the solute relative to the network mesh
size. [185] Relatively rapid release (1-7 days) of low molecular weight proteins
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comparable to growth factors that is primarily diffusion-mediated has been reported for
several PEG-diacrylate hydrogels. [177, 186] In contrast, Quick and colleagues showed
that release of high molecular weight solutes such as nonviral polyelectrolyte complexes
of pDNA is primarily degradation-limited. [119] Kasper and colleagues also pointed out
that DNA release kinetics from OPF-based hydrogel was controlled by hydrogel
degradation and plasmid size. [127] In our study, preliminary experiments demonstrated
>50% release of albumin and IgG from 10 and 20% PEG-bis-acrylate hydrogels within
24-48 h (data not shown) due to their sufficiently small size (IgG=150kDa,
albumin=65kDa) compared with hydrogel mesh size. Increasing the macromer
concentration to 40% substantially reduced diffusive release and allowed sustained
release of IgG as a function of macromer composition and degradation rate. The
approximate 60% total recovery from PEG-bis-AA hydrogels is consistent with previous
studies of protein release from photopolymerized networks and may be attributed to free
radical-mediated protein damage or crosslinking to the polymer network. [177]
Unfortunately, hydrogel coatings within the grooves of CCP fibers were unstable
in the aqueous environment. Although the fiber was modified by plasma treatment and
subsequent PEGDA grafting at the surface, there was no improvement in hydrogel
fixation within the grooves. Inefficient crosslinking may be considered as the unfavorable
factor to cause more swelling behavior in hydrogel. All free radical polymerizations are
sensitive to oxygen inhibition and polymerization between microscope slides that is a
conventional technique to minimize this interference was not possible for fiber coatings.
Although an argon box was used to attempt to eliminate the presence of oxygen, this
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approach was also unsuccessful. The swelling behavior of linear PEG-based hydrogel
caused by both the hydrogel itself property and less crosslinking density resulted from
incomplete photopolymerization severely led the problematic hydrogel fixation on the
fiber. Another explanation is that heating during exposure to UV light may have resulted
in partial dehydration during crosslinking, substantially increasing the driving force for
swelling upon exposure to water. Although usually considered negligible in other studies
using volumes greater than 100 ml and thickness in the 1 mm range, the potential
consequences of dehydration to the micrometer scale coatings within channel grooves
may have been significant.
5.5.

Conclusions
Crosslinkable,

hydrolytically

degradable

PEG-based

macromers

were

successfully prepared with high conversion efficiency by a novel two-step synthetic route
using difunctional chemical intermediaries. Through variation in the alkyl chain length of
the chemical intermediary, significant variation in degradation rate was achieved, while
consistent physical properties were maintained. The synthetic approach is readily
applicable to other hydroxyl terminated multi-functional polymers such as poly (vinyl
alcohol) and multi-arm PEG polymers and may be useful for the creation of
polymer/drug conjugates with varying hydrolytic stability. However, the geometrical
instability of these PEG-based hydrogels in the aqueous environment was unfavorable to
continue this study in order to develop a controlled gene delivery matrix composed of
hydrogel compositions with fibers. Future studies address alternative macromer
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compositions and crosslinking mechanisms to reduce hydrogel swelling and avoid the
potential for dehydration.
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CHAPTER SIX
PHYSICAL AND CHEMICAL PROPERTIES OF TETRONIC®-BASED
HYDROGELS

Abstract
Poloxamines or Tetronic®s are 4-arm amphiphilic AB block copolymers of
polypropylene oxide (PPO) and polyethylene oxide (PEO). In aqueous solutions,
Tetronic®s exhibit thermosensitive properties including spontaneous aggregation to form
micelles consisting of hydrophobic polypropylene oxide (PPO) cores surrounded by
hydrophilic polyethylene oxide (PEO) shells. [187, 188] If the temperature or the
concentration is high enough, Tetronic® shows a reversible thermogelation in the
aqueous solution. [85, 187, 189-191] Two Tetronic®s (T1107, T904) with different
molecular weight and hydrophilic/lipophilic balance were modified with acrylate groups,
mixed at varying mass ratios, and crosslinked with dithiothreitol by Michael-type
addition. Temperature-dependent analysis demonstrated that the resulting hydrogels
exhibited physical properties derived from both covalent and noncovalent mechanisms.
Various degradation profiles were obtained ranging from 18-36 days depending on
Tetronic® composition. Hydrogels consisting entirely of T904 exhibited no significant
change between initial and equilibrium swelling ratio and were shown to form stable
coatings on the surface of CCP fibers.

Keywords: controlled release, hydrogel coating, micelle formation, Michael-type
addition, physical gelation, Poloxamine, synthetic hydrogel, Tetronic®, thermosensitivity
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6.1.

Introduction
Poloxamines or Tetronic®s (BASF Corporation) are tetrafunctional AB block

copolymers of polyethylene oxide (PEO) and polypropylene oxide (PPO) bonded to an
ethylene diamine central group. Due to their amphiphilic polymeric structure, these
copolymers spontaneously aggregate in an aqueous environment, forming micelles
consisting of hydrophobic polypropylene oxide (PPO) cores surrounded by hydrophilic
polyethylene oxide (PEO) shells. [187, 188] Micellization, critical micellar concentration
(CMC) and critical micellar temperature (CMT) vary depending upon the molecular
weight and PEO/PPO balance of various Tetronic®s. Fernandez-Tarrio and colleagues
characterized micellization behavior of three Tetronic®s and found that Tetronic®
macromers of lower molecular weight required higher concentration to induce selfassociation and formed micelles are easily destabilized by dilution. (Table 6.1) [189] The
self-association of poloxamines to form micelles is strongly dependent on not only the
concentration and the composition of the copolymer, but also the temperature, the pH and
the ionic strength of the aqueous solution. (Table 6.2) [85, 187, 189-191] When the
polymer concentration (≥ 20% w/v) and temperature (≥ room temperature) exceed the
CMC and CMT, these micelles can rearrange to form liquid crystal phases (=lyotropic)
and eventually become a “gel-like system”. (Figure 6.2) [192-194]
Tetronic® polymers are very similar in their physical/chemical properties to the
Pluronic family of PEO/PPO/PEO triblock copolymers. Several Pluronics (particularly
F127) exhibit thermoreversible gelation and have been widely studied as matrices for
drug and gene delivery (reference some reviews here). One limitation of these systems is
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that implantation and exposure to biological fluids results in an effective dilution of the
polymer concentration. Once the concentration drops below the CMC, rapid dissolution
and release of entrapped biomolecules occurs. Therefore, additional covalent crosslinking
is required to slow the dissolution kinetics and provide controlled release of an
encapsulated molecule.

Figure 6.1. Synthetic route for preparation of acrylated Tetronic® macromers
Cellesi first described a “tandem” gelation process combining thermally-induced
gelation and covalent crosslinking of Tetronic® 1107 for cell microencapsulation. [193]
Cells were suspended in a solution of acrylate-functionalized T1107, mixed with thiolfunctionalized T1107 at room temperature, rapidly dispensed as microspheres through an
encapsulator apparatus, and collected in a hardening bath at 37°C. This process allowed
the microsphere structure to be immediately stabilized in the collection bath by
thermally-induced gelation, while slower Michael-type addition reactions between the
acrylates and thiols provided additional covalent crosslinking. The resulting microspheres
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exhibited temperature-dependent swelling, indicating the final physical properties were
derived from both physical and chemical crosslinking.

Figure 6.2. Phase diagram of aqueous solutions of Tetronic® 908 [194]
[Reprinted from Physical review E, 65 (2002) 041802, C. Perreur, J-P. Habas, J.
François, and J. Peyrelasse, Determination of the structure of the organized phase
of the block copolymer PEO-PPO-PEO in aqueous solutions under flow by smallangle neutron scattering, Copyright (2002) with permission from the American
Physical Society]
It was hypothesized that this type of “tandem” crosslinking would significantly
reduce hydrogel swelling at 37°C after application to CCP fibers. Michael-type addition
is also insensitive to the presence of oxygen and does not require the generation of free
radicals that may be detrimental to incorporated DNA. In addition, Pluronics and
Poloxamines (Tetronic®) have been widely investigated as drug/gene delivery agents due
to their micelle formation with DNA or gene complex caused by their amphiphilic
structure. [85, 187, 195, 196]
The aim of these studies was to investigate the gelation and swelling of
Tetronic®-based hydrogels. Various compositions of Tetronic® 1107 (T1107; MW15K,
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HLB: 18-23) and 904 (T904; MW6.7K, HLB: 12-18) were prepared. T1107 was chosen
as a macromer known to undergo thermoreversible gelation while T904 was included
based its higher hydrophobic content that was expected to further reduce swelling. The
hydrogels were covalently crosslinked via Michael-type addition and characterized in
terms of their viscosity, gelation point, swelling behavior, hydrolytic degradation
kinetics, and cytotoxicity. In addition, hydrogels were applied as coatings to CCP fibers
and the stability of hydrogel coating within the grooves was characterized. To improve
fixation of hydrogel to the fiber, plasma treatment was performed on the surface of CCP
fibers.
Table 6.1. Structural properties and CMC at pH7.4 and 25°C [85]
pKa2
CMC (mM)
Tetronic®
Mw
HLB
pKa1
304
1650
12-18
4.30
8.14
5
904
6700
12-18
4.03
7.81
0.3
1307
18000
>24
4.62
7.80
0.1
[Modified from AAPS PharmSciTech, 9 (2008) 471-479, M. Fernandez-Tarrio, F.
Yañex, K. Immesoete, C. Alvarez-Lorenzo and A. Concheiro, Pluronic and Tetronic
Copolymers with Polyglycolyzed Oils as Self-Emulsifying Drug Delivery Systems,
Copyright (2008) with permission from American Association of Pharmaceutical
Scientists]
Table 6.2. Tetronic® 1107 CMC values at four different pHs and 23°C±0.5°C [197]
pH
CMC (% w/v)
2.0
0.61
5.8
0.51
7.4
0.49
12.0
0.16
[Reprinted from European journal of pharmaceutics and biopharmaceutics, 69
(2008) 535-545, D. A. Chiappetta, J. Degrossi, S. Teves, M. D’Aquino, C. Bregni, A.
Sosnik, Triclosan-loaded poloxamine micelles for enhanced topical antibacterial
activity against biofilm, Copyright (2007) with permission from Elsevier B.V.]

6.2.

Materials and Methods
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6.2.1. Materials
Tetronic® 1107 (T1107, MW15K) and 904 (T904, MW6.7K) were kindly
donated by BASF corporation (USA). 4-arm PEG (MW10K) was purchased from Nektar
(Huntsville, AL, USA). Acryloyl chloride, celite fine 500 and 4-methoxyphenol were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Toluene (HPLC grade), ethyl
ether (anhydrous, BHT stabilized), hexanes (HPLC grade), and anhydrous sodium sulfate
were purchased from Fisher scientific (NJ, USA). Dichloromethane (HPLC grade),
triethylamine (TEA), dithiothreitol (DTT), sodium bicarbonate, calcium hydride and
CDCl3 were obtained from Acros organics (NJ, USA). Dichloromethane was dried with
calcium hydride and stored over molecular sieves (Grade 514, Type 4A). All other
chemicals were used as received. Texas Red®-X goat anti-mouse IgG (H+L) was
purchased from Invitrogen.
6.2.2. Acrylation of Tetronic®
6.2.2.1. Preparation of acrylated T1107 (Acryl-T1107)
Acrylated T1107 or Acryl-T1107 prepared by reaction of the Tetronic® terminal
hydroxyl groups with acryloyl chloride (Figure 6.1). All glassware was dried in a heating
vacuum oven. 15g of T1107 (1 mmol) was dehydrated by azeotropic distillation with
toluene over two hours, and the toluene was then removed by rotary evaporation (Buchi
Rotavapor®, Switzerland) at 90°C. After cooling to room temperature, dehydrated T1107
was dissolved in 120ml of dry dichloromethane in a 250ml round bottom flask under an
argon atmosphere. Once the T1107 was completely dissolved, 4 mmol TEA was added
and the reaction flask cooled on an ice bath. 8 mmol acryloyl chlorides in 30ml of dry
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dichloromethane were dropwise-added with an addition funnel over two hours. The ice
bath was removed after 2 hours and the reaction was allowed to continue at room
temperature for 24 hours. The reactant was filtered through celite fine 500 to remove
TEA-HCl salt, and then concentrated by rotary evaporation to reduce the solvent amount
to 1/10th of its initial volume. The residue was precipitated in 500ml of cold ethyl ether (20°C), recovered by filtration, and dried under vacuum for a few hours. The product was
redissolved in dry dichloromethane (150ml), washed repeatedly with 15ml of 10% w/v
sodium bicarbonate solution until the pH of the solution was neutral, followed by water
washes (15ml each) until the pH of water was neutral, and then dried with anhydrous
sodium sulfate. The solution was concentrated by rotary evaporation, the residue
precipitated in ethyl ether (-20°C), and washed 3 times with cold ethyl ether. The final
product was recovered by filtration and dried in a vacuum desiccator. The final structure
and acrylation efficiency were determined by 1H-NMR (Bruker Avance-300MHz) using
CDCl3 solvent.
6.2.2.2. Preparation of acrylated T904 (Acryl-T904)
Acrylated T904 or Acryl-T904 was synthesized in a similar manner with minor
changes to account for reduced thermal stability and different solubility properties.. 15g
of azeotropically dried T904 (~2.24mmol) was reacted with 17.92mmol acryloyl
chlorides in the presence of 8.96mmol TEA in 150ml of dry dichloromethane. This
product was very sensitive to temperature, so the reaction was kept at 4°C in order to
allow the reaction to continue for 24 hours. The reactant was filtered through celite fine
500 to remove TEA-HCl salt, and then concentrated in the presence of 4-methoxyphenol
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by rotary evaporation to reduce the solvent amount to 1/10th of its initial volume. The
residue was precipitated in a total volume of 500ml of the cold hexane/ethyl ether (50/50
volume ratio), kept at -20°C for a few hours, and the precipitating solution quickly
decanted. The product was redissolved in dry dichloromethane (150ml), washed
repeatedly with 15ml of 10% w/v sodium bicarbonate solution until the pH of the
solution was neutral, followed by water washes (15ml each) until the pH of water was
neutral, and then dried with anhydrous sodium sulfate. The solution was concentrated in
the presence of 4-methoxyphenol by rotary evaporation, the residue precipitated in a total
volume of 500ml of 50/50 hexane/ethyl ether system, and washed 2 times with cold ethyl
ether. The final product was recovered by decantation of the precipitating solution and
dried under vacuum within an ice chamber. Products were analyzed by 1H-NMR and
acrylation efficiency (%) was calculated based on the ratio of the integrals of the PEG
back bone (δ=3.5~3.7) and the acrylate peaks (δ=6.4).
6.2.3. Gelation analysis
This study investigated four different formulations of Tetronic® macromers
prepared at varying T1107/T904 mass ratios (100/0, 75/25, 50/50, 0/100). Unmodified
(reverse thermal gelation) or acrylated (covalent crosslinking) Tetronic® macromers
were dissolved at a nominal concentration of 30% w/v in PBS (pH7.4, 50mM; 5.75g/l
Na2HPO4, 0.88g/l NaH2PO4, and 4.8g/l NaCl). Due to the volume change of PBS solution
by macromer dissolution, 1g of macromer was assumed to be equal to 1ml. Table 6.3
summarizes the composition of each group. A 4-arm PEG macromer was included as a
control. The pH of all macromer solutions was adjusted to pH 7.2 at 23°C (±~1°C).
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6.2.3.1. Reverse thermal gelation
Thermally-induced noncovalent gelation was assessed using both the tube
inversion method and rheometry. For the tube inversion test, 2 ml Tetronic® solutions in
5 ml vials were placed in a temperature-controlled water bath at 4°C. The bath
temperature was increased 1°C/5 minutes and at each time point the samples were
removed and inverted. The gel point was recorded as the temperature at which the
solution did not flow.
Rheological analysis was performed using a Physica rheometer (Anton Paar,
USA) and parallel plate geometry (50mm diameter). Tetronic® solutions (4°C) were
pipetted onto the bottom plate (pre-cooled to 4°C) and the top plate was lowered to create
a 0.2 mm gap. A temperature-sweep (1.2°C/min) from 4-40°C was performed at constant
frequency (0.1 Hz) and strain (0.01). The gel point was determined as the crossing point
of the storage (G’) and loss (G”) moduli. The viscosity of the various Tetronic® solutions
was characterized at 4°C, 24°C and 37°C. Samples were loaded and allowed 15 minutes
to achieve uniform temperature. Viscosity was measured as a function of shear rate
ranging from 0.01 to 1 s-1.
6.2.3.2. Covalent crosslinking
Acrylated Tetronic® macromers were covalently crosslinked using dithiothreitol
(DTT) as a model thiol-containing compound. Crosslinking kinetics was analyzed by
parallel plate rheology. Solutions of acrylated Tetronic® and DTT prepared at 4°C were
mixed at a 1:1 thiol:acrylate molar ratio (30% w/v final Tetronic® concentration),
quickly vortexed, centrifuged to remove air bubbles, and pipetted on the center of the
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bottom plate pre-warmed to 37°C. The top plate was lowered to create a 0.2 mm gap and
oscillatory shear immediately performed at constant frequency (0.1 Hz) and strain (0.01).
Storage and loss moduli were recorded as a function of time. The gelation time was
determined as the temperature at which the storage modulus exceeded the loss modulus.
Table 6.3. The formula for preparing Tetronic®-based hydrogel crosslinked via
Michael-type addition
Acrylated Tetronic® solution
DTT solutiona
PBS
T1107/T904
PBS
Acryl-T1107
Acryl-T904
(50mM, pH
composition
DTT (50mM, pH 7.4)
(mg)
(mg)
7.4)
(Total 100%)
(mg)
(µl)
(µl)
100/0
30
0
0.6
75/25
22.5
7.5
0.8
60
10
50/50
15
15
1
0/100
0
30
1.3
a
For unmodified Tetronic® experiments, 10µl 50mM PBS was added instead of
DTT solution

6.2.4. Degree of gelation and swelling behavior
Various T1107/T904 formulations (30% w/v) were covalently crosslinked with
DTT in 100µl sample volumes between glass coverslips separated by 1 mm Teflon
spacers overnight at 37°C. The initial wet weight of polymerized hydrogel discs was
measured right after polymerization (Wi), freeze-dried (FreeZone® 4.5 Benchtop freeze
dry systems of ©Labconco Corp.; RV5 rotary vane pump of BOC Edwards), weighed
(Wd1) and then allowed to swell in 37°C PBS (pH 7.4) for 24 hours to remove any
uncrosslinked residual macromer. The discs were lyophilized and weighed (Wd2). The gel
content was calculated as

Gelcontent(%) =
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Wd2
×100
Wd1

For the equilibrium swelling ratio, the dry hydrogel discs were immersed in PBS
(pH 7.4) for 24 hours and allowed equilibrate. To investigate thermosensitivity of
hydrogels, the hydrogel discs were swelled in 4°C and 37°C PBS (pH 7.4). Excess buffer
solution on the surface of gels was blotted moderately with a piece of Kimwipe paper and
the wet weights of gels both at 4°C (W4) and at 37°C (W37) were measured. The swelling
ratio was expressed as the volumetric swelling ratio (Q).

Volumetric swelling ratio (Q) = 1 +

ρp
ρs

 Mw


− 1
 Wd2


Here ρp is the density of the polymer (1.04 g/ml) and ρs is the density of the
solvent (1g/ml for PBS). Values for Mw were considered as Wi for the initial wet weight
of a gel disc right after Michael-type addition, W4 and W37 for the swollen disc weight at
different temperature.
6.2.5. Hydrogel degradation

Hydrogel discs covalently crosslinked as described above were incubated in 37°C
PBS (pH7.4) overnight to remove any unreacted macromer, freeze-dried, weighed (Wd0),
and incubated in 4ml of PBS (pH 7.4) at 37°C on a shaker plate. At specified time points,
gel discs (n=4 / time point) were collected, weighed wet, rinsed with water, and then
freeze-dried to determine their final mass (Wdt). Hydrogel degradation was assessed by
volumetric swelling and percent mass loss determined using the following equation:

Massloss (%) =

(Wd0 − Wdt )
×100
Wd0

6.2.6. Cytotoxicity
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Hydrogel cytotoxicity was tested using NIH 3T3 fibroblasts by the direct contact
method. NIH 3T3 cells were routinely cultured in DMEM/F-12 50/50 (1X) supplemented
with 10% bovine growth serum (BGS) and 1% penicillin (10000I.U.)-streptomycin
(10000µg/ml) and used between the 4th and 6th passage. Macromer solutions were mixed
with DTT as described above, pipetted into the center of tissue culture wells (24-well
plates), incubated at 37°C overnight, and seeded with 4.2×104 cells/well. After 1 and 4
days in culture, cells were stained with 1mM fluorescein diacetate (FDA) and 2.5mM
propidium iodide (PI), rinsed with PBS, visualized by fluorescence microscopy (Zeiss
Axiovert 200), and digitally imaged.
6.2.7. Hydrogel coating

PLLA CCP fibers were cleaned by ultrasonication and, dried under vacuum, and
coiled around glass frames. Both fiber ends were glued to the glass frame by Loctite®
3311TM light cure adhesive via UV photocrosslinking under UV light (Model B 100 AP
of Blak-ray®; wavelength: 365 nm; intensity: 15 mW/cm2). As hydrogel coating solution,
both Acryl-T904 solution and DTT solution was prepared. For hydrogel coatings, the pH
of T904 solution was adjusted from pH7.4 to pH7.2. Because a higher pH caused a
quicker increase in viscosity, which shortened handling time to coat hydrogel over fiber.
However, we did not want to change gel properties due to the alteration of pH, so pH7.2
was chosen to avoid the property change as well as increase handling time. Immediately
after mixing two solutions, fibers were dipped in the hydrogel coating solution. Fiber
samples coated with Acryl-T904-based hydrogels were incubated at 37°C overnight for
complete polymerization.
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6.2.8. Plasma surface modification

Although Tetronic®-based hydrogel ameliorates a change in hydrogel volume due
to swelling in the aqueous solution, hydrogel anchorage only depends on its swelling
property. As hydrogel is degraded over time, the physical tightness of hydrogel within
fiber grooves will be changed and loosened. In order to improve hydrogel binding with
fibers, plasma surface modification was applied. Plasma treatment technology is one of
the common ways to introduce chemically reactive groups on a material surface that can
easily react with the contact material. [178] Its process is very simple and the cost is
rather low than other surface treatment such as chemical modification by oxidation. [179]
In this study, air plasma (20% oxygen) was applied by use of a basic plasma cleaner
(Harrick plasma; PDC-32G) to modify the CCP PLLA fiber surface chemistry through
abstraction of hydrogens from the polymer chains, creating free radicals (peroxide
groups). [180] Applied frequency was 13.54MHz. The pressure in the plasma chamber
was reduced to 80mtorr, followed by introduction of air into the plasma chamber at
300mtorr for 5 minutes. Right after plasma treatment, the modified fibers was dipped in
polyethlyene glycol diacrylate for 30 minutes.
6.2.9. Characterization of hydrogel coating
6.2.9.1.Quantification of hydrogel coating

A Wyko Profilometer was used to measure a change in depth and width of
grooves before and after hydrogel coating. Data was analyzed using Wyko vision 32
software. Two or three grooves were observed on the detected plane. Depth and width
were calculated from the actual profilometer data. (See Appendix B) The range was
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determined as increasing 2µm in size from minimum length. Percentage population was
calculated by a ratio of the sample number, which had the depth or width within a range,
to total collected sample number.
6.2.9.2.Visualization of hydrogel stability on the CCP fibers

Hydrogel coatings within the grooves could not be readily distinguished under the
microscope. Texas Red-conjugated IgG was mixed into hydrogel solution at 1% v/v ratio
as a fluorescent labeling agent. Fibers were coated with macromer solutions with and
without fluorescently labeled IgG and crosslinked overnight at 37°C in a humid
environment. Fiber without hydrogel coating was used as a control group. An inverted
microscope, Zeiss Axiovert 200 microscope (Carl Zeiss, Inc.) equipped with HAL 100
and HBO 100 lamps powered by an ebq100 isolated power supply was used for
investigation. Axiovision AC software was used for image collection. To observe
samples in dry condition after polymerization, a 10×Ph1 objective lens was used. Since
the CCP fiber itself exhibits some degree of autofluorescence, the light exposure time and
light intensity were adjusted to the extent unable to detect a fiber in order to make a
distinction between coated and uncoated fibers. The light exposure times of both halogen
and fluorescent light sources, and fluorescent alone were 510ms and 3.5s, respectively.
For wet condition right after contact of the hydrogel/fiber composite with water (37°C),
the exposure time of only the fluorescent light source was changed to 5s.
6.2.10. Statistical analysis
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Quantitative data for gel content, equilibrium water content, and mechanical
properties were compared by ANOVA using Tukey’s method for post-hoc comparisons.
p values <0.05 were considered to be statistically significant.
6.3.

Results

6.3.1. Tetronic® acrylation

The reaction between the four terminal hydroxyl groups on T1107 or T904 and
the acryloyl chloride resulted in the formation of ester bonds. (Figure 6.1) Representative
NMR spectra of Acryl-T1107 and Acryl-T904 are shown in Figure 6.2.
Acryl-T1107 and Acryl-T904: δ= 1.1 (m, PPO CH3), 3.4 (m, PPO CH), 3.54 (m, PPO

CH2), 3.65 (m, PEO CH2), 4.32 (t, -CCH2OC(=O)-), 5.8 and 6.4 (d, 2H, acrylic –CH2),
6.15 (q, 1H, acrylic –CH) ppm. Acrylation efficiency: 94-100% for Acryl-T1107 and 8490% for Acryl-T904.
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Figure 6.3. Tetronic® structure (T1107: n=60, m=19; T904: n=15, m=17) and
representative 1H-NMR spectrum of Acryl-T1107

6.3.2. Reverse thermal gelation

Overall, the viscosity of Tetronic® solution exhibited a shear-thinning response
as a function of shear rate ranging between 0.01 and 1s-1. At all shear rates, viscosity
dramatically increased with increasing T1107 content and the temperature. (Figure 6.4)
The value of viscosity was lower than 0.3Pa.s at all shear rates at 4°C. At 24°C, the
viscosity of 75/25 and 100/0 groups dramatically increased to about 20kPa.s and 55kPa.s
at 0.01 s-1 shear rate, respectively. At 37°C, the 50/50 group showed a large increase in
viscosity to about 22kPa.s at 0.01 s-1 shear rate. Figure 6.5 shows the difference in
viscosity between 4 and 37°C at a fixed shear rate of 0.1s-1. Again, viscosity at 4°C was
very low in comparison with viscosity at 37°C and increased with increasing T1107
content at 37°C.
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(a)

(b)
Figure 6.4. The effect of temperature on the viscosity of Tetronic® solutions
containing different composition of T1107 and T904 at 30% w/v; 100/0 (×), 75/25 (●),
50/50 (■), and 0/100 (▲). (b) A figure is shown the result of viscosity only at 4°C
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Figure 6.5. Viscosity of the Tetronic® solution containing different composition of
T1107 and T904 (30% w/v) at 0.1s-1 shear rate

Table 6.4. Rheological properties of various acrylated Tetronic®-based hydrogels
Thermogelation via hydrophobic effecta
Covalent crosslinking
via Michael-type
Tube
T1107/T904
Rheometry
addition
inversion
composition
Plateau storage
(Total 100%) Gelation Gelation
Gelation time at 37°C
modulusb
point
point
(sec)
(kPa)
(°C)
(°C)
100/0
22
19.22±1.28
23.25±1.8
23.5±2.12
75/25
26
20.95±1.77
17.74±3.16
24.17±5.58
50/50
31
24.46±2.67
9.74±1.59
88.33±12.58
0/100
153.33±5.77
a
Thermogelation was monitored in the range of temperature between 4°C and 40°C
b
Plateau storage modulus can be considered as a measure of the extent of hydrogel
network formation or gel intensity

Gelation points determined by the tube inversion method and rheometric
temperature scans are shown in Table 6.4. First of all, 0/100 group or 100% T904 at a
concentration of 30% w/v in PBS (50mM, pH7.4) did not exhibit thermal gelation
behavior within the range of temperature between 4°C and 40°C. Gelation points of the
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rest three groups decreased with increasing T1107 content, which was induced by the
hydrophobic aggregation of T1107 molecules. The plateau storage modulus can be
considered as a measure of the extent of hydrogel network formation or gel intensity.
Consistently, increasing T1107 content caused gel-like phase transition, resulting in
higher plateau storage modulus.
6.3.3. Chemical gelation via Michael-type addition

Gelation time during chemical crosslinking via Michael-type addition was
rheologically analyzed. Chemical gelation times were less than 3 minutes for all groups.
(Table 6.4) Increasing Acryl-T904 content increased chemical gelation time.
6.3.4. Degree of gelation and swelling behavior

The gel contents of 30% (w/v) hydrogels with various compositions are shown in
Table 6.5. Gel content was consistently high (around 97%) and not significantly affected
by variation in macromer composition.
Table 6.5. Gel content of various acrylated Tetronic®-based hydrogels
T1107/T904 composition
Gel content (%)
(Total 100%)
100/0
96.50±1.17
75/25
97.90±2.30
50/50
98.73±1.62
0/100
97.17±2.09
a
4-arm PEG
96.38±3.04
a
4-arm PEG was used as control, also crosslinked via Michael-type addition

The swelling property of each hydrogels was characterized by the volumetric
swelling ratio. While the swelling ratio of 4-arm PEG-based hydrogels exhibited a
fourfold increase, the volumetric swelling ratio of Tetronic®-based hydrogels increased
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less than two times as high as the initial value. In the case of 0/100 group, no significant
change in the volumetric swelling ratio was observed. (Figure 6.6) The effect of
temperature on the swelling behavior is shown in Figure 6.7. At 4°C where hydrophobic
interactions are reduced, 100/0 group hydrogel composed of only Acryl-T1107 showed
the highest swelling ratio and 4-arm PEG-based hydrogel and hydrogel in 75/25 group
exhibited similar swelling ratio, which might result from the similar mesh size between 4arm PEG acrylates (~MW10K) to one between Acryl-T904 (~MW6.7K) and AcrylT1107 (~MW15K). The groups with higher T904 content such as 50/50 and
0/100showed lower swelling ratio than the other three groups. In comparison with the
results at 4°C, when hydrogels were equilibrated in 37°C PBS, the higher temperature
induced the hydrophobic interaction within crosslinked molecules and the volumetric
swelling ratios of all groups decreased to half or less than half of that observed at 4°C,
except for 4-arm PEG-based hydrogel.
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Figure 6.6. Volumetric swelling ratio of various Tetronic®-based hydrogels
immediately following polymerization (initial) and at equilibrium, p<0.05, *
represents the significant difference between initial and equilibrium, letters
represent significant difference between groups

Figure 6.7. The effect of temperature on the volumetric swelling ratio of various
Tetronic®-based hydrogels, p<0.05, * represents significant difference between two
temperatures, letters represent the significant difference between groups
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6.3.5. Hydrogel degradation

The degradation characteristics of hydrogels in this study were expected to be
bulk hydrolysis and the degradation times varied from 18 days to 38 days, depending on
the composition of Acryl-T1107 to Acryl-T904. Figure 6.8 shows the percent mass loss
and the volumetric swelling ratio of Tetronic®-based hydrogels at varying composition
of Acryl-T1107 and Acryl-T904. All of the hydrogels exhibited small mass loss of 20%
or less within three weeks. After 20% mass loss, however, the rate of degradation
increased sharply. The time required for complete degradation increased with increasing
Acryl-T904 content, consistent with increased crosslinking density. 100/0 group
hydrogels completely degraded by 18 days, followed thereafter by 75/25, 50/50 and
0/100 gels, which exhibited total mass loss after 24 days, 28 days, and 38 days,
respectively. The volumetric swelling ratios of various hydrogels increased with
degradation of the hydrogels over time.
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(a)

(b)
Figure 6.8. Degradation (a) and swelling behavior (b) of various Tetronic®-based
hydrogels; 100/0 (×), 75/25 (●), 50/50 (■), and 0/100 (▲)
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6.3.6. Cytotoxicity

Representative fluorescent images of live (green) and dead (red) cells are shown
in Figure 6.9. The hydrogel discs exhibited autofluorescence in the red wavelength. After
1 day in culture, the cell clusters around the hydrogel disc showed a high uptake of FDA
stain, indicating that the majority of cells were alive. Hydrogels including higher AcrylT904 content showed an increased number of dead cells. After 4 days in culture, although
there were a few dead cells observed, the majority of fibroblasts proliferated and spread
out.
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(a)

(b)
Figure 6.9. In vitro cytotoxicity determined by live/dead assay; (a) 1 day NIH 3T3
fibroblasts culture and (b) 4 days culture around Tetronic®-based hydrogels (Scale
bars = 50µm)
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6.3.7. Hydrogel coating characterization

Due to the lack of a significant change in swelling between initial and equilibrium
conditions of T904 at 37°C, hydrogel coatings on the CCP fiber were well maintained
within the grooves. Various ranges of width and depth of a single CCP fiber were
detected by a profilometer as shown in Table 6.6 and 6.7. Two or three grooves on the
side were clearly detected by profilometer. None of treatments such as plasma treatment,
PEGDA grafting and hydrogel coating influenced width, which indicated that the
hydrogel coating was only filled within the grooves. (Table 6.6) In contrast, hydrogel
coating with (100%) or without (~73%) PEGDA grafting reduced depth lower than 6µm.
(Table 6.7)
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Table 6.7. Depth of the groove in the dry state

Plasma treated fiber, bPEGDA grafting after plasma treatment, conly hydrogel coating on the fiber, dhydrogel
coating after plasma treatment, ehydrogel coating after plasma treatment and PEGDA grafting

a

Table 6.6. Width of the groove in the dry state

Hydrogel coatings within the grooves could not be readily visualized. Figure 6.10
shows that fluorescence within the hydrogel coatings could be readily visualized in both
the dry and wet states at 37°C and the stability of hydrogel coating in the aqueous
environment.
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(a)

(b)

(c)

(d)

(e)

(f)

Figure 6.10. Phase contrast (left column) and fluorescent (right column) images of
hydrogel coatings on the capillary channel polymer (CCP) fiber; (a, b) images of
only fiber without hydrogel coating (c, d) hydrogel-coated fiber before immersion in
37°C water, (e, f) hydrogel-coated fiber immediately after immersion in 37°C water
(Scale bars = 100µm)
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6.4.

Discussions

Thermosensitive sol-gel phase transition is an in situ crosslinking mechanism that
has been widely studied. [198] However, there are some limitations of the application of
noncovalent gelation including short residence time, high permeability, nonbiodegradability and limitation of molecular weight. [199] Tetronic® or poloxamer is a
copolymer of 4-armed PPO-PEO that exhibits sensitivity to temperature, concentration
and pH, resulting in micellization and liquid crystal phases beyond a certain level of
those variables. Cellesi and others first described the temperature-dependent swelling of
T1107-based hydrogels, suggesting that their physical properties originate from both
covalent and noncovalent crosslinking mechanisms. [193, 200] In this chapter, the
preparation of acrylated Tetronic®-based hydrogels with differing Acryl-T1107 and
Acryl-T904 contents was described with the goal of determining how changes in
macromer composition affect the physical properties of the resulting hydrogels.
Throughout these studies, experiments were performed at both physiological temperature
and 4 C where noncovalent, hydrophobic interactions are minimized in order to
determine the relative contribution of the different crosslinking mechanisms. It was seen
that viscosity was related to the thermogelation behavior. Physical thermogelation
occurred only in the hydrogels including Acryl-T1107 with an increase in the
temperature, which was proved by viscosity data in the current study and previous
reports. [193] (Figure 6.4 and 6.5, and Table 6.2) Both 100/0 and 75/25 groups exhibited
a sol-gel transition around room temperature, which induced effective entanglements
between the single molecule chains. This is consistent with the previous data reported by
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Cellesi and colleagues [193, 201] Cellesi and colleagues also showed a gelation behavior
of 30 wt% T1107 in water at 21°C. T904 at a concentration of 30% w/v did not show a
thermogelation behavior in the temperature range between 4 and 40°C, while the physical
gelation point of 10% T904 was reported at 62.4°C. [85] T904 predominantly forms the
monoprotonated type in the pH range between 4.0 and 7.9. [187] The protonation occurs
due to the proton association with the nitrogen atoms on the central ethylene diamine
group, which interferes with PPO chain aggregation due to the coulombic repulsions
among positive charges and the increased hydrophilicity of the macromolecules. [187]
This coulombic repulsion and interference with micelle formation may be the reason that
the T904 in pH7.4 PBS did not show physical gelation within the experimental
temperature range. In fact, various Tetronic® polymers exhibited similar range of pKa
caused by two tertiary amines as pKa(2H+ to H+) or pKa1 for the first amine and pKa(H+
to none) or pKa2 for the second amine are pH3.8-5.6 and pH6.2-8.2, respectively. This
property indicates that these values are unlikely to correspond to the length of the PEOPPO blocks. (Table 6.8) [191, 195, 197] That is, T1107 supposedly undergoes resistance
of the proton to micelle association. In this case, the factor of micellization can be
considered not environmental features such as pH or temperature, but compositional
parameters. Micellization is strongly dependent on the content number of propylene
oxide (PO) groups in PPO blocks. [202] An increase in either PO groups or MW of
copolymers with similar EO/PO ratios results in lower CMC and CMT values. [202-204]
Higher number of PO groups lowered the CMC as shown in Table 6.1. Although T1107
has the higher content of PEO than T904, T1107 has longer PPO chains and higher MW
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than T904, which possibly induce lower CMC and CMT and stronger micelle formation.
This result is consistent with the micellar formation of T1307 which has high MW (18K)
and high HLB (>24, 70 wt % PEO). (Table 6.1 and 6.8) [195] In addition to active
micelle formation, T1107 eventually experienced “gel-like system” or crystalline phases.
[194] The resulting gelation points showed some deviation depending on the testing
method. The rheological gelation point indicates the crossing points between elastic or
storage (G’) and viscous or loss (G”) shear modulus, whereas the tube inversion test can
be less accurate to catch that crossing points and in fact, a viscous polymer solution still
flowed until it completely became a gel. There was a point where G’ sharply increased
after the gelation point, for example, 20.73±0.23°C for 100/0, 24.60±0.0°C for 75/25, and
31.63±0.46°C. Interestingly, these values were comparable with the tube inversion point.
Table 6.8. Structural Properties of Different Tetronic® Derivatives [195]
Mean
Mean
number of number of
Physical state
Mw
pKa1,
Tetronic®
EO units
HLB
PO units
at 25°C
(Da)
pKa2
per PEO
per PPO
block
block
T304
Liquid
1650
3.7
4.3
12-18
4.3, 8.1
T901
Liquid
4700
2.7
18.2
1-7
5.1, 7.6
T904
Paste
6700
15
17
12-18
4.0, 7.8
T908
Cast solid
25000
114
21
>24
5.2, 7.9
T1107
Cast solid
15000
60
19-20
18-23
5.6, 7.9
a
met-T1107
Powder
15030
60
20
T1301
Liquid
6800
4
26
1-7
4.1, 6.2
T1307
Cast solid
18000
72
23
>24
4.6, 7.8
T150R1
Liquid
7900
5
29
1-7
4.8, 7.5
a
methylated T1107
[Modified from Langmuir, 24 (2008) 10688-10697, J. Gonzalez-Lopez, C. AlvarezLorenzo, P. Taboada, A. Sosnik, I. Sandez-Macho, and A. Concheiro, SelfAssociative Behavior and Drug-Solubilizing Ability of Poloxamine (Tetronic) Block
Copolymers, Copyright (2008) with permission from American Chemical Society]
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The chemical gelation time exhibited the consistent tendency with the physical
gelation and the previous report of self-aggregation. [200] Acryl-T1107 readily
aggregated to form a gel almost instantaneously when these macromer solutions were
exposed to temperatures higher than their gelation point (>22°C). Adding Acryl-T904
into the system increased the gelation time or handling time. This is consistent with the
fact that higher T1107 content induced a stronger gel-like phase transition within
molecules, which may cause to reduce the polymerization time.
Tetronic®-based hydrogels were further crosslinked by Michael-type addition and
their physical properties examined. Crosslinking efficiencies or gel contents were
achieved up to 99%, suggesting that these end-linked networks are almost free of defects
such as intramolecular non-crosslinking cycles or incomplete conversion of monomers.
[174] Tetronic®-based hydrogels presented low equilibrium swelling compared to 4-arm
based PEG at 37°C. Cellesi and others also reported T1107 swelling ratio at different
temperatures as a function of time, resulting in significantly less swelling ratio at 37°C.
[200] Immediately after all the hydrogel samples were crosslinked, the difference in
swelling behavior was significant, but small. However, due to the absence of PPO chains
in the polymer structure of 4-arm PEG, these hydrogels do not have the property of
hydrophobic self-aggregation and resulted in large volumetric change when equilibrium
swelling was achieved. The hydrogels containing higher Acryl-T1107 content swelled
more due to their large MW and a consequent large mesh size as well as increased
hydrophilicity due to longer PEO chains. When the hydrophobic effects were inhibited at
4°C, swelling behavior was dependent only on the mesh size and chemical-crosslinking
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density. [205] Therefore, the volumetric swelling ratios of Tetronic® based hydrogels
exhibited a more than twofold increase relative to those at 37°C. The resulting swelling
ratio of 4-arm PEG was not significantly different from the 75/25 group at 4°C probably
due to the similarity of the overall average molecular weight between crosslinks and
crosslinking density. Blending Acryl-T904 and Acryl-T1107 induced a change in
polymer length between thiol linkers in comparison to a hydrogel network composed of
only Acryl-T1107 or Acryl-T904. [174]
The degradation of Tetronic® based hydrogels ranged from 18 (2.6 weeks) to 38
days (5.4 weeks) according to the formulation. Their mass was maintained higher than
80% within 2-3 weeks corresponding to the ordinary time of wound healing, and then
decreased quickly. An idealized schematic of hydrolytic degradation within the
Tetronic® based hydrogel network and the expected degradation products is shown in
Figure 6.11. Degradation rates commonly achieved through changes in macromer
concentration and molecular weight result in corresponding changes in molecular weight
between crosslinks, crosslink density, and mechanical properties. The hydrogel of 100/0
group degraded faster than other groups due to higher water uptake resulting from their
large size or MW and long PEO chains,. In addition, the amount of reactive functional
groups in the 100/0 group is smaller than those of the other groups at the same
concentration solution, which influences the amount of the reaction between acrylate and
thiol groups or crosslinking density via Michael-type addition.
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Figure 6.11. Degradation mechanism of acrylated Tetronic®-based hydrogel and expected
products

The presence of hydrogels produced very minimal cytotoxicity and had no effect
on the cell proliferation. The reason for the formation of cell clusters was that cells did
not adhere to the surface of the hydrogel and became concentrated on the culture plate
adjacent to the gel. Although there was no or minimal indication of cytotoxicity, the main
concern at this point is the use of DTT. DTT has been widely used in cell biology,
biochemistry, and biomedical investigation as an antidote, a protector of SH groups
against uncontrolled oxidation, a radioprotector an antioxidant, and so on, whereas in
some cases DTT was involved in apoptosis, generated toxicity and reactive oxygen
species in the presence of ions such as Fe and Cu and damaged the cells. [206] The
previous study already proved the feasibility and in vivo biocompatibility of PEG of
which the terminal hydroxyl groups were modified with thiol groups. [207] Ultimately
DTT will be replaced with thiol-modified PEG macromers.
Tetronic®-based hydrogels, especially T904 based hydrogels, exhibited
geometrical stability within the channels of CCP fibers because they did not take up
additional water above the volume used in the initial crosslinking reaction. Profilometer
data suggested that the proper coating of hydrogel on the CCP fiber was achieved; only
filling in the grooves. The main drawback of using newly developed liner PEG-based
hydrogel in Chapter 5 was geometric instability in the aqueous environment. In contrast,
T904 based hydrogels exhibited long-term stability in the 37°C water. This suggests the
suitability of Tetronic® based hydrogels to further application in fiber/hydrogel
composites for gene delivery.
6.5. Conclusions
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The physical properties of Tetronic®-based hydrogels have been examined to
evaluate their suitability as a fiber coating for controlled gene delivery. The sensitivity of
these gels to their environmental conditions such as temperature was investigated, and it
was shown that noncovalent, hydrophobic interactions strongly influenced their
properties, resulting in distinction from regular PEG-based hydrogels. Due to the
different composition of polymeric chains in T1107 and T904 macromers, each
Tetronic® based hydrogel had distinct properties. Hydrogels with higher T1107 content
underwent more swelling and quicker degradation. Increasing T904 content reduced
swelling and increased degradation time. Overall, degradation times varied from 2 to 5
weeks. Cell cultures displayed minimal cytotoxicity of crosslinking Tetronic® based
hydrogels and the presence of hydrogels did not affect cell proliferation. Their
geometrical stability suggests that Tetronic®-based hydrogels are capable of performing
composite materials as coatings on polymeric fibers. In conclusion, Acryl-T904 was
chosen in order to carry on the following studies.
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CHAPTER SEVEN
PRELIMINARY STUDIES ON GENE DELIVERY FROM TETRONIC®BASED HYDROGELS

Abstract

The objective of these studies was to achieve nonviral vector-mediated direct
gene transfer to target cells that adhere to thin degradable hydrogel coatings. In the
previous chapters, the preparation conditions of lyophilized nonviral vector complexes
with a cryoprotectant were optimized and hydrogel materials with variable degradation
rates were developed. T904-based hydrogels formed by Michael-type addition were
selected for these studies based on their limited swelling and suitability for fiber coating.
In this chapter, the preparation conditions of Acryl-T904-based hydrogels incorporating
lyophilized gene complexes with sucrose were optimized by the evaluation of DNA
stability before and after exposure to hydrogel components and crosslinking, in vitro
release kinetics of pDNA, and the addition of adhesive ligands to support cell attachment.
Finally, the potential of the hydrogel gene delivery system was addressed through cell
transfection on the degradable, thin hydrogel. PEI-pGFP (16µg) complex was prepared in
two different volumes with a different amount of sucrose and then incorporated into
hydrogels prepared by Method I and II. Esterase was employed to accelerate hydrogel
degradation rate. It appeared that groups containing increased amounts of sucrose within
the hydrogel exhibited transfection at early time point of hydrogel degradation during the
course of this study. Although further study is required to determine the relationship of
transfection efficiency with hydrogel degradation, the transfection in the presence of
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serum at early time point of hydrogel degradation as well as the geometrical stability of
Acryl-T904-based hydrogel showed the potential of hydrogel-mediated gene delivery
system as well as topographic support for cells.

Keywords: controlled release, gene complex incorporation with hydrogel, hydrogel

degradation products, micelle formation, PicoGreen assay, T904 based hydrogel,
transfection
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7.1.

Introduction

The overall goal of matrix-based gene delivery is to achieve localized, sustained
expression of a therapeutic molecule. One major limitation of nonviral gene delivery
technology is the external barrier of efficient vector transport and concentration at the cell
surface. The incorporation of nonviral gene complexes into scaffolds is expected to
increase the localization of vectors to the implant site and protect genes from their loss by
degradation or clearance, resulting in an increase in the amount of gene complex at the
cell surface. [21, 22] In these studies, it was hypothesized that nonviral vector release in
intimate spatial proximity with adherent cells would minimize the external barrier of
vector transport to the cell surface and increase transfection efficiency relative to
conventional bolus transfection techniques. Using hydrogels will provide the capability to
achieve controlled release kinetics of DNA, which is expected to be primarily a function
of hydrogel degradation due to the relatively large size of gene complexes compared to
the mesh size of crosslinked hydrogel networks. The application of hydrogels as thin
coatings on CCP fibers will combine biochemical and structural stimuli for tissue
regeneration. In addition, different groups of fibers can be coated with hydrogels
providing distinct degradation profiles and including different biomolecules, which
provide a basis for temporal and spatial patterning of gene expression.
In the previous chapters, the preparation conditions of lyophilized nonviral vector
complexes with a cryoprotectant were optimized and hydrogel materials with variable
degradation rates were developed. In this chapter, lyophilized gene complexes were
incorporated in Acryl-T904-based hydrogel and in vitro vector release from the resulting
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hydrogel was tested. Addition of cell adhesive molecules such as fibronectin and
acrylated RGD peptide was evaluated to support cell attachment and provide the optimal
environment for DNA delivery in the direct contact mode. Finally, the potential of this
optimized hydrogel gene delivery system was addressed through cell transfection on thin
hydrogel films.
7.2.

Materials and Methods

7.2.1. Gene complex incorporation within hydrogels

Both LC PEI and LC XG were prepared with 10% w/v sucrose in advance and
dried by lyophilization. 100µl sample volumes for hydrogel crosslinking were composed
of 90µl of Acryl-T904 solution (30mg Acryl-T904) and 10µl DTT solution (130mg/ml).
T904 and DTT were both prepared in 50 mM PBS, syringe-filtered with a 0.2 µm
Nalgene® filter, and the pH of T904 solution adjusted to pH7.2 prior to use. In the first
method (Method I), lyophilized gene complexes (2µg pGFP per hydrogel) were
resuspended in 10µl DTT solution first and then mixed with the T904 solution. For the
second method (Method II), lyophilized gene complexes were resuspended in 90µl
Acryl-T904 solution and then mixed with the DTT solution. Crosslinking was performed
overnight at 37°C. LC PEI incorporating hydrogel and LC XG incorporating hydrogel
were termed LC PEI-T904 hydrogel and LC XG-T904 hydrogel, respectively. To assess
whether lyophilized complexes remained intact or pDNA remained supercoiled after
Michael-type addition, LC PEI was resuspended either in DTT solution or in Acryl-T904
solution and hydrogel was prepared by Method I and II. Hydrogel was degraded by pH12
TE, neutralized, and then treated with 120mg/ml STP solution for decomplexation.
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Collected DNA was analyzed by agarose gel electrophoresis and naked DNA was used as
a control.
7.2.2. The effect of hydrogel degradation products on PicoGreen assay

The products expected to result from degradation of Tetronic®-based hydrogels
included original, hydroxyl-terminated Tetronic® polymers and a low molecular weight
carboxylic-acid terminated form of DTT. To determine the interference of degradation
products with the PicoGreen assay, the amount of DNA detectable by PicoGreen assay
was measured both in the presence and absence of hydrogel degradation products. The
planned conditions of the release study (100µl volume samples of 30% w/v crosslinked
T904 incubated in 2.5 ml PBS) were calculated to theoretically result in a 1.2% w/v
concentration of hydrogel degradation products, assuming complete degradation.
Therefore, in this study, 1% w/v and 2% w/v degradation concentrations were
investigated. According to the previous studies, pH12 TE and 120mg/ml STP were
compared for decomplexation. Hydrogel discs were prepared, following the method in
7.2.1, and quickly degraded in pH12 TE. For pH12 TE decomplexation, a proper
concentration of degradation solution in pH12 TE was used without further alteration.
For 120mg/ml STP treatment, degraded gel solution was neutralized to pH7.4 and a
proper amount of STP was added to make the final concentration of hydrogel degradation
products 1% w/v and 2% w/v. An equal amount of gene complex solution and
decomplexation solution including degradation products was mixed to a final volume of
100µl and incubated at room temperature for 30 minutes. The samples were then
analyzed by the PicoGreen assay as described above (section 4.2.7 in Chapter 4).
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7.2.3. Interaction of hydrogel degradation product with released DNA

In Chapter 6, the effect of pH changes on the charge of the two amine groups in
the center of Tetronic® structure was described. This property can induce negatively
charged plasmid DNAs to bind to positively charged nitrogens, resulting in lower amount
of DNA measured by PicoGreen assay. To characterize this interaction, 2µg of naked
pGFP was mixed with 100µl of 30% w/v unmodified T904 solution in 50mM PBS
adjusted to varying pH (pH 6.5, 7.2, and 8.0) and the resulting solution was incubated at
37°C for 4 hours. After incubation, the DNA amount was determined by PicoGreen
assay. These samples, which were a mixture of pGFP and unmodified T904 at different
pH, were added to 2.5ml PBS (pH7.4) and incubated overnight. Again, the DNA amount
was measured by the PicoGreen assay. The DNA amount of all samples was compared
with 2µg of naked pGFP in pH7.4 PBS as a control group.
7.2.4. Determination of plasmid DNA incorporation efficiency

The initial DNA amount loaded within hydrogels was measured by PicoGreen
assay. pH12 TE and 120mg/ml STP were compared in their decomplexation function.
First, hydrogels were prepared by Methods I and II as described in 7.2.1 except
lyophilized naked pGFP with sucrose was added as a control group. The resulting gels
were quickly degraded in pH12 TE and neutralized to pH7.4. To achieve a concentration
of DNA within a range suitable for the PicoGreen assay, the proper volume of each
sample was calculated to make a final concentration for the PicoGreen assay to 100ng/ml.
The samples were mixed with each decomplexation solution at a 1:1 volume ratio and

146

incubated at room temperature for 30 minutes. The efficiency was calculated from the
amount of DNA recovered after gelation over the initial loaded DNA amount.
7.2.5. In vitro release of plasmid DNA

To test controlled release of DNA from the degradable hydrogels, hydrogel was
prepared by Methods I and II as described in 7.2.1. 2µg of pGFP was loaded to each
hydrogel (100µl). After overnight polymerization at 37°C, each hydrogel was placed in a
scintillation vial containing 2.5ml PBS (pH7.4) and incubated on a shaker plate at 37°C.
At each time point, the buffer solutions were sampled and replaced. The collected
samples were frozen until PicoGreen analysis. The release samples at each time points
were mixed with either pH12 TE or 120mg/ml STP for decomplexation of DNA at a 1:1
volume ratio and incubated at room temperature for 30 minutes. The amount of DNA
from LC PEI was measured as the initial amount of DNA loaded to hydrogel, based on
which the released DNA amount was calculated. The amount of release DNA was
measured by the PicoGreen assay as described in Chapter 4 (4.2.7).
7.2.6. Modification of hydrogels with adhesive ligands

The favorable substrate for cells to attach and proliferate is important for
transfection in the direct contact mode. The Tetronic® based hydrogel itself used in this
study is nonadhesive due to PEG-based repulsion of protein adsorption and the lack of
specific adhesive ligands. Hydrogels were prepared as described above (7.2.1) with the
addition of cell adhesive molecules such as fibronectin or acrylated RGD peptide.
Acrylated peptide was synthesized via aminolysis of the N-hydroxy succinimide ester of
acrylate-PEG-NHS (Nektar, 3400 MW) by the α-amine terminus of the peptide sequence
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(GRGDS, Bachem). [176] When using fibronectin, 30mg of Acryl-T904 was dissolved in
60µl of 50mM PBS and its pH was adjusted to pH7.2. DTT solution was prepared at the
concentration of 173mg/ml and 7.5µl of DTT solution was mixed for at least 5 minutes
with 2.5µl of fibronectin stock (1mg/ml, Sigma). This 10µl solution was added to AcrylT904 solution to make a hydrogel. When using acrylated peptide, 30mg of Acryl-T904
was dissolved in 50µl of 50mM PBS and its pH was adjusted to pH7.2. 10µl of acrylated
peptide (10µmol/ml) was mixed in Acryl-T904 solution and then the final solution was
mixed with 10µl of DTT solution (130mg/ml). 80µl of hydrogel solution was pipetted
onto a slide glass and another slide glass was placed over the drop, separated by 1mm
Teflon spacers. Hydrogel discs were attached to tissue culture plates (24-well) using UVsterilized silicon grease. NIH 3T3 fibroblasts (1×104 cells/ml) were seeded on the
hydrogel disc and their adhesion and proliferation was observed by FDA/PI staining.
7.2.7. Cell transfection through hydrogel compositions

In Chapter 4, the preparation method of N/P7.5 LC PEI containing 10% w/v
sucrose with total complex volume of 70µl was optimized. Sucrose solubility in water is
2.039 g/ml at 20 °C. As increasing the amount of pGFP, resuspension of lyophilized
complex with small volume of hydrogel component solution can limit sucrose dissolution.
In this chapter, two methods of complex preparation were compared for cell transfection.
For the first method, total gene complex volume (70µl) and sucrose concentration (10%
w/v) were fixed while the amount of pGFP and PEI was increased at the N/P ratio of 7.5,
For the second method, the complex volume was proportionally increased with an
increase in pGFP amount as well as an increase in the amount of PEI and sucrose.
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Although sucrose concentration was fixed to 10% w/v, its total amount was increased
with an increase of total complex volume. Before performing cell transfection through
hydrogel compositions, transfection efficacy of gene complexes prepared by both
methods was tested using NIH 3T3 fibroblasts (1×105cells/ml, 12well-plate). Considering
cytotoxicity due to its high amount of DNA (16µg pGFP) and PEI, each LC PEI was
resuspended with 560µl deionized water and then 2µg DNA (70µl LC PEI) was added to
each well. At 48 hours post-transfection, cells were fixed, stained with DAPI and the
transfection efficiency determined based on the percentage of GFP+ cells. For cell
transfection through hydrogel compositions, LC PEIs were from different solution
volumes as described above. Each lyophilized complex was resuspended in either DTT
solution (Method I) or Acryl-T904 solution (Method II), followed by mixing with either
T904 solution or DTT solution, respectively. The prepared solution was pipetted into a
12well-plate and spread to make a very thin gel. Hydrogels were maintained with cell
culture media with or without syringe-filtered esterase (15units/ml) and new media
replaced at each time point (0, 1, 3, 7 and 10days). 1×105 cells/well of NIH 3T3 fibroblast
suspension in 300µl media was added after a change in media at each time point.
7.2.8. Statistical analysis

Statistical analysis was performed by single factor ANOVA using Tukey's HSD
method for post hoc comparisons. p values <0.05 were considered to be statistically
significant. All results were expressed as mean ± standard deviation.
7.3.

Results

7.3.1. The effect of hydrogel components on DNA stability
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Figure 7.1 shows that neither hydrogel component solution affected the
complexation between PEI and pGFP. pGFP of supercoiled form was maintained after
the crosslinking process in either hydrogel preparation method in comparison with DNA
bands of LC PEI in Figure 4.6(a) in Chapter 4. Light intensity of supercoiled form of
DNAdecreased. However, there was no increase in relaxed or linear conformations of
DNA. It was already seen that lyophilization process somehow reduced supercoiled form
in the DNA conformation in the case of LC PEI and transfection efficiency. (Figure 4.3
and 4.6 in Chapter 4) As same as shown in Figure 4.6(a) in Chapter 4, DNA dissociated
from PEI complexes appeared as a dim line of supercoiled conformation due to some loss
of supercoiled form by lyophilization process. The unusual traces moving from the well
to cathode were observed only in samples containing Acryl-T904. (Figure 7.1(b))
The electrophoretic behavior of T904 or Acryl-T904 is shown in Figure 7.2.
Figure 7.2 shows that T904 itself had a tendency to move toward cathode and emit light
under UV. A mass of polymers could be seen with the naked eye above the wells without
any staining dye.
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(a
(a)

(b)

Figure 7.1. The effect of Michael
Michael-type addition polymerization on the stability of
gene complexes and released DNA following hydrogel preparation by Method I (a)
or Method II (b). (a) Lane 1: 1kb DNA ladder, Lane 2: naked pGFP, Lane 3: naked
pGFP + DTT solution, Lane 4: LC PEI + DTT solution without decomplexation,
Lane 5: after crosslinking, decomplexation with 120mg/ml STP. (b) Lane 1: 1kb
DNA ladder,, Lane 2: naked pGFP, Lane 3: naked pGFP + Acryl-T904
T904 solution,
Lane 6: LC PEI without decomplexation, Lane 7: LC PEI + Acryl-T904
T904 solution
without decomplexation, Lane 8: after crosslinking, decomplexation with 120mg/ml
STP

151

(a)

(b)

Figure 7.2. Electrophoretic behavior of T904; (a) Agarose gels containing EtBr;
Lane 1: naked pGFP+Acryl
Acryl-T904, Lane 2: naked pGFP+unmodified T904, Lane 3:
LC PEI+Acryl-T904,
T904, Lane 4: LC PEI+unmodified T904, (b) Agarose gels prepared
without EtBr; Lane 5 and 7: Acryl-T904 with EtBr, Lane 6 and 8: unmodified T904
without EtBr; For lane 5 and 6, 20µl of 30% w/v either Acryl-T904 or unmodified
T904 solution was added. The image of lane 7 and 8 is a visible light photograph of
lane 5 and 6

7.3.2.

The effect of the hydrogel degradation products on PicoGreen assay
Figure 7.3 shows the effect of the presence of hydrogel degradation products on

DNA detection by the PicoGreen assay when various concentrations of degradation
solution were added to naked DNA and each gene complex. Detected DNA amounts
varied depending on the decomplexation method. When pH12 TE buffer was used, the
DNA amount significantly decreased with an increase in the amount of degradation
products. For 120mg/ml STP solution, samples in the presence of degradation
degradat
products
except for naked DNA group changed the DNA amounts by less than 14% in comparison
with hydrogel-free samples.
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(a)

(b)
Figure 7.3. The effect of concentration of the hydrogel degradation products on
DNA detection by PicoGreen assay; (a) Decomplexation by use of pH12 TE and (b)
120mg/ml STP treatment for decomplexation, p<0.05, * and # represent significant
difference in comparison with 0% w/v degradation product and 1% w/v
degradation product, respectively
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7.3.3. Interaction of hydrogel degradation product with released DNA

Increasing amounts of DNA were recovered as the pH of unmodified T904
solution was reduced Figure 7.4. The self-aggregation strongly occurred at 37°C at 30%
w/v T904, which reduced the DNA amount to 74% (±5.25) in pH6.5 in comparison with
the control group in pH7.4 PBS. After dilution in 2.5ml PBS (pH7.4) at 37°C, pH effect
significantly disappeared, while micelle formation with DNA still existed. Only 72.64%
to 77.66% of the initial DNA amount was detected. This result was consistent with the
effect caused by hydrogel degradation products in Figure 7.3.

Figure 7.4. Interaction of unmodified T904 macromers (100µl, 30% w/v in 50mM
PBS) with DNA, p<0.05, letters and * represent significant difference between
groups and in comparison with pH7.4 PBS group, respectively

7.3.4. Plasmid DNA incorporation efficiency

The measurement of the initial DNA amount within T904 hydrogels was shown in
Figure 7.5. The measured DNA amount decreased after hydrogel crosslinking. In the
naked DNA case, the measured DNA amounts in the presence of 2% w/v hydrogel
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degradation products were 74.83% (±0.57) over the initial DNA amounts. (Figure 7.3(b))
In addition, the detected DNA amount in the presence of unmodified T904 and dilution in
pH7.4 PBS in Figure 7.4 was 74.47% (±7.95) in the pH7.2 group. When naked DNA
actually underwent hydrogel crosslinking process and then was released from a hydrogel,
the recovered amount was 53.30% (±0.68) in Method I and 63.25% (±1.16) in Method II
of the initial loaded amount under a neutral condition (pH7.4), whereas addition of STP
solution lowered DNA detection more. (Figure 7.5) Total DNA recovery was
significantly better in the hydrogel group prepared by Method II than the group prepared
by Method I (except for pH12 TE treatment). The complexation with PEI also
significantly influenced DNA release or detection. When STP was used for
decomplexation, the measured initial DNA amounts of LC PEI-T904 hydrogel prepared
by both Method I and II decreased significantly in comparison with DNA-T904 hydrogel,
resulting in 24.71% (±0.54) in Method I and 37% (±1.83) in Method II. pH12 TE
treatment exhibited the worst DNA recovery, 14.02% (±3.00) in Method I and 13.56%
(±4.30) in Method II.
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Figure 7.5. Initial DNA amount loaded within T904 based hydrogel; p<0.05, letters
represents significant difference between groups, Method I: DNA or LC PEI was
resuspended in DTT solution, Method II: DNA or LC PEI was resuspended in
Acryl-T904 solution

7.3.5. In vitro release of plasmid DNA

Figure 7.6 shows the release profiles for the different hydrogel preparation and
decomplexation methods. Overall, the release profile of DNA from hydrogels prepared
by Method I showed consistent release over time and closely matched the hydrogel
degradation profile. In the case of Method II, there was a small initial burst detected on
day 1, likely due to a small amount of unincorporated DNA, and substantial burst release
at the last point measured prior to reverse gelation and hydrogel dissolution. As shown in
Figure 7.6, 120mg/ml STP solution exhibited more effective as a decomplexation agent
than pH12 TE buffer and was less influenced by hydrogel degradation products. The
results in Figure 7.6 (b) show the increased DNA amounts detected for both loading
Methods, resulting in 32.57% (±1.08) recovery in Method I and 40.95% recovery (±2.28)
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in Method II. In spite of a change in the DNA amount detected, the choice of
decomplexation method had no effect on the overall release kinetics.

(a)

(b)
Figure 7.6. In vitro release of DNA from LC PEI-T904 hydrogels; DNA
decomplexation (a) by pH12 TE treatment and (b) by 120mg/ml STP treatment,
Method I: LC PEI was resuspended in DTT solution, Method II: LC PEI was
resuspended in Acryl-T904 solution
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7.3.6. Modification of hydrogels with adhesive ligands

Both fibronectin and acrylated peptide (GRGDS) were investigated to induce cell
attachment and proliferation. When fibronectin was used, cell behavior was inconsistent,
independent of the hydrogel preparation methods. Most of the time, cells tended to form
clumps and partially survived on the hydrogel. Their growth was very slow and the
morphology of fibroblasts was more in rounded form, different from their longitudinal
shape. Figure 7.7 (a) and (b) show a selected portion of a hydrogel where fibroblasts were
attached after 4 days in culture. Unfortunately, the rest of the hydrogel surface was
unable to support cell growth. In contrast, acrylated peptide improved cell attachment and
proliferation consistently, resulting in uniform cell adhesion and growth on the hydrogel
surface. (Figure 7.7 (c) and (d)) Fibroblasts on the peptide-T904 hydrogel grew relatively
faster in longitudinal shape than on the fibronectin-T904 hydrogel.
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(a)

(b)

(c)
(d)
Figure 7.7. NIH 3T3 proliferation on the LC PEI-T904 hydrogels with various cell
adhesive molecules; 4 days in culture on (a, b) fibronectin-modified hydrogels and (c,
d) acrylated peptide-modified hydrogels, figures on the left are hydrogel prepared
by Method I and figures on the right are hydrogel prepared by Method II (Scale
bars = 100µm)

7.3.7. Cell transfection through hydrogel compositions

This study investigated the transfection of fibroblasts in direct contact with thin
hydrogel films. Lyophilized complexes were prepared either by mixing 16µg pDNA in
70µl with 10% w/v sucrose (7mg) or by mixing 16µg pDNA in 560µl with 10% w/v
sucrose (56mg). Both gene complexes exhibited fibroblast transfection without
significant difference in performance between preparation methods when using
conventional bolus injection in serum-free medium (data not shown). However, the
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groups prepared by the method that increased the complex volume with increased sucrose
amount within the hydrogel started exhibiting cell transfection 1day after cell seeding on
samples maintained in buffer for 1 day (data not shown). In addition, esterase accelerated
hydrogel degradation, resulting in transfection at earlier time points of hydrogel
degradation in comparison with the groups without esterase in the culture media. Figure
7.8 and 7.9 show cell transfection around hydrogels at 1day and 3days of hydrogel
degradation, caused by release of gene complex from hydrogels in the esterase-containing
media. Both hydrogel groups prepared by Method I and II with gene complexes with
increased volume exhibited sustained gene expression up to 6 days in culture. However,
the transfection efficiency was very low with less than 1% of adherent cells exhibiting
GFP fluorescence.
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(a)

(b)
Figure 7.8. Transfection
ransfection of NIH 3T3 fibroblasts at 48 hour post-transfection
transfection in the
presence of 10% BGS and esterase (15units/ml) via gene complex released from
T904-based hydrogel prepared by Method I; (a) 1day and (b) 3days hydrogel
degradation. Gene complex with increased volume was used. Phase contrast and
fluorescent images on the left column and only fluorescent images on the right
column.. Asterisk and arrows indicate a hydrogel and transfected cells, respectively.
(4x magnification, Scale bars = 100µm)
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(a)

(b)
Figure 7.9. Transfection of NIH 3T3 fibroblasts at 48 hour post-transfection in the
presence of 10% BGS and esterase (15units/ml) via gene complex released from
T904-based hydrogel prepared by Method II; (a) 1day and (b) 3days hydrogel
degradation. Gene complex with increased volume was used. Phase contrast and
fluorescent images on the left column and only fluorescent images on the right
column. Asterisk and arrows indicate a hydrogel and transfected cells, respectively.
(4x magnification, Scale bars = 100µm)
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7.4.

Discussions

The incorporated LC PEI was released from the T904-based hydrogel and DNA
dissociated from those complexes was primarily in the supercoiled forms, whereas total
amount seemed decreased. (Figure 7.1) A decrease in DNA amount can be caused by
lyophilization process as shown in Figure 4.6 in Chapter 4 rather than Michael-type
addition polymerization. Neither hydrogel component solution damaged LC PEI or
pGFP. In the previous studies, the photoencapsulated DNA was severely damaged by UV
light, resulting in loss of supercoiled conformation and potentially decrease in
transfection efficacy. [118, 119] Removal of free radicals within the system via Michaeltype addition improved DNA protection. In this study, the electrophoretic behavior or
T904 was evaluated. The unusual traces moving toward cathode was not related to DNA
binding to T904 molecules. Instead, T904 itself has the own electrophoretic property,
possibly positively charged, which forced polymers to move to the negatively charged
pole. (Figure 7.2) Also, T904 (or acrylated) was detectable under the UV and with bare
eyes without dye such as EtBr.
As mentioned before, the majority of degradation products are theoretically
Tetronic® polymers or T904 in this case, it is possible for T904 to form micelles at high
pH like pH12 and high temperature (> room temperature, 37°C) and trap DNA or gene
complexes within those micelles. This event interfered with the interaction between
PicoGreen reagent and dsDNA, resulting in poor efficiency of the PicoGreen assay.
(Figure 7.3) STP solution was able to reduce the pH effect on T904 macromers. (Figure
7.3 (b)) However, micelle interference still remained in the presence of hydrogel
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degradation products, due to the pH of the STP solution (pH8.2-8.3). To make sure that
reduction in the detected DNA amount was caused by T904 micellization, the pH effect
on T904 was further studied. Ideally, protonated amines in low pH lead to columbic
repulsion and reduce aggregation. [195] However, if negatively charged DNA binds to
these protonated amines electrostatically, repulsion between polymers can be reduced and
the micelle formation can be increased. Decreasing pH could help DNA binding as well
as micellization, resulting in a decrease in DNA detection by the PicoGreen assay.
However, as shown in Figure 7.4, higher pH induced more loss of detection efficiency,
that is, the micellization driven by pH was more dominant event rather than electrostatic
binding. The following dilution of these samples (100µl) in higher volume (2.5ml)
reduced pH-driven columbic repulsion and confirmed that the micelle formation of
Acryl-T904 polymers with DNA was only reason to reduce the efficiency of PicoGreen
assay-based DNA detection. And furthermore, the effect of Acryl-T904 polymers on
DNA or gene complexes released from degradable hydrogels was investigated. (Figure
7.5) Again, a basic environment caused by use of both STP and pH12 TE facilitated
polymer micelle formation and interfered with the PicoGreen assay. Comparing the DNA
amount after STP treatment, the release of complexes was significantly lower than that
obtained for plasmid alone in both methods. It seemed that LC PEI incorporated into the
hydrogels was primarily retained within the hydrogel. In vitro release data also showed
the similar tendency to reduced DNA amount, approximately 33% and 41% of for
Method I and II, respectively. (Figure 7.6) Similarly, Wieland and others reported the
reduced release of DNA when PEI-DNA complexes were incorporated into PEG-HA
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based hydrogels. In their case, for example, only 14% of the initial DNA was measured in
one type of hydrogels that exhibited 80% release of the initial DNA. The reduction in the
DNA amount can be induced by nonspecific interaction between PEI and hydrogel
polymer. One possible reason can be the reaction of primary or secondary amines in PEI
with polymer groups such as vinyl groups in Acryl-T904. Those amines can undergo
Michael-type addition with acrylate groups. In fact, several studies used this
polymerization process to improve PEI function as gene delivery vector by conjugating
with various acrylated polymers including PEG diacrylates, PCL diacrylates, etc. [208210] Unlike Michael-type addition between thiol and acrylate groups within the hydrogel
network, their crosslinking process required higher temperature than 37°C, organic
solvent or a certain catalyst. So, those studies cannot fully explain the happening in our
system. However, when LC-PEI was resuspended in Acryl-T904 solution (Method II),
the DNA release was almost detained until the hydrogel was completely degraded and
released gene complexes in a burst manner. In contrast to Method II, LC-PEI
resuspended in DTT solution first had less chance of exposure to acrylate groups in
Acryl-T904. The hydrogel prepared in Method I allowed DNA release in the more linear
feature. It is necessary to conduct further experiment in order to understand the
interaction of PEI with acrylated hydrogel polymers. On the other hand, Tetronic®
polymers have been investigated as gene delivery systems due to micellar formulations
based on their amphiphilic structural property. [190, 196, 211, 212] If the unfavorable
reaction between amines in PEI and acrylates in Acryl-T904 is removed by incorporating
only plasmid DNA, Tetronic® based hydrogels via Michael-type addition will provide
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DNA protection as well as the structural and release stability unlike easily reversible,
thermally generated gel. The previous studies indicated that the in vivo application of
naked DNA loaded-Tetronic® molecules as gene delivery increased several fold the
transfection efficiency and the production of recombinant proteins, which suggested that
the co-existent hydrogel degradation product may help to stabilize gene complexes
released from our gene delivery system and to improve transfection efficiency.
For reverse gene delivery or surface-mediated DNA delivery, providing cellfriendly environment at the substrate is the crucial factor. In this study, fibronectin and
acrylated peptide was incorporated with T904 based hydrogel. (Figure 7.7) Fibronectin is
an adhesive glycoprotein and one of popular adhesive proteins to mediate cellular
adhesion to the matrix. As one of approach of substrate-mediate delivery system,
manipulating the surface properties of a substrate is the critical factor to impact cellular
response and gene delivery. The adsorption of adhesive proteins including ECM proteins
has been used as a simple approach to increase the positive interaction of both DNA/gene
complex and cells onto the material surface, resulting in an increase in gene expression
levels and gene-expressing cell numbers. Shea group investigated the mechanism and
optimal conditions of various serum (e.g. BSA, FBS, fibronectin) and ECM proteins (e.g.
fibronectin, collagen, laminin) to enhance transgene expression in substrate-mediate
delivery via lipoplexes (lipofectamin) or polyplexes (PEI). [23, 130, 137, 138] Based on
their results, fibronectin mediated the highest levels of transgene expression, whereas the
protein identity did not influence substrate binding. [23, 130] It was expected that
incorporation of fibronectin with the current Tetronic® based hydrogels might improve
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cell adhesion as well as potential support for gene internalization. However, the
fibronectin effect on cell attachment was very inconsistent at each try. This event can be
explained by pH-dependent conformational states of fibronectin. [213-215] A
conformational change occur when solution pH deviates from physiological range of pH,
for example, unfolded form of fibronectin at pH 2 or 11. In our cases, although pH did
not exceed neutral condition, each sample might have slightly different pH so that caused
a change in the fibronectin conformation. In spite of using microorganisms, Ito and
colleagues indicated that subtle pH changes such as that from 6.8 to 7.6 caused a
conformational change in fibronectin. The same phase in fibronectin possibly happened
in our study. In contrast, peptide-T904 based hydrogels exhibited the uniform fibroblasts
attachment at the overall hydrogel surface. While mild evidence of cell death was
observed in fibroblasts cultured on the hydrogel surface, the promoted cell adhesion and
spreading on the hydrogel were seen. Several studies showed the same data that
incorporated peptide into nonadhesive PEG-based hydrogels dramatically reduced their
protein repellant properties and increased the number of attached cells, correlated with a
strong cell spreading. [176, 216-218] Acrylated RGD peptide (or acryoly PEG-RGD)
seemed to be more affected by their concentration for the application and MW of PEG
spacer rather than pH that there has not been yet any study related to pH.
Finally, transfection of NIH 3T3 fibroblasts in direct contact with thin hydrogel
films in the presence of serum was investigated. It appeared that groups containing
increased amounts of sucrose within the hydrogel exhibited transfection at early time
point of hydrogel degradation during the course of this study. The large amount of
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sucrose within hydrogel (56mg sucrose/100µl hydrogel) appeared to change the hydrogel
crosslinking rate, especially Method I (data not shown). The effect of the sucrose amount
on the hydrogel crosslinking rate might cause a change in hydrogel network or
crosslinking density, resulting in the different transfection performance due to a change
in degradation kinetics. In fact, increasing the sucrose amount reduced the pH, which
might have caused a pH change in the final hydrogel solution after resuspending
lyophilized gene complexes. Alternatively, the inclusion of a large amount of sucrose
may have produced defects in the network structure, increasing the effective network
mesh size, and allowing accelerated vector release. Esterase was expected to promote
hydrogel degradation as described in the previous studies. [219-221] Although the effect
of esterase on the hydrogel degradation kinetics was not investigated in this study, it
seemed that esterase might enhance the hydrogel degradation and the subsequent gene
complex release, resulting in the cell transfection at early time points (Day 1 and 3
hydrogel degradation) in comparison with the condition without esterase. In the case of
hydrogels with the small amount of sucrose (7mg sucrose/100µl hydrogel), however, the
effect of esterase was not as beneficial as when it was used for hydrogel with the large
amount of sucrose within the designed time period in this study. As shown in Figure 7.6,
the DNA amount released from hydrogel was lower than 2% of the initial loaded DNA
within 7days of hydrogel degradation in the case of 120mg/ml STP decomplexation. The
release kinetics was also very low until the end point of hydrogel degradation; perhaps
the poor transfection in the group with the small amount of sucrose was due to an
insufficient supply of DNA for cell transfection. The problem observed in this study was
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the poor cell adherence to the hydrogels, which caused only cell transfection around the
hydrogel, not at the hydrogel in the direct contact mode. Although acrylated RGDpeptide improved cell attachment and proliferation on the hydrogel surface as shown in
Figure 7.7, its effect seemed to be dulled by the incorporation of lyophilized gene
complexes. Further study is required to explain the cause of a change in peptide activity
within hydrogels.
7.5.

Conclusions

This study has shown that DNA in an active, supercoiled form can be released
from degradable hydrogels prepared by Michael-type addition. Due to the unique
properties of Tetronic® or T904 in this case, unique conditions were requred to analyze
released DNA, reducing the interaction of polymer with released DNA via micelle
formation. Unspecified reactions occurred between PEI complex and acrylated polymer,
which detained gene complex release and subsequently induced a decrease in total
amount of DNA released. Although peptide-T904 based hydrogels exhibited uniform
fibroblast attachment at the overall hydrogel surface, lyophilized PEI-pGFP complexes
affected peptide activity, resulting in the poor cell adherence to the hydrogel and the
subsequent poor transfection. However, the sustained gene expression was observed
around the hydrogel, which contained the large amount of sucrose, in the presence of
both serum and esterase during the designed time period in this study. Above all, the
suggested approach in this study is unique in its ability to facilitate the simultaneous gene
expression and support of transfected cell growth. Combination strategies combining
these controlled, substrate-based gene delivery system and topographical support by the
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grooved fibers will provide a large step to mimic the multifaceted nature of complex
tissue regeneration.
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CHAPTER EIGHT
CONCLUSIONS AND RECOMMENDATIONS

8.1.

Conclusions

The major objective of this dissertation was to develop hydrolytically degradable
hydrogels incorporating nonviral vectors and providing, controlled vector release based
on hydrogel polymer properties. Furthermore, combining this system with the
topographical guidance as the combinatorial strategy was suggested to increase the
potential of these hydrogel compositions to mimic the multifaceted nature of complex
tissue regeneration. As seen in the reverse transfection as a pilot study, the result of the
dramatic increase in transfection in the presence of serum suggested that hydrogel-based
delivery of nonviral vectors may concentrate vectors near the surface of adherent cells in
a similar manner and also achieve improved transfection efficiency. Relative to substratemediated reverse transfection approaches, it is expected that encapsulation of vectors
within a hydrogel matrix may provide improved vector stability and avoid an initial burst
release. This research project was conducted in three main sections: optimal formulation
of gene complex able to be condensed throughout hydrogel-based gene delivery system,
development and characterization of hydrogel matrix capable of controlled release as
well as geometrically stable under physiological condition, and evaluation of effective
gene delivery in a controlled manner based on a population of cells in proximity to
biodegradable hydrogel.
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To design gene delivery system incorporating gene complex, lyophilization
process was required to concentrate a sufficient amount of DNA within the hydrogel
delivery system. To protect gene complex from in-process damage during lyophilization,
the effect of different cryoprotectant agents was evaluated. In these preliminary studies,
all X-tremeGene (XG) formulations and N/P 7.5 PEI complex lyophilized with 10%
sucrose exhibited similar transfection efficiencies following lyophilization. Because XG
is a proprietary material of undisclosed composition, N/P 7.5 PEI was selected for the
entire study. At the same time, identifying the most effective decomplexation method was
fundamental for the current study to measure the amount of released nonviral-DNA
complexes from hydrogels. In comparison of various solutions to dissociate DNA from
complexes, 120 mg/ml STP treatment was found to provide the highest level of DNA
recovery and detection.
One important component associated with matrix-based system is the
maintenance of cell viability and proliferation, which is a critical factor to accomplish
local DNA delivery to a population of cells proximal to the material surface. Although
both linear poly(ethylene glycol)(PEG)-based hydrogels and Tetronic®-based hydrogels
appeared noncytotoxic, hydrogels do not contain any bioactivity. Therefore, it is essential
to modify those hydrogels with cell adhesive molecules. Addition of RGD peptide into
the both linear PEG-based and Tetronic®-based hydrogel networks provided ligands for
cell adhesion.
In the case of substrate-mediated gene delivery, the nature of DNA
immobilization method hindered sustained gene delivery, resulting in either uncontrolled
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initial burst release due to non-specific DNA adsorption to the surface or suppressed
DNA release due to strong binding with substrate. In contrast, both linear PEG-based and
Tetronic®-based hydrogels achieved significant variation in degradation rate and
exhibited potential as a controlled release system. Crosslinkable, hydrolytically
degradable PEG-based macromers were successfully prepared with high conversion
efficiency by a novel two-step synthetic route using difunctional chemical intermediaries.
Through variation in the alkyl chain length of the chemical intermediary, significant
variation in degradation rate was achieved without significantly altering the gel physical
properties. The sustained release profile of immunoglobulin G (IgG) suggested the
feasibility of these PEG-based hydrogels for gene delivery system in spite of different
nature of IgG from DNA. However, the delamination of these PEG-based hydrogels as
fiber coatings in the aqueous environment was limited for their application in
combinatorial system investigated in this dissertation. Also, free radicals generated
during photopolymerization should be taken into account.
On the other hand, Tetronic® polymers have the distinct properties from PEG
polymers due to their polymeric structure, two amine groups in the center and four-armed
amphiphilic chains, which result in the self-aggregation depending on environmental
conditions such as temperature and pH. Tetronic®-based hydrogels prepared via
Michael-type addition showed its ability to release DNA in an active, supercoiled form
with a profile closely correlated to hydrogel degradation kinetics as well as significantly
improved, geometrical stability when coated on polymer fibers. However, this release
profile was dependent on the hydrogel type and preparation method with gene complex.
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Hydrogels with higher Tetronic® 1107 (T1107) content or lower Tetronic® 904 (T904)
content underwent more swelling and quicker degradation, which will shorten the period
of DNA release (at least 18days). T904-based hydrogel used in this study exhibited the
least change in its size and prolonged degradation kinetics. When lyophilized PEI-DNA
complex was resuspended in dithiothreitol (DTT) solution, DNA release was more
sustained than one resuspended in T904 solution. It was concluded that there were
nonspecific interactions between PEI complex and acrylated polymer, which delayed
gene complex release and subsequently induced a decrease in total amount of DNA
released. In addition, the self-aggregation properties of Tetronic® polymers influenced
not only hydrogel network structure but also the gene complex behavior. The hydrogel
degradation products interfered with the DNA detection assay (PicoGreen assay),
resulting in a decrease in the measured amount of DNA. In vitro DNA detection may be
problematic with the presence of degradation product, mainly Tetronic® polymer itself.
However, several studies indicated that the in vivo application of naked DNA loadedTetronic® molecules as gene delivery increased several fold the transfection efficiency
and the production of recombinant proteins, which suggested that the co-existent
hydrogel degradation product may help to stabilize gene complexes released from our
gene delivery system and to improve transfection efficiency at least in in vivo models.
Although there was some positive transfection in the presence of serum for the group
with increased amount of sucrose, in vitro transfection was very limited and its efficiency
was lower than 1%. Low transfection efficiency in vitro might be due to the non-linear
degradation kinetics of Acryl-T904 hydrogels, which caused the delayed DNA release at
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early time point of hydrogel degradation. Again, in vivo application of the current gene
delivery system based on the Tetronic®-based hydrogels may enhance the degradation
rate, resulting from hydrolysis and enzymatic degradation caused by the cellular
environment. Increased degradation kinetics of the hydrogel will enhance the DNA
release rate, possibly resulting in an increase in transfection efficiency.
8.2.

Recommendations

The key challenges identified in these studies were 1) non-linear vector release
kinetics and 2) limited in vitro transfection. There are several potential solutions to these
problems. A likely factor contributing the delayed release of vectors from T904-based
hydrogels is the relatively large size of the gene complexes (~100nm). Therefore,
significant degradation was required in order for the mesh size to sufficiently expand to
allow vector release. One approach to overcoming this problem is the creation of blends
of Acryl-T904 and acrylated T904 modified with the chloroacetyl chloride chemistry
described in Chapter 5. The presence of an additional ester bond in this second product
will likely accelerate degradation and various blends are expected to exhibit degradation
profiles with increased linearity and concurrent improvements in vector release. A similar
principle has been demonstrated by Anseth’s group using photopolymerized PEGdiacrylates prepared with oligo-alpha hydroxyl acid sequences of varying composition,
degree of polymerization, and hence susceptibility to hydrolytic degradation. [118, 119]
Within the context of the present work, the effect of Tetronic® polymers or
degradation products on the transfection is yet unknown in this study. They could hinder
gene delivery by forming micelles to retain gene complex and/or by covalent links to
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PEIs. It was noticed the possibility of the nonspecific interaction between PEI and
Tetronic® polymers according to in vitro release data. If only considering of this side
reaction between two molecules, replacing PEI with other nonviral vectors with less
amine contents can be a simple approach. Cationic lipid-based vectors can be alternative.
However, it was known that positively charged surface of both polyplex and lipoplex
limits their transfection efficacy in vivo.
An alternative approach would be the use of Tetronic®-based hydrogels for the
delivery of naked plasmid DNA. Although almost universally ineffective in vitro, several
groups have continued to pursue naked DNA delivery in vivo and demonstrated effective
transfection in several tissues. [196, 222] Recent work on noncationic vectors has also
suggested that amphiphilic block copolymers, although they cannot condense DNA in the
manner of PEI, can promote transfection and gene expression, although the mechanisms
responsible remain largely unknown. In addition, Tetronic®-DNA complexes showed
promising results including gene transfer in skeletal and heart muscle in vivo. [211]
Therefore, there is the possibility that Tetronic® degradation products help gene delivery
by protecting DNA from environmental barriers via hydrophilic chains as well as
association with cell membrane via hydrophobic chains. Several groups have shown that
naked DNA can be released by diffusion from hydrogels that severely restrict the release
of gene complexes. [19, 115, 128] So, using only naked DNA with Tetronic®-based
hydrogels may be another approach to avoid the nonspecific interaction with cationic
polymers used for gene complexes and increase transfection efficiency in vivo. Using
T904-based hydrogels, released naked DNA may spontaneously associate with T904
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degradation products to take advantage of this effect, which will provide more controlled
gene delivery due to removal of the potential covalent binding to polymers. Also, it was
noticed that lyophilization process damaged DNA in some degree even in the presence of
a cryoprotectant; PEI-mediated complex with sucrose in this study. Adjusting DNA
concentration during purification process may remove lyophilization process and in-situ
process damage on DNA. In addition, in vitro transfection in the presence of serum was
resulted with very limited transfection for a short time. Further studies addressing the
long-term DNA release and the subsequent transfection efficiency are required. However,
several studies showed that the efficacy of transfection was different between in vivo and
in vitro applications. Since Tetronic®-based hydrogels exhibited the delayed degradation

properties, in vivo application may increase the degradation rates caused by hydrolysis as
well as enzymatic degradation (e.g., esterase released from cells).
As combinatorial strategy, hydrogel-based gene delivery should be combined with
the CCP fiber as a topographical support. Although initial geometric stability of T904based hydrogel was observed, hydrogel stability will change over time with hydrogel
degradation, so long-term monitoring of hydrogel coating state should be followed.
However, when target cells adhere to the coating surface, the degradation rate will be
changed or increased, which can contribute two ways; i) to stimulate gene release from
hydrogel as well as transfection of cells, and ii) hydrogel escape/dissociation from the
fiber. However, the second phase may not be problematic depending on the cell density
on the surface. It will be dependent on the cell affinity to the surface in vitro and in vivo
and cell clearance by inflammatory and immune cells in the body. To this end, multiple
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therapeutic gene delivery through various hydrogel coating on the fiber will be feasible.
Each fiber can be coated with distinct degradation profile of hydrogels carrying different
biomolecules, which will satisfy the complexity of tissue regeneration such as spinal cord.
For the clinical application, the proper sterilization and packaging techniques should be
investigated. For sterilization, terminal sterilization is more active method to destroy
viable microorganisms than aseptic processing, and can be done by various procedures
including steam sterilization, ethylene oxide (EtO) sterilization, hydrogen peroxide (H2O2)
sterilization, gamma radiation, and autoclave. [223, 224] However, each procedure has its
own advantages and disadvantages and will affect the properties of hydrogels as well as
the stability of gene complexes. Also, the reproducibility of sterilization is important.
Therefore, it is essential to examine the effects of sterilization process on the properties
of polymeric materials including morphological structure, thermal behavior, swelling and
degradation behavior, as well as DNA release profile. The choice of packaging
techniques will play an important role in the success of hydrogel-based gene delivery
system in this study as merchandise as well as appeal to clinicians. Due to the
lyophilization of gene complexes and the geometrical stability of T904-based hydrogels
after swelling at 37°C, the dry product can be commercialized and can be directly
implanted to the targeting site such as the lesion at the spinal cord. At this point, the main
concern will be the proper time point to use the developed gene delivery system in this
study. For example, the phase of damage varies over time in the spinal cord injury, which
requires the different protein factors at each time point. Again, combining the multiple
therapeutic genes through distinct degradation profile of hydrogel coatings on the fibers
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should be followed for each application. However, suturing the end points to the host
tissue is still required during implantation, which may cause further damage to the lesion
and host tissue. Therefore, the study of an alternative to suturing will be required.
As an unexpected outgrowth of this project, Tetronic®-based hydrogels were
noted to have interesting and potentially useful mechanical properties including the
ability to withstand substantially higher levels of deformation than observed for
hydrogels crosslinked by free radical polymerization (see Appendix D). When applied to
tissue surfaces, these materials are able to achieve bonding strengths at least as high as
conventional hydrogel-based sealants such as PEG-diacrylates and fibrin glue. Therefore,
Tetronic®-based hydrogels may be useful in tissue adhesive/sealant applications with the
capability for modulating the wound healing process through the gene delivery strategies
developed in this dissertation. Although a seemingly minor point, Tetronic®s may also
be advantageous due to their limited swelling after crosslinking under physiological
conditions relative to PEG-based hydrogels that swell considerably (up to 5-10 times
initial swelling ratio) after crosslinking. To our knowledge, the effects of this swelling
and/or resulting pressure if it is restricted on surrounding tissue have not been studied.
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Appendix A
N/P ratio calculation
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Figure A-1: Adenine-nucleotide; one base of DNA
A.1. Introduction

The N/P ratio is a measure of the ionic balance of the complexes, referring to the
number of nitrogen residues of the vector per the number of DNA phosphate groups.
A.2. The number of phosphate in 1µg DNA

DNA is made up of four building blocks, called nucleotides. The molecular
weights of these four nucleotides (A,C,G,T) are not identical, so in routine work we
usually average the molecular weights of all four and go with 330 Daltons (Da) per
nucleotide in DNA (=330 g/mol of individual nucleotides). MW of a nucleotide pair in
the double strand DNA would be 660 g/mol.
i.

The number of phosphate/mol = 2/mol

ii.

DNA mole in 1µg =

1µg
= 0.0015µmol
660 g / mol
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iii.

Therefore,

1µg
× 2 phosphate/ mol = 0.003 × 10 −3 phosphates
660 g / mol

A.3. The number of nitrogen in 1µg PEI

Since 25kDa b-PEI was used in this study and repeating unit of PEI is 43g/mol,
i.

The number of nitrogen/mol =

ii.

PEI mole in 1µg =

iii.

Therefore,

25000 g / mol
= 581.40 / mol
43 g

1µg
= 0.00004 µmol
25000 g / mol

1µg
25000g / mol
×
nitrogen/mol = 0.023 × 10 −3 nitrogen
25000g / mol
43g

A.4. Conversion of N/P number ratio to mass ratio of PEI to DNA

If calculating N/P ratio of 1 µg PEI and DNA,

N/P =

1µg PEI
0.023 × 10 − 3
=
= 7.667
1µg DNA 0.003 × 10 − 3

i.

If N/P = 1 =

ii.

If N/P = 5 =

iii.

If N/P = 7.5 =

1

7.667

1

=

0.13 µg PEI
1µg DNA

0.13µg PEI × 5
1µg DNA

=

0.65µg PEI
1µg DNA

0.13µg PEI × 7.5
1µg DNA
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=

=

1.3µg PEI
2 µg DNA

0.975µg PEI
1µg DNA

=

1.95µg PEI
2 µg DNA

Appendix B
Calculation of depth and width of the CCP fiber
Data from profilometer analysis only gives the surface roughness (= shape).
Contour processed data can be converted to 2D profile. To calculate depth and width of
untreated or special treated fiber such as plasma treatment, hydrogel coating etc., Y
profile in 2D profile was used. Software (Wyko vision 32) gave length of x and y axis by
moving the plot cursor that indicated the cursor position and the distant difference. Width
and depth were calculated by following equations;

Width = x 2 + y 2
Depth =

1


xc + (xy − bc − ay − ac )

2
2
2

x +y 
2

Width

Depth

Figure B-1: Calculation of depth and width of one groove at the capillary channel
polymer (CCP) fiber
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Appendix C
Mechanical properties of photocrosslinked, linear PEG-based hydrogels
C.1. Mechanical analysis

Hydrogels were photopolymerized from solutions of varying macromer
composition and concentration as described earlier, cut into dog-bone shaped specimens
according to ASTM D 5937, and equilibrated in distilled water overnight. Five to six
specimens of each group were subjected to uniaxial tensile testing at a constant crosshead
speed of 10 mm/min using an MTS Synergie 100 equipped with a 10 N load cell. In order
to facilitate gripping of the specimens, pieces of Kimwipe were applied to the grip
portions of the dog bones. All samples were subjected to two cycles of 20% strain and
relaxation to ensure sample slippage did not occur, and then strained to failure. The
Young's modulus, elongation at break and ultimate tensile strength (UTS) were
determined for each sample.
C.2. Results
C.2.1. Influence of macromer concentration on mechanical properties

The corresponding initial (Day 1) tensile properties of PEG-bis-AA hydrogels
prepared at various concentrations are summarized in Table C-1. With increasing
macromer concentration, the hydrogels became stiffer and less elastic, exhibiting
significant increases in Young's modulus and ultimate tensile strength (UTS) among all
samples and decreased elongation at break. Comparing 10% w/v and 40% w/v hydrogels,
elongation at break was reduced by approximately half, whereas Young's modulus and
UTS both increased by more than an order of magnitude.
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Table C-1. Tensile properties of hydrogels polymerized from solutions containing
varying concentrations of PEG-bis-AA macromers
Young's Modulus
Elongation at Break
Concentration
UTS (kPa)
(kPa)
(% w/v)
(%)
10
73.72±9.43
45.72±16.13
63.05±19.96*
20
429.26±12.34
164.09±19.31
47.29±6.02*
40
1041.89±40.00
262.08±8.19
31.09±3.13
*All values were significantly different with exception of elongation at break (%)
between 10 and 20% w/v

C.2.2. Influence of macromer chemical composition on mechanical properties

Young's modulus, UTS, and percent elongation at break of hydrogels prepared
from the different macromers are shown in Table C-2. No significant differences in
mechanical properties were observed among the hydrogels prepared from macromers
based on the different chemical intermediaries.
Table C-2. Tensile properties of 10% w/v PEG-bis-acrylate hydrogels with varying
chemical composition
Young's Modulus
Elongation at
PEG-bis-Acrylates
UTS (kPa)
(kPa)
Break (%)
PEG-bis-AA
73.72±9.43
45.72±16.13
63.05±19.96
PEG-bis-AP
69.55±5.62
38.23±8.68
57.48±9.78
PEG-bis-AB
72.78±2.19
37.38±4.79
58.75±9.47
*No significant differences were observed among different hydrogel chemical
compositions for each mechanical parameter evaluated
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Appendix D
Mechanical properties of Tetronic®-based hydrogels
D.1. Mechanical analysis
D.1.1. Tensile properties

Hydrogels were polymerized from solutions of varying macromer composition of
Acryl-T1107 and Acryl-T904 as described above, cut into dog-bone shaped specimens
according to ASTM D5937, and equilibrated in 37°C PBS (pH7.4) overnight. Five to six
specimens of each group were subjected to uniaxial tensile testing at a constant crosshead
speed of 10 mm/min using an MTS Synergie 100 equipped with 10N load cell. In order
to facilitate gripping of the specimens, pieces of Kimwipe were applied to the grip
portions of the dog bones. All samples were subjected to two cycles of 20% strain and
relaxation to ensure sample slippage did not occur, and then strained to failure. The
Young’s modulus, tensile elongation at break and ultimate tensile strength (UTS) were
determined for each sample.
D.1.2. Bonding strength

The bonding strength was investigated using rat skin referring to ASTM 2255.
The rats were humanely euthanized using a CO2 chamber. Rat skins were collected using
sterile surgical tools, were stored in 150mM sterile NaCl and were cut into 4cm×1cm
strips. The hydrogel solutions were applied at one end (approximately 1cm×1cm) of one
skin strip and another skin strip was placed over it. The polymerization was maintained at
37°C overnight in a humidified atmosphere and then equilibrated in 37°C PBS (pH7.4)
before testing. More than five specimens of each group were subjected to uniaxial
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strength at a constant crosshead speed of 10 mm/min using an MTS Synergie 100
equipped with 10N load cell. In order to facilitate gripping of the specimens, pieces of
Kimwipe were applied to both ends of rat skins. All samples were strained until two skins
were detached from each other. The bonding strength were determined Test samples
were kept at 37°C and were tested at room temperature.
D.2. Results
D.2.1. Tensile properties

The tensile properties of Tetronic®-based hydrogels were tested over the different
temperature. (Figure D-1) With increasing Acryl-T904 content, the hydrogels saturated
with 37°C PBS became more elastic as well as more firm, exhibiting increased Young’s
modulus and increased strain to failure. In comparison with Tetronic®-based hydrogels,
4-arm PEG-based hydrogels appeared easily breakable at 44% strain with low Young’s
modulus (ca. 181.21kPa). In comparison with 37°C testing temperature, Young’s
modulus of the specimens, which were saturated at 4°C, decreased and lowered than 4arm-based PEG at 37°C in the case of 100/0, but still tended to increase as an increase in
Acryl-T904 content. However, strain to failure of all groups decreased to exhibit close to
strain of 4-arm-based PEG at 37°C.
Young’s modulus is a bulk property of the hydrogel and correlates with the
hydrogel’s cohesive strength. Figure D-1 shows that increasing Acryl-T904 content
caused an increase in Young’s modulus at both 37°C and 4°C. As explained before, the
solution of Acryl-T904 has more functional groups reactive with thiol groups than one of
Acryl-T1107 at the same concentration, resulting in more crosslinking density within the
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gel networks and stronger hydrogels with higher tensile strength (data not shown).
Interestingly, the strain to failure of Tetronic®-based hydrogels increased with an
increase in Acryl-T904 contents at 37°C or was higher than 4-arm PEG. It will give the
flexibility as the adhesives. Exclusive of hydrophobic effects, this may be due to the
increased number of thiol linkers that form elastically active chain. [174] However, data
from 4°C didn’t support this assumption because their strain to failure exhibited similar
values among groups. Therefore, hydrophobic effects had a greater influence on the
mechanical properties of hydrogels than the chemical crosslinking composition.
D.2.2. Bonding strength

The tissue bonding strength of all Tetronic®-based hydrogels ranged between
approximately 10-25 kPa except for 4-arm PEG hydrogels. (Figure D-2) Bonding
strength was significantly higher in all formulations including Acryl-T904 relative to
homogeneous Acryl-T1107. This likely reflects reduced average macromer molecular
weights and subsequent increased number of reactive functional groups available to react
with the skin tissue.
The observation from Figure D-2 is that the different composition did not appear
to affect the adhesive’s strength significantly except for 100/0 group. However, the
average bonding strength of each group had a tendency to increase with an increase in
Acryl-T904 content. Consistently, hydrophobic interaction strongly affected hydrogel
bonding strength, resulting from the very weak bonding of 4-arm PEG-based hydrogel.
An advantage of Tetronic®-based hydrogel is a high bonding strength to soft tissues
(skin). The adhesive strengths for Tetronic®-based hydrogels ranged from 18.3 (±1.42)
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to 21.68 (±1.03) kPa except for 11.54 (±0.93) kPa of 100/0 group, suggesting a stronger
adhesiveness than fibrin-based sealants and comparable with other tissue adhesives used
in clinical and experimental procedures.

Figure D-1: Tensile properties of various Tetronic®-based hydrogels, p<0.05, *
represents significant difference between two temperatures, letters represent the
significant difference between groups
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Figure D-2: Bonding strength of various Tetronic®-based hydrogels, p<0.05, letters
represent significant difference between groups
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Appendix E
Reversible swelling behavior of Tetronic®-based hydrogels
E.1. Test of reversible swelling behavior

The reversible swelling behavior of the hydrogels at consecutive time intervals
was measured according to the volumetric swelling ratio equation as well. All the
hydrogel discs were prepared at 37°C according to the methods as stated above, and
submerged in 4ml of 37°C PBS (pH 7.4). Then, the sample bottles were stored at 4°C
room for 24 hours, followed by storing at 37°C for another 24 hours. The total incubation
time was 98 hours with the storing temperature alternated every 24 hours.
E.2. Results

The temperature-reversibility of the hydrogel or the reversible swellingdeswelling kinetics of hydrogels is illustrated in Figure 5.6. Hydrogel samples were
prepared in 37°C PBS (pH7.4) and then placed in the 4°C environment. The hydrogels
increased their swelling ratio, showing the average volumetric swelling ratio of 13.2 for
100/0 group, 11.5 for 75/25 group, 10.4 for 50/50 group and 9.3 for 0/100 group,
respectively. When hydrogels were placed in the 37°C environment, the hydrogels
collapsed and showed a dramatic decrease in swelling ratio. Increasing Acryl-T904
content induced more shrink, for example, for 0/100 group showing 62.37% decrease in
the volumetric swelling ratio in comparison to 49.24% decrease for 100/0 group. They
were returned to 4°C and increased their size again. The swollen networks reverted to
relatively shrunk networks whenever the temperature increased.
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The dynamic or reversible swelling behavior exhibited that increasing Acryl-T904
contents induced more contraction of gel networks. Although raw T904 did not show the
physical gelation within the experimental temperature (up to 40°C), Acryl-T904-based
hydrogels strongly exhibited hydrophobic aggregation of the PPO chains. After
polymerization, Acryl-T904 molecules were fixed within the gel networks and the
repulsions among positive amine groups were dismissed. T904 has longer PPO chains
than PEO chains (PPO:PEO=17:15), so hydrophobic attraction among PEO chains and
the hydrogen-bonding of water rearranged around the hydrophobic molecules drove the
hydrophobic effect on the hydrogel networks. Therefore, the aggregation of PPO chains
strongly impacted the water uptake of 0/100 group hydrogels, corresponding to the
contraction of a half portion of gel networks. For Acryl-T1107-based hydrogels, even an
increase in temperature caused hydrophobic aggregation, PEO chains of T1107 are
roughly three times longer than PPO chains, which resulted in better water uptake than
Acryl-T904 hydrogels.

Figure E-1. The reversible swelling behavior of various Tetronic®-based hydrogels;
100/0 (×), 75/25 (●), 50/50 (■), and 0/100 (▲). The change in temperature ranged
from 4°C to 37°C

192

REFERENCES

1.
2.
3.
4.
5.
6.
7.
8.

9.
10.
11.
12.
13.
14.
15.
16.
17.

Murray, M. and I. Fischer, Transplantation and gene therapy: combined
approaches for repair of spinal cord injury. Neuroscientist, 2001. 7(1): p. 28-41.
Park, T.G., J.H. Jeong, and S.W. Kim, Current status of polymeric gene delivery
systems. Adv Drug Deliv Rev, 2006. 58(4): p. 467-86.
Rubanyi, G.M., The future of human gene therapy. Mol Aspects Med, 2001. 22(3):
p. 113-42.
Crystal, R.G., Transfer of genes to humans: early lessons and obstacles to success.
Science, 1995. 270(5235): p. 404-10.
Han, S., et al., Development of biomaterials for gene therapy. Mol Ther, 2000.
2(4): p. 302-17.
Kodama, K., et al., The features and shortcomings for gene delivery of current
non-viral carriers. Curr Med Chem, 2006. 13(18): p. 2155-61.
Marshall, L.H., Careful planning created the Society for Neuroscience. Science,
2000. 290(5500): p. 2259.
Abdallah, B., et al., A powerful nonviral vector for in vivo gene transfer into the
adult mammalian brain: polyethylenimine. Hum Gene Ther, 1996. 7(16): p. 194754.
Gao, X., K.S. Kim, and D. Liu, Nonviral gene delivery: what we know and what
is next. Aaps J, 2007. 9(1): p. E92-104.
Jackson, D.A., S. Juranek, and H.J. Lipps, Designing nonviral vectors for efficient
gene transfer and long-term gene expression. Mol Ther, 2006. 14(5): p. 613-26.
Ledley, F.D., Nonviral gene therapy: the promise of genes as pharmaceutical
products. Hum Gene Ther, 1995. 6(9): p. 1129-44.
Nishikawa, M. and L. Huang, Nonviral vectors in the new millennium: delivery
barriers in gene transfer. Hum Gene Ther, 2001. 12(8): p. 861-70.
Sakurai, H., et al., Innate immune response induced by gene delivery vectors. Int J
Pharm, 2008. 354(1-2): p. 9-15.
Chollet, P., et al., Side-effects of a systemic injection of linear polyethylenimineDNA complexes. J Gene Med, 2002. 4(1): p. 84-91.
Moghimi, S.M., et al., A two-stage poly(ethylenimine)-mediated cytotoxicity:
implications for gene transfer/therapy. Mol Ther, 2005. 11(6): p. 990-5.
Gautam, A., C.L. Densmore, and J.C. Waldrep, Pulmonary cytokine responses
associated with PEI-DNA aerosol gene therapy. Gene Ther, 2001. 8(3): p. 254-7.
Segura, T. and L.D. Shea, Materials for non-viral gene delivery. Annu Rev Mater
Res, 2001. 31: p. 25-46.

193

18.
19.
20.
21.
22.
23.

24.
25.
26.
27.
28.
29.
30.
31.
32.

33.
34.
35.

Bonadio, J., et al., Localized, direct plasmid gene delivery in vivo: prolonged
therapy results in reproducible tissue regeneration. Nat Med, 1999. 5(7): p. 753-9.
Shea, L.D., et al., DNA delivery from polymer matrices for tissue engineering. Nat
Biotechnol, 1999. 17(6): p. 551-4.
Robbins, P.D. and S.C. Ghivizzani, Viral vectors for gene therapy. Pharmacol
Ther, 1998. 80(1): p. 35-47.
Laporte, L.D. and L.D. Shea, Matrices and scaffolds for DNA delivery in Tissue
engineering. Adv Drug Deliv Rev, 2007. 59(4-5): p. 292-307.
Houchin-Ray, T., et al., Patterned PLG substrates for localized DNA delivery and
directed neurite extension. Biomaterials, 2007. 28(16): p. 2603-2611.
Bengali, Z., J.C. Rea, and L.D. Shea, Gene expression and internalization
following vector adsorption to immobilized proteins: dependence on protein
identity and density. J Gene Med, 2007. 9(8): p. 668-78.
Annex, B.H. and M. Simons, Growth factor-induced therapeutic angiogenesis in
the heart: protein therapy. Cardiovasc Res, 2005. 65(3): p. 649-55.
Pannier, A.K. and L.D. Shea, Controlled release systems for DNA delivery. Mol
Ther, 2004. 10(1): p. 19-26.
Segura, T. and L.D. Shea, Surface-tethered DNA complexes for enhanced gene
delivery. Bioconjug Chem, 2002. 13(3): p. 621-9.
Cho, E., et al., A novel synthetic route for the preparation of hydrolytically
degradable synthetic hydrogels. J Biomed Mater Res A, 2009. 90(4): p. 1073-82.
Marshall, E., Gene therapy death prompts review of adenovirus vector. Science,
1999. 286(5448): p. 2244-5.
Patil, S.D., D.G. Rhodes, and D.J. Burgess, DNA-based therapeutics and DNA
delivery systems: a comprehensive review. AAPS J, 2005. 7(1): p. E61-77.
Zhang, X. and W.T. Godbey, Viral vectors for gene delivery in tissue engineering.
Adv Drug Deliv Rev, 2006. 58(4): p. 515-34.
Park, F., Lentiviral vectors: are they the future of animal transgenesis? Physiol
Genomics, 2007. 31(2): p. 159-73.
Abdellatif, A.A., et al., Gene delivery to the spinal cord: comparison between
lentiviral, adenoviral, and retroviral vector delivery systems. J Neurosci Res,
2006. 84(3): p. 553-67.
Muruve, D.A., The innate immune response to adenovirus vectors. Hum Gene
Ther, 2004. 15(12): p. 1157-66.
Kennedy, P.G., Potential use of herpes simplex virus (HSV) vectors for gene
therapy of neurological disorders. Brain, 1997. 120 ( Pt 7): p. 1245-59.
Uherek, C. and W. Wels, DNA-carrier proteins for targeted gene delivery. Adv
Drug Deliv Rev, 2000. 44(2-3): p. 153-66.

194

36.
37.
38.
39.
40.
41.
42.
43.

44.
45.

46.
47.
48.

49.

50.

Wolff, J.A., et al., Direct gene transfer into mouse muscle in vivo. Science, 1990.
247(4949 Pt 1): p. 1465-8.
Amiji, M.M., Polymeric Gene Delivery Vehicles: Principles and Applications. 1
(Sep. 29, 2004) ed. 2004: CRC press. 704.
Davis, M.E., Non-viral gene delivery systems. Curr Opin Biotechnol, 2002. 13(2):
p. 128-31.
Zabner, J., et al., Cellular and molecular barriers to gene transfer by a cationic
lipid. J Biol Chem, 1995. 270(32): p. 18997-9007.
Wagner, E., Application of membrane-active peptides for nonviral gene delivery.
Adv Drug Deliv Rev, 1999. 38(3): p. 279-289.
Kichler, A., et al., Influence of membrane-active peptides on lipospermine/DNA
complex mediated gene transfer. Bioconjug Chem, 1997. 8(2): p. 213-21.
Kamata, H., et al., Amphiphilic peptides enhance the efficiency of liposomemediated DNA transfection. Nucleic Acids Res, 1994. 22(3): p. 536-7.
Liu, G., et al., Biological properties of poly-L-lysine-DNA complexes generated
by cooperative binding of the polycation. J Biol Chem, 2001. 276(37): p. 3437987.
Storrie, H. and D.J. Mooney, Sustained delivery of plasmid DNA from polymeric
scaffolds for tissue engineering. Adv Drug Deliv Rev, 2006. 58(4): p. 500-14.
Maruyama, A., et al., Characterization of interpolyelectrolyte complexes between
double-stranded DNA and polylysine comb-type copolymers having hydrophilic
side chains. Bioconjug Chem, 1998. 9(2): p. 292-9.
Choi, Y.H., et al., Polyethylene glycol-grafted poly-L-lysine as polymeric gene
carrier. J Control Release, 1998. 54(1): p. 39-48.
Fischer, D., et al., In vitro cytotoxicity testing of polycations: influence of polymer
structure on cell viability and hemolysis. Biomaterials, 2003. 24(7): p. 1121-31.
Kunath, K., et al., Low-molecular-weight polyethylenimine as a non-viral vector
for DNA delivery: comparison of physicochemical properties, transfection
efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J
Control Release, 2003. 89(1): p. 113-25.
Neu, M., D. Fischer, and T. Kissel, Recent advances in rational gene transfer
vector design based on poly(ethylene imine) and its derivatives. J Gene Med,
2005. 7(8): p. 992-1009.
Godbey, W.T., K.K. Wu, and A.G. Mikos, Tracking the intracellular path of
poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A,
1999. 96(9): p. 5177-81.

195

51.

52.

53.

54.
55.
56.

57.

58.

59.

60.

61.
62.
63.
64.

Sonawane, N.D., F.C. Szoka, Jr., and A.S. Verkman, Chloride accumulation and
swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J
Biol Chem, 2003. 278(45): p. 44826-31.
Thomas, M. and A.M. Klibanov, Enhancing polyethylenimine's delivery of
plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A, 2002. 99(23): p.
14640-5.
Godbey, W.T., K.K. Wu, and A.G. Mikos, Size matters: molecular weight affects
the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater
Res, 1999. 45(3): p. 268-75.
Ogris, M., et al., The size of DNA/transferrin-PEI complexes is an important
factor for gene expression in cultured cells. Gene Ther, 1998. 5(10): p. 1425-33.
Moret, I., et al., Stability of PEI-DNA and DOTAP-DNA complexes: effect of
alkaline pH, heparin and serum. J Control Release, 2001. 76(1-2): p. 169-81.
Segura, T., P.H. Chung, and L.D. Shea, DNA delivery from hyaluronic acidcollagen hydrogels via a substrate-mediated approach. Biomaterials, 2005.
26(13): p. 1575-84.
Goula, D., et al., Size, diffusibility and transfection performance of linear
PEI/DNA complexes in the mouse central nervous system. Gene Ther, 1998. 5(5):
p. 712-7.
Ahn, H.H., et al., DNA/PEI nano-particles for gene delivery of rat bone marrow
stem cells. Colloids and surfaces A: Physicochem. Eng. Aspects, 2008. 313-314: p.
116-120.
Petersen, H., et al., Poly(ethylenimine-co-L-lactamide-co-succinamide): a
biodegradable polyethylenimine derivative with an advantageous pH-dependent
hydrolytic degradation for gene delivery. Bioconjug Chem, 2002. 13(4): p. 81221.
Kukowska-Latallo, J.F., et al., Efficient transfer of genetic material into
mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad
Sci U S A, 1996. 93(10): p. 4897-902.
Wiethoff, C.M. and C.R. Middaugh, Barriers to nonviral gene delivery. J Pharm
Sci, 2003. 92(2): p. 203-17.
Lukacs, G.L., et al., Size-dependent DNA mobility in cytoplasm and nucleus. J
Biol Chem, 2000. 275(3): p. 1625-9.
Watson, J.D., et al., Molecular Biology of the Gene, in Wikipedia, the free
encyclopedia. 2004, Pearson Benjamin Cummings: CSHL Press.
Bessis, N., F.J. GarciaCozar, and M.C. Boissier, Immune responses to gene
therapy vectors: influence on vector function and effector mechanisms. Gene Ther,
2004. 11 Suppl 1: p. S10-7.

196

65.

66.

67.
68.
69.

70.
71.
72.

73.

74.

75.
76.
77.
78.
79.

Zhang, X., et al., The in vivo use of chloroquine to promote non-viral gene
delivery to the liver via the portal vein and bile duct. The jornal of gene medicine,
2003. 5(3): p. 209-218.
Harrington, K., et al., Cells as vehicles for cancer gene therapy: the missing link
between targeted vectors and systemic delivery? Hum Gene Ther, 2002. 13(11): p.
1263-80.
Pouton, C.W. and L.W. Seymour, Key issues in non-viral gene delivery. Adv
Drug Deliv Rev, 2001. 46(1-3): p. 187-203.
Dash, P.R., et al., Factors affecting blood clearance and in vivo distribution of
polyelectrolyte complexes for gene delivery. Gene Ther, 1999. 6(4): p. 643-50.
Zhang, J.S., F. Liu, and L. Huang, Implications of pharmacokinetic behavior of
lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev, 2005. 57(5): p. 68998.
Tuszynski, M.H., Gene therapy: Applications to the neurosciences and to
neurological disease. The neuroscientist, 1998. 4(6): p. 398-407.
Heyde, M., et al., Gene therapy used for tissue engineering applications. J Pharm
Pharmacol, 2007. 59(3): p. 329-50.
Clamme, J.P., J. Azoulay, and Y. Mely, Monitoring of the formation and
dissociation of polyethylenimine/DNA complexes by two photon fluorescence
correlation spectroscopy. Biophys J, 2003. 84(3): p. 1960-8.
Finsinger, D., et al., Protective copolymers for nonviral gene vectors: synthesis,
vector characterization and application in gene delivery. Gene Ther, 2000. 7(14):
p. 1183-92.
Bikram, M., et al., Long-circulating DNA-complexed biodegradable multiblock
copolymers for gene delivery: degradation profiles and evidence of
dysopsonization. J Control Release, 2005. 103(1): p. 221-33.
Levy, R.J., et al., Localized adenovirus gene delivery using antiviral IgG
complexation. Gene Ther, 2001. 8(9): p. 659-67.
Luo, D. and W.M. Saltzman, Enhancement of transfection by physical
concentration of DNA at the cell surface. Nat Biotechnol, 2000. 18(8): p. 893-5.
Luo, D. and W.M. Saltzman, Synthetic DNA delivery systems. Nat Biotechnol,
2000. 18(1): p. 33-7.
Read, M.L., et al., A versatile reducible polycation-based system for efficient
delivery of a broad range of nucleic acids. Nucleic Acids Res, 2005. 33(9): p. e86.
Godbey, W.T., et al., Improved packing of poly(ethylenimine)/DNA complexes
increases transfection efficiency. Gene Ther, 1999. 6(8): p. 1380-8.

197

80.

81.

82.

83.

84.
85.

86.
87.
88.
89.
90.
91.

92.
93.

94.

Fahrmeir, J., et al., Electrophoretic purification of tumor-targeted
polyethylenimine-based polyplexes reduces toxic side effects in vivo. J Control
Release, 2007. 122(3): p. 236-45.
Tseng, W.C., F.R. Haselton, and T.D. Giorgio, Mitosis enhances transgene
expression of plasmid delivered by cationic liposomes. Biochim Biophys Acta,
1999. 1445(1): p. 53-64.
Varga, C.M., et al., Quantitative comparison of polyethylenimine formulations
and adenoviral vectors in terms of intracellular gene delivery processes. Gene
Ther, 2005. 12(13): p. 1023-32.
Tseng, W.C., F.R. Haselton, and T.D. Giorgio, Transfection by cationic liposomes
using simultaneous single cell measurements of plasmid delivery and transgene
expression. J Biol Chem, 1997. 272(41): p. 25641-7.
Varga, C.M., K. Hong, and D.A. Lauffenburger, Quantitative analysis of synthetic
gene delivery vector design properties. Mol Ther, 2001. 4(5): p. 438-46.
Fernandez-Tarrio, M., et al., Pluronic and tetronic copolymers with
polyglycolyzed oils as self-emulsifying drug delivery systems. AAPS
PharmSciTech, 2008. 9(2): p. 471-9.
De Laporte, L., J. Cruz Rea, and L.D. Shea, Design of modular non-viral gene
therapy vectors. Biomaterials, 2006. 27(7): p. 947-54.
Hoffman, A.S., Hydrogels for biomedical applications. Adv Drug Deliv Rev,
2002. 54(1): p. 3-12.
Hubbell, J.A., Biomaterials in tissue engineering. Biotechnology (N Y), 1995.
13(6): p. 565-76.
Luten, J., et al., Biodegradable polymers as non-viral carriers for plasmid DNA
delivery. J Control Release, 2008. 126(2): p. 97-110.
Jang, J.H. and L.D. Shea, Controllable delivery of non-viral DNA from porous
scaffolds. J Control Release, 2003. 86(1): p. 157-68.
Jang, J.H., C.B. Rives, and L.D. Shea, Plasmid delivery in vivo from porous
tissue-engineering scaffolds: transgene expression and cellular transfection. Mol
Ther, 2005. 12(3): p. 475-83.
Cohen-Sacks, H., et al., Delivery and expression of pDNA embedded in collagen
matrices. J Control Release, 2004. 95(2): p. 309-20.
Mooney, D.J., et al., Novel approach to fabricate porous sponges of poly(D,Llactic-co-glycolic acid) without the use of organic solvents. Biomaterials, 1996.
17(14): p. 1417-22.
Harris, L.D., B.S. Kim, and D.J. Mooney, Open pore biodegradable matrices
formed with gas foaming. J Biomed Mater Res, 1998. 42(3): p. 396-402.

198

95.
96.
97.

98.
99.
100.

101.

102.
103.
104.

105.

106.

107.

108.
109.

Dang, J.M. and K.W. Leong, Natural polymers for gene delivery and tissue
engineering. Adv Drug Deliv Rev, 2006. 58(4): p. 487-99.
Fang, J., et al., Stimulation of new bone formation by direct transfer of osteogenic
plasmid genes. Proc Natl Acad Sci U S A, 1996. 93(12): p. 5753-8.
Tyrone, J.W., et al., Collagen-embedded platelet-derived growth factor DNA
plasmid promotes wound healing in a dermal ulcer model. J Surg Res, 2000.
93(2): p. 230-6.
Doukas, J., et al., Matrix immobilization enhances the tissue repair activity of
growth factor gene therapy vectors. Hum Gene Ther, 2001. 12(7): p. 783-98.
Chandler, L.A., et al., Matrix-enabled gene transfer for cutaneous wound repair.
Wound Repair Regen, 2000. 8(6): p. 473-9.
Ochiya, T., et al., New delivery system for plasmid DNA in vivo using
atelocollagen as a carrier material: the Minipellet. Nat Med, 1999. 5(6): p. 70710.
Chandler, L.A., et al., FGF2-Targeted adenovirus encoding platelet-derived
growth factor-B enhances de novo tissue formation. Mol Ther, 2000. 2(2): p. 15360.
Berry, M., et al., Sustained effects of gene-activated matrices after CNS injury.
Mol Cell Neurosci, 2001. 17(4): p. 706-16.
Ochiya, T., et al., Biomaterials for gene delivery: atelocollagen-mediated
controlled release of molecular medicines. Curr Gene Ther, 2001. 1(1): p. 31-52.
Kyriakides, T.R., et al., Regulation of angiogenesis and matrix remodeling by
localized, matrix-mediated antisense gene delivery. Mol Ther, 2001. 3(6): p. 8429.
Fukunaka, Y., et al., Controlled release of plasmid DNA from cationized gelatin
hydrogels based on hydrogel degradation. J Control Release, 2002. 80(1-3): p.
333-43.
Kushibiki, T., et al., In vivo release and gene expression of plasmid DNA by
hydrogels of gelatin with different cationization extents. J Control Release, 2003.
90(2): p. 207-16.
Kushibiki, T., et al., Controlled release of plasmid DNA from hydrogels prepared
from gelatin cationized by different amine compounds. J Control Release, 2006.
112(2): p. 249-56.
Yamamoto, M. and Y. Tabata, Tissue engineering by modulated gene delivery.
Adv Drug Deliv Rev, 2006. 58(4): p. 535-54.
Guo, T., et al., Porous chitosan-gelatin scaffold containing plasmid DNA
encoding transforming growth factor-beta1 for chondrocytes proliferation.
Biomaterials, 2006. 27(7): p. 1095-103.

199

110.

111.

112.
113.
114.
115.
116.

117.

118.

119.

120.

121.
122.
123.

124.

Megeed, Z., J. Cappello, and H. Ghandehari, Controlled release of plasmid DNA
from a genetically engineered silk-elastinlike hydrogel. Pharm Res, 2002. 19(7): p.
954-9.
Megeed, Z., J. Cappello, and H. Ghandehari, Genetically engineered silkelastinlike protein polymers for controlled drug delivery. Adv Drug Deliv Rev,
2002. 54(8): p. 1075-91.
Megeed, Z., et al., In vitro and in vivo evaluation of recombinant silk-elastinlike
hydrogels for cancer gene therapy. J Control Release, 2004. 94(2-3): p. 433-45.
Meilander-Lin, N.J., et al., Sustained in vivo gene delivery from agarose hydrogel
prolongs nonviral gene expression in skin. Tissue Eng, 2005. 11(3-4): p. 546-55.
des Rieux, A., A. Shikanov, and L.D. Shea, Fibrin hydrogels for non-viral vector
delivery in vitro. J Control Release, 2009. 136(2): p. 148-54.
Kong, H.J., et al., Design of biodegradable hydrogel for the local and sustained
delivery of angiogenic plasmid DNA. Pharm Res, 2008. 25(5): p. 1230-8.
Sawhney, A.S., C.P. Pathak, and J.A. Hubbell, Bioerodible hydrogels based on
photopolymerized poly(ethylene glycol)-co-poly(.alpha.-hydroxy acid) diacrylate
macromers. Macromolecules, 1993. 26(4): p. 581-587.
Metters, A.T., C.N. Bowman, and K.S. Anseth, A Statistical Kinetic Model for the
Bulk Degradation of PLA-b-PEG-b-PLA Hydrogel Networks. Journal of Physical
Chemistry B (J. Phys. Chem. B), 2000. 104(30): p. 7043-7049.
Quick, D.J. and K.S. Anseth, Gene delivery in tissue engineering: a photopolymer
platform to coencapsulate cells and plasmid DNA. Pharm Res, 2003. 20(11): p.
1730-7.
Quick, D.J. and K.S. Anseth, DNA delivery from photocrosslinked PEG hydrogels:
encapsulation efficiency, release profiles, and DNA quality. J Control Release,
2004. 96(2): p. 341-51.
Quick, D.J., K.K. Macdonald, and K.S. Anseth, Delivering DNA from
photocrosslinked, surface eroding polyanhydrides. J Control Release, 2004. 97(2):
p. 333-43.
Wieland, J.A., T.L. Houchin-Ray, and L.D. Shea, Non-viral vector delivery from
PEG-hyaluronic acid hydrogels. J Control Release, 2007. 120(3): p. 233-41.
Chun, K.W., et al., Controlled release of plasmid DNA from photo-cross-linked
pluronic hydrogels. Biomaterials, 2005. 26(16): p. 3319-26.
Temenoff, J.S., F.K. Kasper, and A.G. Mikos, Fumarate-based macromers as
scaffolds for tissue engineering applications, in Topics in Tissue engineering, N.
Ashammakhi, R. Reis, and E. Chiellini, Editors. 2007.
Jo, S., et al., Synthesis and Characterization of Oligo(poly(ethylene glycol)
fumarate) Macromer. Macromolecules, 2001. 34(9): p. 2839-2844.

200

125.

126.

127.
128.

129.
130.

131.
132.
133.
134.
135.

136.
137.
138.
139.

Temenoff, J.S., et al., Effect of poly(ethylene glycol) molecular weight on tensile
and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for
cartilage tissue engineering. Journal of Biomedical Materials Research (J Biomed
Mater Res), 2002. 59(3): p. 429-437.
Kasper, F.K., et al., Characterization of DNA release from composites of
oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro.
Journal of Biomedical Materials Research (J Biomed Mater Res), 2006. 78A(4): p.
823-835.
Kasper, F.K., et al., In vitro release of plasmid DNA from oligo(poly(ethylene
glycol) fumarate) hydrogels. J Control Release, 2005. 104(3): p. 521-39.
Huang, Y.C., et al., Long-term in vivo gene expression via delivery of PEI-DNA
condensates from porous polymer scaffolds. Hum Gene Ther, 2005. 16(5): p. 60917.
De Laporte, L., et al., Plasmid releasing multiple channel bridges for transgene
expression after spinal cord injury. Mol Ther, 2009. 17(2): p. 318-26.
De Laporte, L., A.L. Yan, and L.D. Shea, Local gene delivery from ECM-coated
poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury.
Biomaterials, 2009. 30(12): p. 2361-8.
Rives, C.B., et al., Layered PLG scaffolds for in vivo plasmid delivery.
Biomaterials, 2009. 30(3): p. 394-401.
Salvay, D.M. and L.D. Shea, Inductive tissue engineering with protein and DNAreleasing scaffolds. Mol Biosyst, 2006. 2(1): p. 36-48.
Ziauddin, J. and D.M. Sabatini, Microarrays of cells expressing defined cDNAs.
Nature, 2001. 411(6833): p. 107-10.
Bengali, Z. and L.D. Shea, Gene Delivery by Immobilization to Cell-Adhesive
Substrates. MRS Bull, 2005. 30(9): p. 659-662.
Segura, T., M.J. Volk, and L.D. Shea, Substrate-mediated DNA delivery: role of
the cationic polymer structure and extent of modification. J Control Release, 2003.
93(1): p. 69-84.
Segura, T., et al., Crosslinked hyaluronic acid hydrogels: a strategy to
functionalize and pattern. Biomaterials, 2005. 26(4): p. 359-71.
Bengali, Z., et al., Gene delivery through cell culture substrate adsorbed DNA
complexes. Biotechnol Bioeng, 2005. 90(3): p. 290-302.
Jang, J.H., et al., Surface adsorption of DNA to tissue engineering scaffolds for
efficient gene delivery. J Biomed Mater Res A, 2006. 77(1): p. 50-8.
Houchin-Ray, T., K.J. Whittlesey, and L.D. Shea, Spatially patterned gene
delivery for localized neuron survival and neurite extension. Mol Ther, 2007.
15(4): p. 705-12.

201

140.

141.

142.

143.
144.
145.
146.
147.
148.
149.
150.

151.

152.

153.

154.

Pannier, A.K., B.C. Anderson, and L.D. Shea, Substrate-mediated delivery from
self-assembled monolayers: effect of surface ionization, hydrophilicity, and
patterning. Acta Biomater, 2005. 1(5): p. 511-22.
Pannier, A.K., J.A. Wieland, and L.D. Shea, Surface polyethylene glycol enhances
substrate-mediated gene delivery by nonspecifically immobilized complexes. Acta
Biomater, 2008. 4(1): p. 26-39.
Erbacher, P., et al., Transfection and physical properties of various saccharide,
poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene
Med, 1999. 1(3): p. 210-22.
Lai, E. and J.H. van Zanten, Real time monitoring of lipoplex molar mass, size
and density. J Control Release, 2002. 82(1): p. 149-58.
Anchordoquy, T.J. and G.S. Koe, Physical stability of nonviral plasmid-based
therapeutics. J Pharm Sci, 2000. 89(3): p. 289-96.
Anchordoquy, T.J., et al., Physical stabilization of DNA-based therapeutics. Drug
Discov Today, 2001. 6(9): p. 463-470.
Lyscov, V.N. and Y. Moshkovsky, DNA cryolysis. Biochim Biophys Acta, 1969.
190(1): p. 101-10.
Anchordoquy, T.J., et al., Stability of lipid/DNA complexes during agitation and
freeze-thawing. J Pharm Sci, 1998. 87(9): p. 1046-51.
Crowe, J.H., et al., Stabilization of dry phospholipid bilayers and proteins by
sugars. Biochem J, 1987. 242(1): p. 1-10.
Allison, S.D. and T.J. Anchordoquy, Mechanisms of protection of cationic lipidDNA complexes during lyophilization. J Pharm Sci, 2000. 89(5): p. 682-91.
Allison, S.D., M.C. Molina, and T.J. Anchordoquy, Stabilization of lipid/DNA
complexes during the freezing step of the lyophilization process: the particle
isolation hypothesis. Biochim Biophys Acta, 2000. 1468(1-2): p. 127-38.
Armstrong, T.K., L.G. Girouard, and T.J. Anchordoquy, Effects of PEGylation on
the preservation of cationic lipid/DNA complexes during freeze-thawing and
lyophilization. J Pharm Sci, 2002. 91(12): p. 2549-58.
Crowe, J.H., B.J. Spargo, and L.M. Crowe, Preservation of dry liposomes does
not require retention of residual water. Proc Natl Acad Sci U S A, 1987. 84(6): p.
1537-40.
Crowe, J.H., L.M. Crowe, and D. Chapman, Preservation of Membranes in
Anhydrobiotic Organisms: The Role of Trehalose. Science, 1984. 223(4637): p.
701-703.
Koping-Hoggard, M., et al., Improved chitosan-mediated gene delivery based on
easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene
Ther, 2004. 11(19): p. 1441-52.

202

155.
156.

157.
158.

159.

160.
161.

162.
163.
164.
165.

166.

167.

168.

Ferrari, S., et al., ExGen 500 is an efficient vector for gene delivery to lung
epithelial cells in vitro and in vivo. Gene Ther, 1997. 4(10): p. 1100-6.
Boussif, O., et al., A versatile vector for gene and oligonucleotide transfer into
cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A, 1995.
92(16): p. 7297-301.
Godbey, W.T., K.K. Wu, and A.G. Mikos, Poly(ethylenimine) and its role in gene
delivery. J Control Release, 1999. 60(2-3): p. 149-60.
Molina, M.C., S.D. Allison, and T.J. Anchordoquy, Maintenance of nonviral
vector particle size during the freezing step of the lyophilization process is
insufficient for preservation of activity: insight from other structural indicators. J
Pharm Sci, 2001. 90(10): p. 1445-55.
Brus, C., et al., Stabilization of oligonucleotide-polyethylenimine complexes by
freeze-drying: physicochemical and biological characterization. J Control
Release, 2004. 95(1): p. 119-31.
Talsma, H., et al., Stabilization of gene delivery systems by freeze-drying. Int J
Pharm, 1997. 157(2): p. 233-238.
Reinisalo, M., A. Urtti, and P. Honkakoski, Freeze-drying of cationic polymer
DNA complexes enables their long-term storage and reverse transfection of postmitotic cells. J Control Release, 2006. 110(2): p. 437-43.
Davis, K.A. and K.S. Anseth, Controlled release from crosslinked degradable
networks. Crit Rev Ther Drug Carrier Syst, 2002. 19(4-5): p. 385-423.
Drury, J.L. and D.J. Mooney, Hydrogels for tissue engineering: scaffold design
variables and applications. Biomaterials, 2003. 24(24): p. 4337-51.
Elisseeff, J., et al., Advances in skeletal tissue engineering with hydrogels. Orthod
Craniofac Res, 2005. 8(3): p. 150-61.
Obara, K., et al., Photocrosslinkable chitosan hydrogel containing fibroblast
growth factor-2 stimulates wound healing in healing-impaired db/db mice.
Biomaterials, 2003. 24(20): p. 3437-44.
Taylor, S.J., J.W. McDonald, 3rd, and S.E. Sakiyama-Elbert, Controlled release
of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release, 2004.
98(2): p. 281-94.
Sakiyama-Elbert, S.E. and J.A. Hubbell, Controlled release of nerve growth
factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control
Release, 2000. 69(1): p. 149-58.
Wallace, D.G. and J. Rosenblatt, Collagen gel systems for sustained delivery and
tissue engineering. Adv Drug Deliv Rev, 2003. 55(12): p. 1631-49.

203

169.

170.

171.

172.
173.
174.

175.

176.

177.

178.

179.
180.

181.

Nuttelman, C.R., S.M. Henry, and K.S. Anseth, Synthesis and characterization of
photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering
scaffolds. Biomaterials, 2002. 23(17): p. 3617-26.
Martens, P.J., S.J. Bryant, and K.S. Anseth, Tailoring the degradation of
hydrogels formed from multivinyl poly(ethylene glycol) and poly(vinyl alcohol)
macromers for cartilage tissue engineering. Biomacromolecules, 2003. 4(2): p.
283-92.
Martens, P.J., C.N. Bowman, and K.S. Anseth, Degradable networks formed from
multi-functional poly(vinyl alcohol) macromers: comparison of results from a
generalized bulk-degradation model for polymer networks and experimental data.
Polymer (Polymer), 2004. 45(10): p. 3377-3387.
Wang, D.A., et al., Synthesis and characterization of a novel degradable
phosphate-containing hydrogel. Biomaterials, 2003. 24(22): p. 3969-80.
Elbert, D.L., et al., Protein delivery from materials formed by self-selective
conjugate addition reactions. J Control Release, 2001. 76(1-2): p. 11-25.
Metters, A. and J. Hubbell, Network formation and degradation behavior of
hydrogels formed by Michael-type addition reactions. Biomacromolecules, 2005.
6(1): p. 290-301.
Vyavahare, N.R., M.G. Kulkarni, and R.A. Mashelkar, Matrix systems for zeroorder release : facile erosion of crosslinked hydrogels. Polymer (Polymer), 1992.
33(3): p. 593-599 (20 ref.).
Hern, D.L. and J.A. Hubbell, Incorporation of adhesion peptides into nonadhesive
hydrogels useful for tissue resurfacing. J Biomed Mater Res, 1998. 39(2): p. 26676.
Lin, C.C. and A.T. Metters, Enhanced protein delivery from photopolymerized
hydrogels using a pseudospecific metal chelating ligand. Pharm Res, 2006. 23(3):
p. 614-22.
Park, K., et al., Surface modification of biodegradable electrospun nanofiber
scaffolds and their interaction with fibroblasts. J Biomater Sci Polym Ed, 2007.
18(4): p. 369-82.
DILSIZ, N., Plasma surface modification of carbon fibers: a review. J. Adhesion
Sci. Technol., 2000. 14(7): p. 975-987.
Lee, S.D., et al., Plasma-induced grafted polymerization of acrylic acid and
subsequent grafting of collagen onto polymer film as biomaterials. Biomaterials,
1996. 17(16): p. 1599-608.
Shaffer, C.B. and F.H. Critchfield, The absorption and excretion of the solid
polyethylene glycols ("carbowax" compounds). J Am Pharm Assoc, 1947. 36: p.
152-157.

204

182.

183.

184.
185.
186.
187.

188.
189.

190.
191.

192.

193.

194.

195.

Kutty, J.K., et al., The effect of hyaluronic acid incorporation on fibroblast
spreading and proliferation within PEG-diacrylate based semi-interpenetrating
networks. Biomaterials, 2007. 28(33): p. 4928-38.
Shah, N.M., M.D. Pool, and A.T. Metters, Influence of network structure on the
degradation of photo-cross-linked PLA-b-PEG-b-PLA hydrogels.
Biomacromolecules, 2006. 7(11): p. 3171-7.
Schoenmakers, R.G., et al., The effect of the linker on the hydrolysis rate of druglinked ester bonds. J Control Release, 2004. 95(2): p. 291-300.
West, J.L. and J.A. Hubbell, Photopolymerized hydrogel materials for drugdelivery applicatioins. React Polym, 1995. 25: p. 139-147.
Mason, M.N., et al., Predicting controlled-release behavior of degradable PLA-bPEG-b-PLA hydrogels. Macromolecules, 2001. 34: p. 4630-4635.
Alvarez-Lorenzo, C., et al., Tetronic micellization, gelation and drug
solubilization: Influence of pH and ionic strength. Eur J Pharm Biopharm, 2007.
66(2): p. 244-52.
Missirlis, D., et al., Doxorubicin encapsulation and diffusional release from
stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci, 2006. 29(2): p. 120-9.
Fernandez-Tarrio, M., C. Alvarez-Lorenzo, and A. Concheiro, Calorimetric
approach to tetronic/water interactions. J. Ther. Anal. Calorimetry, 2007. 87: p.
171-178.
Roques, C., Y. Fromes, and E. Fattal, Hydrosoluble polymers for muscular gene
delivery. Eur J Pharm Biopharm, 2009. 72(2): p. 378-90.
Armstrong, J.K., et al., The effect of pH and concentration upon aggregation
transitions in aqueous solutions of poloxamine T701. Int J Pharm, 2001. 229(1-2):
p. 57-66.
Habas, J.P., et al., Nanostructure in block copolymer solutions: rheology and
small-angle neutron scattering. Phys Rev E Stat Nonlin Soft Matter Phys, 2004.
70(6 Pt 1): p. 061802.
Cellesi, F., N. Tirelli, and J.A. Hubbell, Towards a fully-synthetic substitute of
alginate: development of a new process using thermal gelation and chemical
cross-linking. Biomaterials, 2004. 25(21): p. 5115-24.
Perreur, C., et al., Determination of the structure of the organized phase of the
block copolymer PEO-PPO-PEO in aqueous solutions under flow by small-angle
neutron scattering. Phys Rev E Stat Nonlin Soft Matter Phys, 2002. 65(4 Pt 1): p.
041802.
Gonzalez-Lopez, J., et al., Self-associative behavior and drug-solubilizing ability
of poloxamine (tetronic) block copolymers. Langmuir, 2008. 24(19): p. 10688-97.

205

196.
197.

198.
199.
200.

201.

202.

203.

204.

205.
206.
207.
208.
209.

Prokop, A., et al., Maximizing the in vivo efficiency of gene transfer by means of
nonviral polymeric gene delivery vehicles. J Pharm Sci, 2002. 91(1): p. 67-76.
Chiappetta, D.A., et al., Triclosan-loaded poloxamine micelles for enhanced
topical antibacterial activity against biofilm. Eur J Pharm Biopharm, 2008. 69(2):
p. 535-45.
Jeong, B., S.W. Kim, and Y.H. Bae, Thermosensitive sol-gel reversible hydrogels.
Adv Drug Deliv Rev, 2002. 54(1): p. 37-51.
He, C., S.W. Kim, and D.S. Lee, In situ gelling stimuli-sensitive block copolymer
hydrogels for drug delivery. J Control Release, 2008. 127(3): p. 189-207.
Cellesi, F. and N. Tirelli, A new process for cell microencapsulation and other
biomaterial applications: Thermal gelation and chemical cross-linking in
"tandem". J Mater Sci Mater Med, 2005. 16(6): p. 559-65.
Cellesi, F., et al., Towards a fully synthetic substitute of alginate: optimization of
a thermal gelation/chemical cross-linking scheme ("tandem" gelation) for the
production of beads and liquid-core capsules. Biotechnol Bioeng, 2004. 88(6): p.
740-9.
Chiappetta, D.A. and A. Sosnik, Poly(ethylene oxide)-poly(propylene oxide) block
copolymer micelles as drug delivery agents: improved hydrosolubility, stability
and bioavailability of drugs. Eur J Pharm Biopharm, 2007. 66(3): p. 303-17.
Oh, K.T., T.K. Bronich, and A.V. Kabanov, Micellar formulations for drug
delivery based on mixtures of hydrophobic and hydrophilic Pluronic block
copolymers. J Control Release, 2004. 94(2-3): p. 411-22.
Alexandridis, P., et al., Surface activity of poly(ethylene oxide)-blockpoly(propylene oxide)-block-poly(ethylene oxide) copolymers. Langmuir, 1994.
10: p. 2604-2612.
Lutolf, M.P., et al., Systematic modulation of Michael-type reactivity of thiols
through the use of charged amino acids. Bioconjug Chem, 2001. 12(6): p. 1051-6.
Solovieva, M.E., et al., Vitamin B12b enhances the cytotoxicity of dithiothreitol.
Free Radic Biol Med, 2008. 44(10): p. 1846-56.
Wallace, D.G., et al., A tissue sealant based on reactive multifunctional
polyethylene glycol. J Biomed Mater Res, 2001. 58(5): p. 545-55.
Arote, R., et al., A biodegradable poly(ester amine) based on polycaprolactone
and polyethylenimine as a gene carrier. Biomaterials, 2007. 28(4): p. 735-44.
Park, M.R., et al., Highly efficient gene transfer with degradable poly(ester amine)
based on poly(ethylene glycol) diacrylate and polyethylenimine in vitro and in
vivo. J Gene Med, 2008. 10(2): p. 198-207.

206

210.

211.
212.
213.
214.
215.
216.

217.
218.

219.
220.
221.

222.

223.
224.

Forrest, M.L., J.T. Koerber, and D.W. Pack, A degradable polyethylenimine
derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem,
2003. 14(5): p. 934-40.
Pitard, B., et al., Negatively charged self-assembling DNA/poloxamine
nanospheres for in vivo gene transfer. Nucleic Acids Res, 2004. 32(20): p. e159.
Richard, P., et al., Amphiphilic block copolymers promote gene delivery in vivo to
pathological skeletal muscles. Hum Gene Ther, 2005. 16(11): p. 1318-24.
Tooney, N.M., et al., Solution and surface effects on plasma fibronectin structure.
J Cell Biol, 1983. 97(6): p. 1686-92.
Benecky, M.J., et al., Ionic-strength- and pH-dependent conformational states of
human plasma fibronectin. Biochemistry, 1991. 30(17): p. 4298-306.
Williams, E.C., et al., Conformational states of fibronectin. Effects of pH, ionic
strength, and collagen binding. J Biol Chem, 1982. 257(24): p. 14973-8.
Shu, X.Z., et al., Attachment and spreading of fibroblasts on an RGD peptidemodified injectable hyaluronan hydrogel. J Biomed Mater Res A, 2004. 68(2): p.
365-75.
Groll, J., et al., A novel star PEG-derived surface coating for specific cell
adhesion. J Biomed Mater Res A, 2005. 74(4): p. 607-17.
Burdick, J.A. and K.S. Anseth, Photoencapsulation of osteoblasts in injectable
RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials, 2002.
23(22): p. 4315-23.
Xu, H., et al., Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified
with cleavable PEG-lipid derivatives. J Control Release, 2008. 130(3): p. 238-45.
Pitarresi, G., et al., A new biodegradable and biocompatible hydrogel with
polyaminoacid structure. Int J Pharm, 2007. 335(1-2): p. 130-7.
Tsai, M.F., et al., Characterization of hydrogels prepared from copolymerization
of the different degrees of methacrylate-grafted chondroitin sulfate macromers
and acrylic acid. J Biomed Mater Res A, 2008. 84(3): p. 727-39.
Moghimi, S.M. and A.C. Hunter, Poloxamers and poloxamines in nanoparticle
engineering and experimental medicine. Trends Biotechnol, 2000. 18(10): p. 41220.
Kanjickal, D., et al., Effects of sterilization on poly(ethylene glycol) hydrogels. J
Biomed Mater Res A, 2008. 87(3): p. 608-17.
Eljarrat-Binstock, E., et al., Preparation, characterization, and sterilization of
hydrogel sponges for iontophoretic drug-delivery use. Polymers for advanced
technologies, 2007. 18(9): p. 720-730.

207

